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 Abstract 
 
As early biological responses to foreign objects in the body can be influenced by 
their bound proteins, the nanomaterial hard protein corona (the collection of slow 
exchange proteins that associate with nanomaterials) is an emerging area of 
interest in nanotoxicology.  There is a limited but growing appreciation of the role 
these interactions have in influencing nanomaterial toxicity.  
 
This research dealt with (i) the characterisation of iron oxide and silica particles 
with and without a plasma, serum and lung lining fluid protein hard corona, (ii) 
the identification of the proteins in the hard corona that associate with the 
particles and (iii) the effect of the hard corona on influencing particle cytotoxicity 
in a J774.A1 macrophage cell line. 
 
Initial investigation of the particles illustrates the advantages in using a variety of 
characterisation techniques to better elucidate particle properties.  Subsequent 
characterisation of the hard corona protein profile demonstrated a clear difference 
in the biological identity of the particles in a plasma, serum and in a lung lining 
fluid corona.  Although it is difficult to associate the impact of any individual 
protein identified in the hard corona to cytotoxicity this study indicates that the 
binding of proteins plays a significant role in altering the cytotoxic potential (as 
determined by LDH release) in macrophages.  The work also demonstrates the 
hard corona has an impact on macrophage chemotaxis, which further strengthens 
the hypothesis that the corona is a key consideration in nanoparticle toxicity.  
 
Ultimately this thesis finds that the nanomaterial hard corona is an important 
element to consider in experimental design and highlights the concept of creating 
particle preparation protocols to mimic the corona composition in vivo when 
examining in vitro cellular responses.  This research highlights the implications 
for interpretation of data from in vitro cell culture tests that do not take the protein 
corona into consideration.  
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Chapter 1  Introduction 
 
1.1 Nanotechnology and Nanomaterials  
 
The ‘nano-revolution’ that nominally began with the Feynman Lecture of 1959 
‘Plenty of room at the bottom’ [2] has progressed considerably in the last fifty 
years. Today the applications of nanotechnology represent a vast potential for 
innovation. The ability to design at the nanoscale, to create tailor made 
nanomaterials (NMs) means technology can be developed to have real and 
significant socioeconomic, health and environmental benefits.  The current state 
of nanotechnology is a long way from the promise of what the technology holds 
(to transform communications, in medical diagnostics and treatments, the way 
energy is generated, the way all our materials, consumer goods and food are 
manufactured, etc.) but one sector of nanotechnology that is progressing rapidly is 
the production of engineered nanoparticles (NPs) and NMs. 
 
According to the European Commission’s definition a “nanomaterial” refers to 
any ‘natural, incidental or manufactured material containing particles, in an 
unbound state or as an aggregate or as an agglomerate and where, for 50% or 
more of the particles in the number size distribution, one or more external 
dimensions is in the size range 1nm – 100nm’[3].  Clearly this definition focuses 
on the size criterion as opposed to other nano specific properties of NMs.  The 
purpose of such a definition which applies to a heterogeneous set of materials is 
primarily to have consistent terminology. From a scientific context this is 
important to allow consistency across the published literature, it is also important 
in a legal context.  Size is a measurable criterion can be applied to all NMs. It is 
an evolving definition and it will be reviewed again by the European Commission 
in 2014.  The definition differs subtly from the definition of a NP, in that NPs are 
distinct entities which have one or more dimensions of the order of 100nm or less 
[4].  When materials are synthesized at the nanoscale their properties often change 
in comparison to larger particles - for example, the magnetism of iron NMs can be 
greatly enhanced in the nano scale as opposed to their bulk form [5], the large 
surface area of nano silica gives them superior absorbent properties [6] and gold 
NMs have enhanced optical properties at the nanoscale.   
2 
 
These unique properties make NMs useful in developing new materials with 
applications in almost every sector of the world’s economy (see figure 1.1).  For 
example, NMs are used in healthcare (magnetic resonance imaging and anticancer 
treatments [7]), in consumer products (see figure 1.2), in the electronics and 
construction industry (sensors and creation of durable light weight resistance 
materials [8]), in the food industry [9], in environmental remediation [10] and in 
the energy sector (efficient energy storage) [11].  
 
NMs have occurred in the environment for millennia as they can be generated in a 
wide variety of biogenic processes, for example, biological synthesis by bacteria, 
geological processes such as the generation of volcanic ash and anthropogenic 
processes such as industrial or combustion derived and manufactured/engineered  
NMs.  While we have been exposed to NMs for a long time the types and routes 
of this exposure have been limited, however today increasing production and use 
of a wide variety of NMs that vary in composition and physicochemical 
characteristics are raising concerns about the impact of engineered NMs on human 
health and in the environment [12]. 
 
 
Figure 1.1: The applications of nanomaterials in a diverse range of 
fields (source: Tsuzuki 2009[13]). 
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There is still a lot of uncertainty on the quantities of NMs being manufactured 
globally.  A recent report by the European Commission (EC) shows that the main 
NMs on the market today include carbon based NMs, metallic and non metallic 
NMs, organic NMs, and composites.  Table 1.2 shows the quantities produced 
annually by tonnage as reported by the EC’s staff working paper on the types and 
uses of NMs [14]. 
 
Table 1.1: Global quantities of nanomaterials produced annually as reported 
in European Commission’s report on ‘types and uses of nanomaterials’[14]. 
 
NM Produced Per Year Tonnage 
Global Quantity  11.5 million  
Carbon Black (CB) 9.6 million  
Amorphous Silica 1.5 million  
Aluminium Oxide 200,000  
Barium Titanate 15,000  
Titanium Dioxide 10,000 t 
Cerium Oxide  10,000 
Zinc Oxide 8,000 
Carbon Nanotubes(CNTs)/Nanofiber  >100 tonnes 
Nanosilver 20 tonnes 
 
Many of the current applications of NMs are in consumer products.  According to 
the Inventory of Nanotechnology over 1000 products containing NMs are now on 
the market [15]. Figure 1.2 illustrates how the number of products available 
continues to increase steadily over the years, tripling in number from 2006 - 2009.  
It is expected that the widespread and expanding use of NMs will result in 
increased human and environmental exposure [16]. 
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Figure 1.2: The number of consumer products on the market 
incorporating NMs from 2006 – 2011 [15]. 
 
These projections on global production and availability of NMs are compounded 
by a lack of regulatory guidelines in dealing with new novel NMs.  Increasing 
mass production and use of NMs will likely lead to their appearance in the 
environment, air, water, soil and organisms, which in turn raises concern 
regarding potential human exposure and environmental contamination.  
Awareness is increasing and studies are being published in a diverse range of 
journals at an accelerated and unprecedented rate as can be seen in figure 1.3.  
 
 
 
Figure 1.3: Review of articles (from Science Direct, Web of Science and 
Scopus) spanning from 1970 to 2011 searching the terms 
nanotoxicology, nanotoxicity and nanoparticles) n increase in the 
amount of published articles can be seen from nineteen ninety onwards. 
The numbers from the earlier decades may be underestimated as they 
would not include ultrafine particle literature due to the nano specific 
search terms used.  
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If the promise of nanotechnology is to be realised it is important to address the 
questions of health and environmental risks.  There is still a considerable amount 
of uncertainty regarding how NMs behave in biological systems.  An ever 
increasing amount of in vitro studies find NMs of many types in various 
treatments are taken up by a wide variety of mammalian cell types (e.g. 
hepatocytes, macrophages, fibroblasts, epithelial cells, red blood cells [17-20] and 
in vivo studies show evidence that NMs, due to their nanoscale size, can cross 
barriers from lungs and the gastrointestinal tract into the blood stream and migrate 
to other parts of the body such as the liver [21-24].  NMs have been shown to lead 
the production of reactive oxygen species (ROS - see section 1.2.).  Such events 
can lead to altered cell signalling [25] causing enhanced transcription of defence 
genes, inflammation and activation of apoptotic pathways or necrosis.  It is 
important to address potential exposure now while production of these materials is 
still relatively low, to mitigate any potential long term risks.  A further 
understanding of how NMs are taken up in the body, how they are distributed, 
how they stimulate an immune response and how they are cleared from the body 
is essential, as this research will maximise the potential of engineered NMs. 
 
1.2 Nanotoxicity 
 
The study of the toxicity of NMs or nanotoxicity has evolved from the knowledge 
gained from particulate toxicology and from research in air pollution studies - 
focusing on respirable and atmospheric particulate matter or ultra-fine particles 
[22].  Ultra fine particles defined as particles less than 100nm are nano sized 
however; they are generally not manufactured intentionally and typically are not 
of a uniform size or composition. Particulate toxicology has a long history dating 
back to the middle ages where writings observing lung health in miners were first 
recorded by Paracelsus (1493 -1541) and Agricola (1494–1555) [26].  It was 
becoming apparent in the late  1900’s that air pollution could be associated with 
adverse effects and by the late 1990’s epidemiology evidence had proven that 
ambient air particle exposure lead to disease and mortality [27].  More recently 
research on biopersistent synthetic vitreous fibres and naturally occurring fibres 
such as asbestos has shown modern particle toxicology to be a multidisciplinary 
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science which ultimately aims to relate particle characteristics to 
pathological/physiological effects.  
 
Today we know that it is the smallest fractions of atmospheric particulate matter 
(i.e. solid or liquid particles found in the air) such as particulate matter 2.5µm or 
less in size and ultra fine particles which are the most toxic on a per mass basis 
and an increase in particulate matter has been found to correlate with morbidity 
and mortality from cardiovascular and respiratory causes in humans [28-31].  This 
has led to the ‘ultrafine hypothesis’ that very small particles can be associated 
with distinct biological effects [28].  There are potentially various toxicological 
mechanisms by which particles exert their effect which of course will depend on 
exposure, the particle type (shape and chemistry), the initial deposition site and 
translocation.  Pathological paradigms of particle toxicity have evolved to include 
physical (penetration), biological (phagocytosis, inflammation, cell signalling) as 
well as chemical processes (free radical production and oxidative stress) [32-34].  
Nanotoxicology must now evolve to consider additional factors such as 
translocation from the lung into the blood/potential target organs and the effect of 
surface area for a wide range of ever increasing novel materials.  It has been 
suggested that the ultrafine paradigm of particle toxicology may also be 
applicable to NMs and thus the emergence of nanotoxicology as a discipline 
essentially follows on from the well-established particle toxicology field. 
 
1.2.1 Mechanisms of Toxicity 
 
Tissues, cells and organs have well defined ways in which they react to any 
exposure.  In nanotoxicology areas of interest include, (i) the association of NMs 
with cells - how they interact with cell membranes at the bio-nano interface and 
their uptake into cells, (ii) direct toxicological effects such as the production of 
free radicals and oxidative stress, (iii) indirect effects such as the ability of 
reactive oxygen species (ROS) to induce inflammation and (iv) damage to DNA 
or genotoxic potential is also a concern as it is known that some low soluble 
fibres/particles such as asbestos and crystalline silica are known carcinogens [35, 
36] 
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1.2.1.1 Interaction of Nanomaterials with Cells  
 
The fate of NMs in the body will depend not only on the physicochemical 
properties of the NMs but also on the forces acting in the interface between the 
NM and the cell [25, 37].  After NM exposure to the body this interface offers a 
first line of defence acting as a barrier protecting the tissues/cells/cell organelles, 
thus, studying the interaction of NM with cell membranes is a crucial step in 
understanding nanotoxicity.  A recent review by Nel et al. [25] lists 
‘hydrodynamic, electrodynamic, electrostatic (or ionic), solvent and steric 
interactions and polymer binding’ as the main forces governing the NM-cell 
interactions.  As these interactions will vary according to the physicochemical 
makeup of the NM - this in some way begins to explain why, if we are to 
understand NM behaviour at the cell interface, a good degree of knowledge on the 
NMs physicochemical makeup is desirable.  It is known that NMs do penetrate 
cell membranes and transport into cells such as endothelial, pulmonary, 
macrophage and neuronal cells [38].  Mechanisms of membrane penetration by 
NMs are not fully elucidated as it will vary depending on the NMs and cell type.  
NMs may cross the cellular membrane lipid bilayer by active uptake mechanisms 
(e.g. phagocytosis, pinocytosis and by clathrin and caveolin-mediated 
endocytosis) or by passive penetration (see figure 1.4) [39, 40].  If NMs enter the 
cell by endocytosis, NM are enclosed by endocytic vesicles and are not directly in 
contact with the cytosol of the cell, however NM internalized by membrane 
penetration enter the cytosol directly.  As targeted entry of NMs into cells is an 
important feature of drug delivery this is the subject of much on-going research 
and many cellular uptake pathways have been described for particle uptake (as 
well as drugs, bacteria and viruses) [1, 41, 42].  In general literature has reported a 
great (and sometimes conflicting) variety in the uptake mechanism - some 
examples are reported in table 1.2. 
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Table 1.2 Particle uptake mechanisms reported in literature for various 
nanomaterials and cell types.  
 
Uptake Mechanism Particles Cell Type Author and 
Year 
Clathrin-Mediated 
Endocytosis 
Latex beads  
50-200nm 
murine melanoma B16-
F10 
Rejman et al., 
2004[42]. 
Caveolin-Dependent 
Endocytosis 
Latex beads ≤ 
500nm 
murine melanoma cell 
line B16-F10 
Rejman et al., 
2004 [42] 
Endocytosis 50nm 
Magnetic NP 
coated in SiO2 
human lung cancer cells - 
A549 
Kim et al., 
2006 [43] 
Endocytosis – possible 
macropinocytosis 
18 ± 5nm 
Polymer NP 
Murine macrophage cells 
- J774A.1 
Fernando et 
al., 
[44] 
Suggested Several 
Uptake Pathways (e.g., 
clathrin and caveolae-
mediated endocytosis, 
and macropinocytosis) 
Hydrophobic 
glycol chitosan 
NPs (359nm) 
Human HeLa cells Nam et al., 
2009 [45]. 
Pinocytosis/Macropino
cytosis 
polystyrene 
NP  (113 nm) 
Human HeLa Cells Dausen et al., 
2008 [46] 
Phagocytosis Metallofullere
nol (100-
157nm) 
macrophages, and 
lymphocytes 
Liu et al., 
2009[47] 
Passive Uptake 
Mechanism 
(diffusion, 
transmembrane 
channels, 
or adhesive 
interactions) 
22nm TiO2  In vivo (rat inhalation) Geiser et al., 
2005 [48] 
Passive uptake 
(membrane 
penetration 
without pore 
formation) 
QDs coated 
with 
zwitterionic 
thiol ligand D-
penicillamine. 
Red Blood Cells Wang et al., 
2012 [49] 
 
A recent study investigating a range of cell types including HeLa (cervical 
cancer), A549 (lung carcinoma) and 1321N1 (brain astrocytoma) cells concluded 
that no one mechanism of transport was responsible for uptake and suggested that 
even for one type of NM the uptake mechanism could be different depending on 
the cell type [50].  
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Figure 1.4: Possible mechanisms of NM cellular uptake – image taken 
from  Zhao et al. [38]. 
 
One emerging area of investigation is the concept of the NM ‘corona’ or the 
ability of NM to absorb biomolecules onto their surface (particularly proteins, 
therefore termed the protein corona).  This is central in shaping the surface 
properties, charges, aggregation behaviour and size of NMs within a biological 
system and has been found to effect the amount of uptake into cells [51].  
Hypothetically this could also affect the interaction of NMs with cell surface 
receptor proteins.  An interaction such as this may lead to 
denaturation/malformation of these cell membrane receptors leading to the 
induction of a biological response causing changes in the signalling pathway of 
target cells [52]. However this hypothesis does lead away from the current 
paradigm of nanotoxicity which is the role of oxidative stress induced toxicity. 
 
1.2.1.2 Oxidative Stress 
 
To date oxidative stress has emerged as the leading paradigm of NM toxicity [53].  
When an atom has unpaired electrons it is termed a free radical - free radicals are 
highly volatile and in a cell will react with cellular molecules (lipids, nucleic 
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acids, etc.) leading to oxidation.  There are many types of radicals and those that 
derive from oxygen are collectively called ROS, examples include the hydroxyl 
radical (
.
OH), superoxide radical (
.
02
-
) and hydrogen peroxide (H202).  The main 
source of ROS in vivo is in the mitochondria - produced during oxidative 
metabolism leading to adenosine triphosphate (ATP) production.  ROS is also a 
feature of many tissues [54] for example many oxidases produce ROS during 
xenobiotic metabolism.  
 
As protection against the damaging effects of ROS cells have evolved to deal with 
these radicals - for example antioxidant enzymes (such as superoxide dismutase, 
catalase and glutathione peroxidase) counteract the effects of ROS [55].  
Generation of ROS is an important cellular function, however oxidative stress 
results when ROS overwhelms the antioxidant system of the cell [56].  This 
increased oxidative stress depletes cellular antioxidants and leads the activation of 
transcription factors for pro-inflammatory mediators such as nuclear factor kB 
(NF kB) and pro-inflammatory cytokines and chemokines [57], causing 
inflammation.  Nel et al. [58] describes the hierarchical oxidative stress 
hypothesis where a lower level of oxidative stress is associated with the induction 
of antioxidant and detoxification enzymes and at higher levels of oxidative stress 
activation of pro-inflammatory mediators can lead to inflammation and 
cytotoxicity and prolonged or excessive ROS generation can lead to cell death. 
Although this hierarchical oxidative stress hypothesis is a basic concept of what is 
no doubt a complex mechanism in vitro it is universally accepted that ROS can 
damage virtually any biomolecules present and oxidative stress is a significant 
event in the mechanism for inflammation based chronic degenerative diseases 
[59] and it has been implicated in diseases such as pulmonary fibrosis, 
atherosclerosis, cancer, neurodegenerative diseases and in aging [56]. 
 
The oxidative stress paradigm for NM toxicity emerged from research in the 
1980s by Mossman et al. [35, 36] who discovered the direct carcinogenic effects 
of asbestos. They saw that the high iron content of the asbestos resulted in the 
generation of reactive species which they suggested could initiate cell signalling 
events to induce cell damage.  One of the first published reports of nanotoxicity 
was conducted in the rat lung by Oberdörster et al. [60] and found that ultrafine 
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TiO2 particles induced a greater inflammatory reaction than fine TiO2. This led 
Stone et al. (1998) to investigate the potential of ultrafine particles to generate 
ROS and the role of this ROS production in the toxicity of the particles [61].  
Today there is evidence from many published studies [22, 32, 62, 63] that NMs 
have the ability to induce oxidative stress and inflammation.  NMs may cause 
oxidative stress either by non-cellular mediated ROS production or by particle 
mediated cellular ROS and reactive nitrogen species (RNS) production [62].  Non 
cellular oxidative stress results from or is enhanced by transition metals. The 
mechanism of toxic action of asbestos for example has been shown to involve the 
ability of iron present in asbestos to form hydroxyl radicals due to iron catalysed 
reactions (Fenton chemistry).  These hydroxyl radicals can go on to cause 
peroxidation and DNA strand breaks.  
 
1.2.1.3 Inhalation Toxicology - The Role of Macrophages 
 
A major source of particle exposure to the body is via inhalation.  Such an 
exposure may occur at the synthesis stage in an occupational setting or due to 
wear and tear from a product containing NMs.  The lung not only has physical 
defence mechanisms which can filter and eliminate particles (i.e. nasal hairs and 
the mucocilliary escalator) but also specialised cells such as Type I and Type II 
epithelial cells and macrophages (interstitial intravascular and alveolar 
macrophages (AM)).  Macrophages are derived from the circulating blood 
monocyte population and are distributed ubiquitously throughout the body where 
they have various roles, for example in phagocytosis and antigen presentation and 
also in cytokine production [64].  AM are large macrophages (12-40µm) [65] and 
continually deal with inhaled foreign substances due to their location in the 
alveolar space.  Their ability to ingest and degrade particulate matter using the 
molecular mechanism of phagocytosis is key in their defence of the lung.  
Macrophages express a variety of cell-surface receptors that can bind to antigens. 
Upon ligand binding, the macrophage cell-surface receptors become activated and 
trigger phagocytosis.  Most of our understanding of the signalling pathways 
leading to phagocytosis in macrophages comes from studies of the Fc receptor 
[66].  Each receptor is involved in a specific response thus macrophages can 
produce a variety of functions depending on the receptors involved in the 
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particular response.  This variety of receptors capable of stimulating phagocytosis 
(e.g. Fc and complement receptors etc.) makes it a complex action to elucidate – 
however recently much progress has been made in understanding the signalling 
pathways that induce phagocytosis [67].  As the cell moves, filopodia up to 20 μm 
in length can be seen, these are supported by actin filaments and these actin 
filaments, in association with structural and regulatory proteins, create the 
molecular mechanics of cell movement [67].  Besides their phagocytic ability 
macrophages (like many other cells of the immune system) have the ability to 
secrete products such as cytokines [68].  
 
Cytokines are soluble cell-signalling proteins which functions in intercellular 
communication regulating cellular responses such as proliferation, differentiation, 
immunoregulation. Upon antigen stimulation macrophages can synthesize/release 
a variety of cytokines (such as IL-1, IL-6, IL-8, IL-10, IL-12, TNF-α, MCP-1), 
which are involved in immune responses, inflammation and other homeostatic 
processes [69]. Cytokines act by binding to their specific cell surface receptors 
which results in a cascade of intracellular signalling.  This can result in processes 
such as upregulation and/or downregulation of genes and their transcription 
factors, resulting in the production of other/more cytokines or in their suppression.  
Macrophages can also secrete chemokines a type of cytokine enabling chemotaxis 
or the recruitment of circulating monocytes within tissues [69].  This will be 
discussed in more detail in Chapter 5. The presence or absence of cytokines in the 
body’s biological fluids at any time reflects a complex relationship between 
activation/production and inhibitory signals acting on the macrophage (or indeed 
any other producer cell) [70]. 
 
1.3 Physicochemical Characteristics of Nanomaterials 
 
The inherent toxicity of NMs and their ability to interact with a biological system 
will vary depending on their individual physicochemical properties [71].  It has 
become apparent that even when NMs are composed of the same elements as their 
bulk counterparts (i.e. uniform particles of similar/same chemical makeup but of a 
larger size); they behave differently as mentioned in 1.1.  It is important to 
ascertain if there is any relationship between the physico-chemical properties of 
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NMs and the induction of any toxic responses in biological systems.  The 
physicochemical properties in question are: small particle size, size distribution, 
specific surface-area, surface structure, molecular and crystal structure, chemical 
composition (including surface coating), physical form, particle density, 
solubility, colloidal stability, bulk density, agglomeration state, porosity and 
surface charge [72, 73].  The particle size can influence the fate of the NM in the 
body and thus the body’s response to the exposure [74].  For example, much 
research in the area of inhaled particles, which have been obtained predominately 
from the rodent model, find that the mechanism of inhaled particle deposition is to 
a great extent dependent on the diameter of the inhaled particles [75].  When 
particles are inhaled the size will determine not only the mechanism of deposition 
but also where in the lung it is deposited.  Particles in the µm range will deposit in 
the upper airways or mouth and throat whereas those smaller in size deposit in the 
alveolar region [75].  Oberdörster et al. [22, 76] reported that the situation for 
NMs is a little more complicated and the deposition behaviour in the respiratory 
system is not linear with size – with NMs in the size range 10 and 50 nm being 
deposited mainly in the alveoli, while smaller and larger ones are more efficiently 
deposited in the higher regions.  This suggests that NMs of different sizes can 
have different effects in different parts of the lungs.  NMs will not necessarily 
remain at their sites of deposition in the respiratory tract. They may undergo 
numerous transport processes within the various tissues of the lungs, including 
clearance from the lungs.  A study by Moller et al. [77] on the retention times of 
NMs in the airways also points to a size relationship.  For example, a human 
inhalation study of 100nm carbon particles found that 25% of the particles were 
cleared after 1 day (due to mucocilliary action) and 75% of the particles were 
persistent in the airways for more than 48 hours.  The mechanism proposed for 
such retention was that deposition of the particles meant they were no longer 
accessible for clearance [75]. 
 
It has been suggested that a particle greater than 100nm in size will not enter cells 
via receptor mediated processes [78, 79].  Other sizes that have been noted as 
important in nanotoxicity are those below 40nm which may have greater access to 
the nucleus and the mitochondria [78] and Elder et al. did show that size was 
important in the neuronal uptake of 31nm Mn oxide NP [80].  In vitro 
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experiments have also demonstrated this size specific effect for example, in the rat 
alveolar macrophages and human blood monocyte cells, 14nm carbon black (CB) 
NPs were shown to induce a calcium influx, which was found to activate 
transcription factors and stimulate the production of pro-inflammatory cytokine 
(TNF-α), significantly compared to treatment with 260nm CB, indicating that the 
effect is size specific [81].  However these size observations will be specific to the 
NM and the cell type employed thus such observations are best used as a general 
guideline.  
Size is also related to surface area, as the size of NM decreases, the surface area 
per unit mass increases and so forces such as gravity may not be as significant 
when compared with  surface forces like van der Waals, electrostatic forces and 
chemical bonding [82].  As the size of the particle decreases and the surface area 
increases more of its atoms or molecules are exposed at the surface rather than the 
interior of the material.  The surface to bulk ratio has been linked to the increased 
biological reactivity of NMs [62, 63].  This large surface to bulk ratio will thus 
allow for binding of proteins and other biomolecules available in the living 
system.  Toxicity data from a pulmonary toxicity study in rats shows that 
inhalation exposures
 
to NMs (TiO2, polystyrene beads and CB) results in 
enhanced toxicity responses
 
when compared with micro-sized particles with a 
comparable chemical
 
composition [22, 83, 84].  For example, in the case of TiO2 
at high dose concentrations the ultrafine TiO2 caused inflammation, and at low 
doses resulted in proinflammatory effects suggesting that the NMs may have a 
greater biological activity than larger particles [34, 85].  The positive effects of the 
large surface to bulk ratio is in creating novel ways of enabling drug delivery, but 
it may also have possible negative cytotoxic effects, given that the interaction of 
NMs with subcellular structures may be different from that of the bulk material.  
For this reason it is important when considering dose and effect that properties 
such as size and surface area are investigated [24, 62, 63].  
 
Shape is an important factor to consider in NM toxicity as evidence from 
investigating materials such as asbestos has shown that shape drives the biological 
response [36, 86].  Fibre-like NMs such as carbon nanotubes (CNTs) have been 
investigated for shape related toxic effects.  For example Brown et al. [87] 
demonstrated the connection between morphology and cellular response in a 
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monocyte cell line finding monocytes exposed to long straight multiwall CNTs 
produced significantly more TNF-α and ROS compared with highly curved 
materials.  Poland et al. [88] showed a similar result in vivo, where long straight 
nanotubes injected into the abdominal cavity of mice produced a similar result to 
that of asbestos, causing an inflammatory response.  This was again in contrast to 
the entangled nanotubes which did not produce a significant inflammatory 
response.  Hamilton et al. [89] study on TiO2 NMs of different shapes concluded 
that AM had more difficulty in processing longer fibers than the shorter fibers and 
concluded that toxicity was altered by the shape of the NM.  In recent years much 
research has been carried out investigating if fibres such as CNTs, due to their 
fibre shape, translocate in a similar way to biopersistent asbestos.  There is 
growing evidence that shows CNT do translocate.  For example, multi walled 
CNTs in vivo (inhalation or aspiration) translocate to sub pleural tissue, where 
they caused fibrosis [90, 91]. The charge of NMs is another aspect that needs 
consideration.  The surface charge of NMs can be measured in solution using zeta 
potential analysis (ZP).  ZP is a measure of the electrostatic forces and so will 
vary depending on the material of interest.  Of course any surface coatings or 
adsorbed material will effect this ZP measurement and as such a single ZP 
measurement without regard to the biological environment (pH, adsorbed 
molecules, etc.) will not be relevant.  As the cell wall has a negative surface 
charge [92] it may seem that positively charged particles would be more likely to 
be drawn to the cell and thus could be more toxic.  Many in vivo and in vitro 
studies have found that cationic particles are more cytotoxic [25], for example 
Goodman et al. found cells exposed to Au NMs were more likely to induce 
haemolysis and platelet aggregation than anionic particles [93].  However the role 
of surface charge in toxicity has been reported for both anionic and cationic 
particles in the literature [94]. 
 
1.4 In vitro Cytotoxicity Testing of Nanomaterials 
 
In toxicology we aim to relate the basal cytotoxicity of a compound in vitro to its 
toxicity in vivo, however there are factors which can complicate this correlation 
and optimisation of in vitro assays is a major concern in toxicology.  It is 
important to ascertain how the physico-chemical properties mentioned in 1.3 will 
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express themselves in biological systems.  As NMs can consist of a wide variety 
of materials characterisation and classification is the first step in addressing 
potential toxicity but of course additional factors are also important when 
considering nanotoxicity.  For example, the nominal NM concentration is difficult 
to determine given the complex nature of NMs and NMs may be influenced by the 
in vitro assay components and properties.  There is a need to develop and design 
assays to consider not just the nominal dose but the free dose available to and 
recognised by the cells.  
 
The route of entry and fate of the NM must be considered; NMs can enter the 
body via inhalation, dermal contact and ingestion, injection or implantation.  The 
lung represents a major route of entry for NMs, where both micro sized particles 
and NM will be cleared via the mucocilliary escalator.  Particles are also cleared 
or undergo phagocytosis by macrophages (as mention previously section 1.2.1.3) 
and transported to the throat where they are cleared.  Renwick et al. [95] showed a 
significant reduction in the ability of macrophages (J774.A1.2) to phagocytose 
particles (fine and ultrafine TiO2, CB and ultrafine CB) and attributed this slowed 
clearance in part to a particle-mediated impairment of macrophage phagocytosis.  
Such an effect may lead to persistence, translocation to other body compartments, 
interaction with other cell types and induction of the biological response.  
Compounding this is the ability of transition metals (for example zinc and iron) to 
potentiate the toxic NM effects [96].  NMs that are effectively cleared from the 
lungs may potentially exert toxic effects in the gut or may translocate via the 
circulatory system to a different tissue or organ.  When designing in vitro 
toxicology assays there is a need to consider a potential target tissue or organs.  
NMs given their size have a greater ability to reach many organs and tissues in the 
body.  If a potential target can be identified the mechanism by which the material 
can produce its effect must be considered.  The rate and frequency of exposure, 
and the fate of the NM once in the body, the absorption, distribution, metabolism 
and elimination are crucial factors when considering the toxicity of NMs.  Borm 
et al. [97] suggested looking at the 5 D’s of particle toxicity in vivo; dose, 
deposition, dimension, durability and defence, when examining nanotoxicity. 
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Many in vivo studies have focused on pulmonary toxicity ([21, 79, 87-89, 98]) but 
NM such as those designed for drug delivery (e.g. iron oxides NMs used in 
magnetic hyperthermia) can also be deliberately introduced into the body by 
injection.  In such cases NMs are generally developed to have specific coatings to 
allow increase blood circulation time, reduce adsorption of protein and promote 
phagocytosis to specific tumour cells [99].  Combinations of both in vivo and in 
vitro studies are useful in elucidating the mechanisms of toxicity.  In vitro it can 
be difficult to determine the actual exposure dose and to correlate any findings 
with the effect as it is difficult to determine the effect of reagents used and the 
effectiveness of the model. It has thus proven to be difficult to elucidate the 
mechanisms of toxicity of NMs.  This emerging complex issue is compounded by 
the fact that different studies reveal differences in NM cytotoxicity ranging from 
non-toxic to highly toxic [100, 101].  NMs cannot be seen as a consistent or 
uniform set of materials with specific toxicity.  The aim must be to understand the 
physicochemical characteristics that drive NM toxicity.  It would seem unlikely 
that given the large diversity in NMs being produced there will be a universal 
biological response.  However the key parameters of concern for most types of 
NMs are emerging to be, good characterisation of NMs, the surface area of the 
NM, the mechanism by which particles binds to biological materials in vivo, the 
identification and affinity of absorbed biological material to NMs in vitro/in vivo, 
their fate, their biopersistance and of course exposure.  Individualised testing of 
every individual NM in production is not a possibility considering the amount of 
experimental work, time, money, and animals that would be required.  However 
understanding the mechanism of nano induced toxicity is something that needs to 
be considered in order to ascertain if any paradigms or trends exist - for example 
the ability of NMs to generate oxidative stress can be an indicator of how toxic it 
may be and could be employed as a screening tool to identify NMs which warrant 
a closer examination. 
 
One area that is emerging to be a big factor in nanotoxicity is the ability of NMs 
to bind biological molecules such as proteins and lipids once in the body.  Once 
particles and NMs enter the body they immediately come into contact with 
biological fluids, the content of which is dependent upon the route of entry [78, 
102-104].  It is well known that early biological responses to foreign objects in the 
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body are influenced by their attached protein [105]. In fact considerable research 
has been done in the medical device field to coat the surfaces of medical devices 
with compounds to prevent and avoid the formation of a biopolymer coating 
between the device or foreign material and the body’s tissues [106, 107].  
Conversely, the ability to control NM binding leads to numerous NM 
applications, for example in nanobiotechnology and drug design [108, 109].  
Although much research has been carried out on these protein-surface interactions 
in the bio-medical industry, to date there is limited understanding of the role of 
these interactions in influencing NM toxicity.  The aim of this thesis is to address 
one of these issues by investigating particle and NM–protein interactions.  
Beginning to understand more about these key concepts will address the gap in 
our knowledge on the role of these interactions in influencing NM induced 
toxicity.  In the long term this may help to close the gap in our knowledge of NMs 
mechanism of toxicity which may result in being able to abandon our case by case 
approach in light of a less time consuming, economical predicative model, which 
would allow for not only faster toxicity assessments but also aid 
commercialisation and bring the field one step closer to realisation of the power of 
nanotechnology. 
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1.5 Aims and Objectives 
 
 This study aims to characterize a set of nanomaterials and investigate how 
their properties (size, composition and charge) may affect their cytotoxicity in 
a J774.A1 macrophage cell line.  Chapter 2 exclusively deals with the 
characterisation of the NM and Chapter 3 and four explores NM toxicity on a 
J774.A1 macrophage cell line 
 
 Use protein characterization techniques to investigate the interactions of NMs 
with proteins and examine how the size, composition and charge influence the 
affinity and degree of protein binding.  Chapter 3 explores this aim with 
respect to iron oxide particles and Chapter 4 with respect to silica particles  
 
 Chapter 5 investigates if the interaction of NMs with biological fluids causes a 
change in the function of the proteins and ultimately aims to understand the 
role this protein-NM interaction has in influencing toxicity of the NMs.   
 
 To develop a better understanding of nanotoxicity by considering the in vivo 
situation.  Thus enabling superior in vivo-in vitro extrapolations to be made 
and gaining more relevant toxicity data.  
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Chapter 2      Characterisation of Nanomaterials 
 
2.1 Characterisation 
 
In order to gain relevant data from in vitro toxicity assessments which are 
reproducible and reliable NMs must be well characterised.  Many of the 
physicochemical characteristics of NMs are still not fully understood/elucidated 
making this a challenging and complex issue.  Thorough characterisation of NMs 
includes measurements before and after dispersion of size, size distribution, 
surface area, morphological features (such as shape, surface roughness and 
porosity), particle chemistry (such as surface chemistry, particle composition, 
solubility) and contamination testing (such as metal analysis and endotoxin 
testing) [110, 111].  Thorough characterisation however may not always be 
possible given the interdisciplinary nature of nanotoxicology.  Knowledge, 
facilities, time and costs are obstacles that may not allow for such exhaustive 
characterisation.  Although not every aspect of the NMs can be meticulously 
characterised at a minimum, key parameters such as charge, shape, size and 
surface area should be known in order to relate any results to exposure.  
 
Many NMs can be purchased commercially for toxicological testing and are 
supplied with manufacturer specifications (for example detailing size and 
composition information).  However simply reporting manufacturers 
specifications is no longer deemed sufficient for a nanotoxicological study, Park 
et al. [112] highlighted that there can be significant differences in values obtained 
for independently characterised NMs and those provided by the supplier or 
manufacturer. 
 
Ideally knowledge of how the NMs behave in the test system (in situ) is of 
interest, for example how the test media or other modifications (such as 
sonicating) will affect the NMs.  If this is not possible, at minimum, the detailed 
experimental conditions should be reported and as much characterisation data as 
possible in the relevant biological media should be completed, without this 
information results from toxicological studies can be meaningless or have limited 
significance.  The addition of serum, for example, is routine in cell culture studies, 
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Murdock et al. [113] found that metal oxide NMs not only tend to agglomerate in 
solution but the addition of serum in the culture media can affect the toxicity in 
vitro.  In general serum in cell culture systems has been reported to interfere with 
in vitro tests, as it can affect the uptake rate of the NMs in question [114-117], can 
coat the particle surface [118] allow binding of test particles to serum proteins, 
may act as an antioxidant and may alter differentiation/cell cycle state of cells 
[119].  It should also be noted that NMs dispersed and sonicated in water and then 
added into dispersant/media/serum may produce different results than NMs 
sonicated in dispersant/media/serum alone and the effect of the dispersant is of 
importance as it may impact on toxicity of the NMs, for example Wang et al. 
[120] found that degradation of dispersants during sonication can be toxic to cells.  
It is known that the serum content in cell culture media varies not only between 
laboratories, but also will vary depending on what cell type is used, which can 
further complicate comparison of results.  NMs characterised in their dry state and 
those characterised in suspension will offer two entirely different sets of data.  It 
is also important to check if NM interacts with the assay components or the 
detection system.  Kroll et al. [121] lists many important properties of NM that 
can interact with the test system such as high adsorption capacity, optical 
properties, catalytic activity and in the specific case of iron oxide NMs factors 
such as magnetism and dissolution must also be considered.  
 
In addition to the fact that NMs samples are not homogenous and that there are no 
nano specific standard characterisation methods, another issue arises from the 
variety of manufacturers producing NMs.  Manufactured NMs are engineered in 
an ever increasing variety of ways and using a wide variety of materials.  They are 
also often produced in relatively small quantities.  This increases the chance of 
having batch to batch variations. Successful measurement will depend on accurate 
and precise sampling, sample preparation and sample measurement.  Thus the first 
task is to accurately obtain a representative sample of the bulk for characterisation 
and experimentation.  Characterisation particularly in situ is a complex procedure 
and the list of available methodologies becomes larger as our understanding 
grows.  It has been suggested that there is a need for guidelines or standard 
methodologies for basic characterisation of NMs [110] however as the term NM 
potentially encompasses such a large diversity of materials each with their own 
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unique properties, each individual NM may require its own unique set of 
characterisation for optimum results on its detailed structure.  For example, 
popular methods such as dynamic light scattering (DLS) for size analysis are only 
suitable for spherical particles, for non-spherical particles alternatives such as 
imaging with transmission electron microscope (TEM) or scanning electron 
microscope (SEM) will be required. 
 
2.1.1 Dispersion 
 
Once sampled, NMs need to be exposed to the test model using a relevant method 
of dispersal in a suitable non toxic media.  The measured size distribution is 
highly dependent on the degree of dispersal [110] and NMs can agglomerate when 
dispersed in high ionic strength or protein rich environments [110].  
Agglomeration/aggregation of NMs need to be considered in experimental design 
so as best to simulate the in vivo behaviour of NMs although the dispersal method 
should not aim to manipulate the sample to produce dispersed NMs that are not 
relevant to real life exposures [110].  Agglomerates can be defined as a ‘collection 
of loosely bound particles or aggregates or mixtures of the two where the external 
surface area is similar to the sum of the surface area of the individual 
components’.  An aggregate can be defined as a ‘particles comprising of strongly 
bonded or fused particles where the external surface area may be significantly 
smaller than the sum of the calculated surface areas of the individual components’ 
[122].  So whereas agglomerates may be easily dispersed using sonication or the 
addition of dispersants, aggregates may not so easily be dispersed.  This leads to 
the question of dose.  The dose in vitro is related to the behaviour of NMs in the 
test media, if for example NMs agglomerate they can settle quicker than their 
monodispersed counterpart onto cells in vitro and may not be available for uptake 
into cells.  Any resulting dose-response curves produced from exposures that do 
not consider dispersal (i.e. transport of NM to cell and time frame to reach cells) 
may be untrustworthy as these variations would be expected to impact the 
magnitude of a cellular response [123].  In summary, an overall understanding of 
the implications of dispersal on the delivered dose is important and whichever 
method of dispersal is used will depend on the type of NM, the state in which it is 
produced (e.g. powder, liquid) and the model system used.  
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2.1.2 Size Measurements  
 
Many techniques are available for measuring the size of NMs.  Today global 
standards from the International Organisation for Standardisation exist not only 
with respect to sampling and dispersion of particles but also for particle size 
analysis [124].  They include information on how to represent the results from 
particle size analysis, determination of specific surface area of solids by gas 
adsorption using a technique known as Brunner-Emmet-Teller (BET), particle 
size analysis using photon correlation spectroscopy (PCS) and particle size using 
image analysis methods.  These methods are not considered a ‘gold standard’ for 
nanotechnology as they relate to diverse particle sizes, however it is generally 
accepted that some form of microscopy such as TEM, SEM or atomic force 
microscopy (AFM)) and one other method, such as dynamic light scattering 
(DLS) or surface area measurements etc., should be used when assessing NM 
size.  
 
PCS, such as DLS, is a common method to measure hydrodynamic diameter of 
spherical NMs.  A Malvern Zetasizer Nano ZS measures size within a 0.6nm to 
6µm range [125].  It determines the size by measuring the Brownian motion of the 
particles in a sample.  Brownian motion is defined as: ‘the random movement of 
particles in a liquid due to the bombardment by the molecules that surround them’ 
[125].  Thus DLS works by illuminating the particles with a laser and analysing 
the intensity fluctuations in the scattered light.  An important feature of Brownian 
motion for DLS is that small particles move quicker than larger particles.  The 
relationship between the size of a particle and its speed due to Brownian motion is 
defined in the Stokes-Einstein equation.  Due to this relationship and that between 
the diffusion speed and size of a particle, the size can be determined. 
 
Nanoparticle tracking and analysis (NTA) is an instrumental technique that allows 
NMs to be sized in a liquid.  According to manufacturer’s specifications NMs in 
liquid suspension with range of 10nm to 1000nm; and with concentration of 
0.1ppm to 40% w/v,
 
in any non-corrosive solvent can be measured.  The sample 
cell has an optical window and a laser beam (40mW, 635nm) is focused through 
the optical flat window on the sample [126].  Particles in the liquid sample pass 
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through the beam and are seen via a microscope as small points of light moving 
due to Brownian motion.  This motion of the particles in Brownian motion is 
captured by camera and recorded - thus what is obtained is a recording of each 
particle being tracked over time.  The recording can be analysed via NTA 
software and the mean square of the displacement over time is determined.  From 
this information the diffusion coefficient and hence the sphere equivalent (the 
hydrodynamic diameter) can be determined again (as with DLS) using the Stokes-
Einstein equations.  As the NTA separately tracks each individual particle the size 
distributions generated reflect the actual number of particles seen in the sample 
and this is a big advantage over PCS, a method where a large number of particles 
are analysed simultaneously and result in a ‘Z-average’ thus being more suited to 
more polydisperse samples [127].  When using PCS if there are aggregates 
present it will lead to a shift in the distribution to the right hiding or obscuring any 
smaller particles present in the sample.  Thus according to the manufacturer, NTA 
analysis allows for a higher resolution and a better understanding of aggregation 
behaviour [128].  An advantage over PCS also lies in the fact that little knowledge 
of the particle properties (i.e. refractive index) is required - and knowledge of 
parameters such as sample viscosity and temperature are sufficient data to input 
when analysing a sample.  In this way the advantage of NTA is that it allows for 
particle populations to be separated by size and intensity and allows complex 
heterogeneous samples to be fully characterised without the intensity bias towards 
large particles [128].  It is important to emphasize that the particles themselves are 
not visualised - the Brownian motion is.  An inherent problem with NM imaging 
analysis is that NMs are too small to be imaged by light dependent microscopy.  
 
Differential centrifugation sedimentation is another method that can be used for 
size analysis for particles that range in size from 5nm to 75µm [129].  Particles in 
a liquid are centrifuged at known speed and allowed to settle.  The particles will 
settle due to gravity according to Stokes law, larger particles will settle faster than 
smaller ones [130].  The system can be optimised for different materials by 
knowing the density of the particles and adjusting the speed of centrifugation.  
 
Size information can also be determined from image analysis of images obtained 
from TEM and SEM.  TEM and SEM can be used to image particles of size from 
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0.3nm up to 1mm.  Visual imaging is one of the most instinctive methods for size 
determination.  Its advantages lie in the fact that it can provide information not 
only on size but also on possible contamination, on composition (using EDX 
metal analysis - see section 2.1.3) and morphology.  Using image analysis 
programmes the size can be estimated and surface area modelled.  However the 
sample preparation process can be complicated and time consuming and can 
introduce artefacts, also due to the fact that the sample is imaged under a high 
vacuum the actual process of imaging can cause agglomeration.  It is also an 
expensive technique and in order to get any meaningful results a large number of 
images may be required for image analysis.  
 
It is important to consider that different methods of sizing can give different 
values, especially if the sample is polydispersed.  Some techniques may measure 
the particle size (e.g. TEM) and other techniques measure hydrodynamic diameter 
(e.g. DLS), thus it is important to gain as much knowledge about a sample before 
analysis. 
 
2.1.3 Other Physicochemical Properties 
 
2.1.3.1 Zeta Potential 
 
When a charged particle is introduced into liquid, ions of an opposite charge will 
be attracted to its surface. Ions close to the surface of the particle will bind more 
than ions that are further away and will form what is called a ‘diffuse layer’[125]. 
Within the diffuse layer there is a boundary around which any ions within the 
boundary will move with the particle when it moves in the liquid and any ions 
outside the boundary will stay where they are.  This boundary is called the 
‘slipping plane’ [125].  The potential that exists at this boundary is known as the 
zeta potential (ZP).  It is important to ascertain the ZP as it gives an understanding 
of the stability of the particle in solution, making ZP a powerful characterisation 
tool.  The ZP is not an actual measurement of the NM surface charge, or a 
measurement of the atomic charge at the surface of the NM.  As described above 
ZP will help in gaining an understanding of how a particle will react in a solution.  
If all particles have a large positive or negative ZP then they will repel each other 
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and these types of particles tend not to agglomerate.  Conversely particles with 
low ZP values will tend to agglomerate as there are no forces stopping them from 
combining.  Particles with a ZP more positive or negative than 30mV are 
considered stable [125]. 
 
There are many factors which will affect the ZP, for example the pH.  ZP should 
always be quoted at its pH, and when doing initial research a ZP versus pH plot 
should be constructed.  The point where this plot passes through zero is called the 
isoelectric point (IEP) [125].  This IEP is normally the point where the particle 
suspension is least stable.  For this reason it is essential to consider the pH when 
carrying out cell studies.  Here again it is necessary to consider routes of exposure 
and the model for NM exposure.  If using NMs in solution with a pH that is the 
same as the pH at the IEP the NMs may agglomerate more than when the pH is 
greater or less than the IEP.  If the route of exposure is via the skin the pH is 5.5 
whereas the blood has a physiological range of pH 7.34 - 7.45.  As NM behaviour, 
including its size, shape and ZP will be affected by pH and this may alter their 
fate and behaviour in the body.  Other issues to be considered in terms of charge 
and pH is that altering the pH also has effects in the amount of soluble ions that 
may be released from the NM again adding another layer of complexity to 
understanding NM toxicity, i.e. differentiating between ion effects and NM 
effects.  
 
ZP can be measured by a variety of techniques.  One such way is by using the 
Malvern Zetasizer Nano instrument.  This instrument uses a combined technique 
of electrophoresis and laser doppler velocimetry, i.e. it uses a laser which is 
passed through the sample to measure ‘the velocity of the particles in an applied 
electric field of known value (electrophoretic mobility)’ [125].  Once the velocity 
of the particle is known and the electrical field applied by using two other known 
constants of the sample (viscosity and dielectric constant) the ZP can be 
calculated. 
 
 
 
 
27 
 
2.1.3.2 Metal Analysis 
 
Knowledge of NM composition is extremely useful for characterization, allowing 
contaminants or unknown elements present in the sample to be identified and 
possibly quantified.  Energy dispersive X-ray spectroscopy (EDS or EDX) is a 
technique used in conjunction with SEM which can identify the elemental 
composition of a sample.  This SEM/EXD method has been used extensively to 
characterize the size, morphology and elemental composition of ambient aerosols 
[131] and is finding increasing use in nano specific studies.  It is a relatively 
simple yet powerful technique with the added advantage of being nondestructive.  
The technique works by bombarding the sample with an electron beam to produce 
x-rays that are detected and analysed.  Each element has a unique atomic structure 
- the atoms from every element release x-rays with unique amounts of energy and 
as the x-ray energy is characteristic of the element from which it was emitted from 
the elemental composition can be determined.  The output shows unique peaks 
corresponding to the energy levels for the X-rays received.  The higher the peak in 
the output spectrum, the more concentrated the presence of the element in the 
specimen.  
 
In summary, it is important to have a range of techniques in order to elucidate the 
most important aspects of the NM characterisation.  Each technique will give its 
own unique model or view of the particles and together this combined approach 
can help to build and an understanding of the complex nature of particles at the 
nanoscale.  
 
2.1.4 Iron Oxide Nanomaterials 
 
Iron NMs have been highlighted by the Organisation for Economic Co-operation 
and Development’s Working Party on Manufactured Nanoparticles’ (WPMN) as 
one of the thirteen NMs they intend to analyse further to examine their 
physicochemical properties, environmental fate, environmental toxicology and 
mammalian toxicology [132].  Chosen for their relevance (in commercialisation, 
production volume and availability) the objective as set out by the WPMN is to 
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provide ‘information on intrinsic properties that may be relevant for exposure and 
effects of NMs through testing’ [132]. 
 
The unique characteristics of iron oxide NMs (e.g. their superior magnetic 
potential at the nanoscale) mean that they are being employed in a vast array of 
applications.  Besides the considerable attention they have received in the 
biomedical field (for example in targeted drug delivery and as magnetic resonance 
imaging contrast agents for example) their magnetic qualities also make them 
useful in a broad range of applications such as pigments in cosmetics and the 
automotive industry, sealants, inks and catalysts [133].  Coated magnetic particles 
also have uses in industrial water treatment, bioremediation and labelling where 
iron oxide NMs allow for effective cell separating techniques [134, 135].  
Currently the biggest use of iron oxide NMs is in magnetic recording media (such 
as magnetic tape, hard drives and removable storage devices) [136].  The current 
global production for iron oxide NMs is estimated to 100 tonnes, however this 
value should be taken as an estimate only as it is difficult to distinguish between 
bulk and nano form materials when making these projections.  With increasing 
applications, ease of production and high production value, human and 
environmental exposure to these NM is likely to increase. 
 
Iron oxide NMs have the greatest potential in medical applications.  Recently they 
are finding applications in targeted drug delivery where cells labelled with the 
NMs can be located and tracked.  This application is useful in cancer treatment 
where current treatments are not as specific and thus not as effective.  They are 
also used as contrast agents in magnetic resonance imaging and their magnetic 
properties are exploited for use in bioassays [134, 137, 138].  Recently it has 
become the first NM to gain European Union (EU) regulatory approval [139] for a 
novel therapy that involves the direct instillation of a fluid containing iron oxide 
NMs into a tumour.  The NM can then be manipulated by an external magnetic 
field causing them to generate heat and kill cancer cells in a technique termed 
magnetic hyperthermia.  The clinical evidence that lead to the approval of this 
treatment has recently been published [140].  The treatment had a significant 
effect on prolonging the life span of patients with recurrent glioblastoma 
multiforme (an aggressive brain tumour).  Side effects of this treatment were 
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noted to include sweating, increased body temperature, tachycardia fluctuations in 
blood pressure, headaches and convulsions).  Fourteen out of sixty six patients 
exhibited motor disturbances; in four of these cases the symptoms appeared 
following the NM instillation.  Overall, the authors reported no prolonged side 
effects and reported no indication of iron being released from the tumour [140].  
Medical treatments do involve the direct injection of large amounts of iron oxide 
NMs into the body [135].  The dose in currently approved treatments (magnet 
resonance imaging contrast agents) can be  50-200mg of iron [141].  Although 
many papers report iron is well tolerated in the body [134, 142] and 
biocompatible, the effects of higher intracellular concentrations of iron NMs on 
cell function is not a topic that has been studied sufficiently.  This is important to 
consider as although the body can lose small amounts of iron there are no 
dedicated pathways by which the body can excrete iron (iron not used in the body 
will be excreted in the faeces over a 3 month period), therefore in mammals iron 
levels are mostly controlled by regulating uptake.  The body (on average) stores 
3500mg iron, of which 0.2mg/g is in the liver and liver toxicity can occur when 
iron levels reach 4mg/g [141].  Although iron oxide NMs have been found to have 
a low level of toxicity, their use has been associated with production of 
inflammatory factors observed in some studies [143-145].  Now that these 
procedures are gaining medical approval it’s important to address the potential 
effects of such large concentrations in the body so as to increase their 
effectiveness as therapeutic agents. 
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2.1.5 Chapter 2 Aims  
 
 To characterise three types of iron particles 280 and 22nm Fe2O3 and 
45nm Fe3O4 (using a variety of techniques) with regards to size, dispersion 
stability and elemental analysis 
 
 To examine the above mentioned particles for the effect of time, 
sonication, particle concentration, ionic strength, pH and the presence of 
foetal calf serum (FCS) on their dispersion stability.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
31 
 
2.2 Materials and Methods 
 
2.2.1 Chemicals 
 
Iron oxide nanoparticles Fe2O3 (280nm and 22nm) and Fe3O4 (45nm) were 
received in 2009 from Prof. Chunying Chen (Laboratory for Bio-Environmental 
Effects of Nanomaterials and Nanosafety and Key Laboratory of Nuclear 
Analytical Techniques, Institute of High Energy Physics, Chinese Academy of 
Sciences, Beijing, China).  The particles were provided as a dry powder and were 
previously reported [146, 147] to have the following characteristics:  
 
Table 2.1: Properties of iron oxide (Fe2O3) particles (280nm and 22nm) as 
previously reported by Zhu et al.[146, 147]. These particles were obtained 
and used for this study. After characterisation (see section 2.3) however the 
22nm Fe2O3 particles were discovered to have different properties from those 
described below.  
 
 
280nm Ferric oxide (α form) 
 
 
Purchased from :  Zunye Nanomaterials Co. Ltd Shenzhen, 
China 
Primary Particle Size (TEM) 280nm 
Structure ( X-Ray diffraction) Rhombohedral Crystal Structure 
Surface Area (BET) 4.25m
2
/g 
Purity (ICP-IES) 99% 
22nm Ferric oxide ( α form) 
 
 
Purchased from :  Haoyun Industrial and Trade Co. Ltd 
Beijing, China 
Primary Particle Size (TEM) 22nm 
Structure ( X-Ray Diffraction) Rhombohedral Crystal Structure 
Surface Area(BET) 53.27m
2
/g 
Purity (ICP-IES) 95% 
Hydrodynamic Diameter (in 
RPMI Cell Culture Media with 
10% Serum)  
144.36nm 
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2.2.2 Sample and Media Preparation. 
 
Particles were weighed in a Sartorius safety weighing cabinet (Model: SWC900).  
Before removal from the cabinet, the particles were suspended in sterile filtered 
water at a concentration of 1mg/ml.  Each sample was sonicated at 200W (32 
kHZ) for five minutes using a bath sonicator (Ultrawave Q series).  
 
For dispersion experiments a 100µg/ml particle solution from the stock was 
prepared in water, RPMI (RPMI 1640 media developed by Moore et al. at 
Roswell Park Memorial Institute obtained from Sigma, UK) and in RPMI with 
increasing amounts of bovine serum albumin (BSA) (0, 0.1, 0.5 and 1%), 5mls of 
this solution was added to 7ml vials.  Each of these vials were vortexed and then 
sonicated for 10 minutes.  These vials were then pictured over time using a digital 
camera (Canon 40D) at 0, 0.15,0, 30, 1, 3, 4, 18 and 24 hours. 
 
For size measurements the 1mg/ml stock solutions were diluted to 1, 10 and 
100µg/ml in filtered sterile deionised water, filtered RPMI (supplemented with 
1% pen/strep) and filtered RPMI (supplemented with 1% Penicillin/Streptomycin) 
with added (1%) BSA.  These were vortexed, sonicated (200W) for 10 minutes 
and analysed immediately.  
 
Sample preparation for light microscopy and SEM involved preparing a glass 
slide with the NMs spun onto their surface (cytospin centrifuge).  A slide was 
prepared by placing a glass cover slip between a glass slide and a cytospin cuvette 
loader and placing in a metal cytospin holder.  Each cuvette loader was loaded 
with 100 µl of sample and spun at 215g for 3 minutes.  After 3 minutes the slide 
was dismantled and the glass cover slide with attached particles was recovered.  
Each cover slip was examined by microscopy to determine the degree of 
agglomeration and coverage.  These samples were imaged by use of a Canon 40D 
camera attached to an inverted microscope.  Once examined under light 
microscopy the same glass slide was used for SEM analysis.  The glass slides 
were mounted onto an aluminium stub.  The slides were attached to the stub using 
silver paint/glue.  Each sample was then introduced into a chamber and coated 
with a very thin film of platinum before SEM imaging. 
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A 10µg/ml dilution of all particle types in water, RPMI and RPMI +1% BSA were 
prepared and deposited on copper grids (Agar Scientific, UK) for TEM analysis.  
The grids were placed in eppendorfs with 200mls of each sample and spun at 
500g to coat the grid.  The slides were recovered and placed in a holder until 
analysis by TEM (Hitachi H -7600). 
 
The samples for the sonication study were prepared as follows.  A 100µg/ml 
sample of each particle type was prepared in sterile deionised water.  The samples 
were placed in a sonication bath and sampled after 5, 10, 15, 20, 30 and 40 
minutes sonication.  The size and zeta potential was measured using the zetasizer 
(Malvern Instruments). 
 
2.2.3 Dynamic Light Scattering Size Measurements  
 
DLS for characterisation of hydrodynamic size was performed using a Malvern 
Zetasizer Nano-ZS instrument.  The instrument was turned on 30 minutes before 
measurements to allow the laser to stabilise.  A 100µl volume of each sample was 
pipetted into a 1ml disposable low volume cuvette care was taken to avoid 
bubbles which can interfere with measurements.  A cap was used to ensure 
thermal stability and to prevent dust interference which can greatly affect sample 
readings.  The sample was placed in the chamber.  Before analysis the 
specifications (material absorption, viscosity and refractive index) were adjusted 
to reflect the material being measured.  The Malvern Zetasizer Nano used 
dispersion technology software (Version 5.1) for data collection and analysis.  
The software collected and interpreted the data and the report gave various 
interpretations for the sample such as volume, size and intensity graphs as well as 
statistical analysis and expert advice on the quality of the sample.  The standard 
report for size measurements is an intensity particle size distribution (PSD).  For 
each measurement the mean particle size was calculated and reported as the Z 
average, it is only comparable to other techniques if the sample is monodispersed, 
spherical and monomodal.  The polydispersity index (Pdi) which is a 
measurement of the size distribution in the sample was also reported.  The Pdi 
scale ranges from 0 to 1, 0 being monodisperse and 1 being polydisperse.  The 
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software calculated the PD1 and the Z average from parameters defined in 
International Standards Organisation documentation (13321: 1996 E). 
 
2.2.4 Zeta Potential Measurements 
 
Zeta potential was measured using the Malvern Zetasizer Nano.  Samples were 
prepared as previously described (2.2.2), vortexed briefly and sonicated for 10 
minutes and then transferred to a 1ml Malvern clear zeta potential cell.  A titration 
was carried out using hydrochloric acid (HCL) and sodium hydroxide (NaOH) to 
determine the IEP, the NM were titrated from acidic pH (pH = 1) to a basic pH 
(pH = 12) and at every 2 pH units (± 0.5 U) the zeta potential were determined.  
The zeta potential measurements were plotted against pH to determine the IEP. 
 
2.2.5 Nanosight Size Measurements 
 
NTA was carried out on a NanoSight LM20 (NanoSight Ltd., UK).  Samples were 
prepared in ultra-pure filtered water.  The sample chamber was removed from the 
unit, dismantled and cleaned first by rinsing with ethanol, then with deionised 
water and then cleaned with lens grade paper.  The sample chamber was 
reassembled and using a 1ml syringe (without a needle) the sample was 
introduced carefully to avoid high pressure and bubbles from forming.  The 
chamber was placed in the unit and aligned to the laser beam.  Using NTA 2.0 
software, the viscosity, temperature and length of film to be captured (166 
seconds) was specified.  The auto settings were used to allow software to 
determine appropriate shutter and gain settings.  The expert mode was used to 
adjust settings such as minimum expected size.  When the quality of the picture 
was deemed “good” and when the settings were saved, the motion was captured.  
The NTA 2.0 software automatically opened in processing mode when a video 
was opened.  The videos were processed and a report was saved to excel and 
exported as a PDF.  
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2.2.6 Differential Centrifugal Sedimentation Measurements  
 
Measurements were carried out using DCS.  A volume of 100μg/ml of each of the 
three particles in water was made up and injected into a differential centrifuge 
(CPS instruments USA) at a speed of 18747g.  Using specific parameters for iron 
oxide NMs the density was specified as 5.24g/cm
3
 (Fe2O3) and 5.17g/cm
3
 (Fe3O4) 
and particle absorbance at 0.5nm.  The sample settled according to the size of the 
particles and the mean size from the resulting peaks was used as the average size 
of the sample.  
 
2.2.7 Light Microscopy 
 
Light microscopy was carried out on an inverted microscope.  A digital camera 
(Canon 40D) was attached to capture the images.  Samples were prepared as 
described (2.2.2), these slides were then analysed under 10, 20 and 100x 
magnification to gain information regarding dispersion state.  
 
2.2.8 Scanning Electron Microscopy (SEM) and EDX  
 
Samples were prepared as described (2.2.2).  SEM was carried out on a Hitachi S-
4800 II.  The resulting images were analysed using Image J (freeware from NIH-
USA) 
 
2.2.9 Transmission Electron Microscopy (TEM) 
 
TEM characterisation was performed to obtain size, size distribution and 
morphology on a Hitachi H -7600.  The samples were prepared as described 
(2.3.2).  Information on mean size and standard deviation was calculated using 
Image J analysis of the images.  
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2.3 Results  
 
2.3.1 Dispersion  
 
A. B.  
Figure 2.1: 280 nm Fe2O3 particles suspended in phenol red free RPMI 
 at 0 minutes (A) and after 24 hours (B) from left to right in 0, 0.1, 0.5 
and 1% BSA. 
A. B.  
Figure 2.2: 22 nm Fe2O3 NM suspended in phenol red free RPMI at 0 
minutes (A) and after 24 hours (B), from left to right in 0, 0.1, 0.5 and 
1% BSA. 
A. B.  
 
Figure 2.3: 45 nm Fe3O4 NMs suspended in phenol red free RPMI at 0 
minutes (A) and after 24 hours (B), from left to right in 0, 0.1, 0.5 and  
1% BSA. 
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A. B.  
 
Figure 2.4: 280 nm Fe2O3 particles suspended in phenol red free RPMI 
at (A)0 minutes and (B) after 48 hours, left to right phenol red free  
RPMI and phenol red free RPMI+10% FCS. 
 
Figures 2.1 - 2.4 show images at time 0 and time 24 hours for 
comparison purposes.  The particles of all sizes tend to settle out of 
solution after 24 hours.  The addition of extra protein had a 
stabilising/dispersing effect keeping the particles in suspension an d 
dispersed for longer.  This can be particularly seen in figure  2.4 which 
shows the 280nm Fe2O3 particles dispersed in RPMI with 10% foetal 
calf serum (FCS).  The 45nm Fe3O4 NM behaved in a different manner 
to the Fe2O3, in that they seem to settle faster out of solution.    
 
2.3.2 Cytospin and Light Microscopy 
 
 
Figure 2.5: Light microscopy at 20X magnification of 280nm Fe2O3 
particles in (a) water, (b) RPMI and in (c) RPMI with 1% BSA showing 
evidence of improved dispersion in cell culture media and cell culture 
media with added protein. 
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Figure 2.6: Light microscopy (20X) of 22nm Fe2O3 particles in (a) water  
(b) RPMI and (c) in RPMI with 1% BSA. 
 
 
Figure 2.7: Light microscopy (20X) of 45nm Fe3O4nm particles in (a) 
water, (b) RPMI and (c) RPMI with 1% BSA. 
Figure 2.5 - 2.7 shows the 280nm, 22nm and 45nm iron particle dispersions in 
different media.  It appears that all particles are more dispersed in RPMI cell 
culture media and medium with added BSA than in water alone (figures 2.5(a), 
2.6(a) and 2.7(a)).  These figures also indicate that agglomeration to some degree 
occurred in all of the media.  This was investigated further using electron 
microscopy. 
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2.3.3 SEM 
 
 
 
Figure 2.8: SEM micrograph showing 280nm Fe2O3 particles in (A) water, (B) 
RPMI AND (C) RPMI with 1% BSA. With scale bar on the right and voltage 
specified on the left.  
B 
A 
C 
C 
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Figure 2.9: SEM micrograph showing 22nm Fe2O3 particles in (A) 
water, (B) RPMI and (c) RPMI with 1% BSA. With scale bar on the right 
and voltage specified on the left.  
A 
B 
C 
41 
 
 
 
 
Figure 2.10: SEM micrograph showing 45nm Fe3O4 particles in (A) 
water (B) RPMI (C) and RPMI with 1% BSA. With scale bar on the right 
and voltage specified on the left.  
A 
C 
B 
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The SEM pictures reveal the particles morphology to be nearly spherical in nature 
with a tendency to agglomerate in all media types.  Both the 280nm and the 22nm 
Fe2O3 look very similar in terms of particle size and morphology and the images 
reveal a slight difference in appearance in the 45nm Fe3O4 iron oxide NMs, which 
appear to be far more agglomerated than the 280 nm Fe2O3 particles.  At this high 
magnification it is difficult to see any differences when the particles are dispersed 
in water, RPMI or RPMI with added protein.  But in all media types the particles 
appear to be agglomerated with a range of particle diameters described in table 
2.2. Calculating size from SEM images was achieved in two ways.  Manually 
counting every particle visually and using a scale bar to estimate particle size and 
also using open source software Image J.   
 
Table 2.2: Particle hydrodynamic diameter as determined from SEM 
micrographs, calculated using Image J software before and after using 
watershed feature.  
 
Particle Type Diameter (nm) Diameter (nm)as 
Determined by Image J 
22nm in water 643.43±84.23 272.39±115.95 
22nm in RPMI 612.90±253.15 228.18±74.55 
22nm in RPMI+0.1%BSA 702.82±129.26 203.08±81.06 
280nm in water 611.96±103.78 253.12±54.07 
280nm in RPMI 231.80±137.59 90.01±9.07 
280nm in RPMI+0.1% BSA 532.27±107.00 185.22±57.31 
45nm in water 1284.51±58.10 59.00±13.88 
45nm in RPMI 356.52±73.15 128.85±170.30 
45nm in RPMI+BSA 388.60±365.40 76.69±105.29 
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2.3.4 TEM 
 
TEM revealed not only size data but also important morphological and structural 
characteristics as can be seen from the figure 2.12 - 2.15.  For example, the Fe2O3 
particles (figure 2.12 and 2.14) images clearly show a polydispersed particle size 
distribution.  
 
   
Figure 2.11: TEM micrograph of 280nm Fe2O3 particles dispersed in 
water. Size bar represents 1 µm. 
 
   
Figure 2.12: TEM micrograph showing 22nm particles dispersed in 
water Size bar represents 200nm. 
 
 
Figure 2.13: TEM micrograph showing 45nm Fe3O4 particles dispersed 
in water. Size bar represents 1 µm. 
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2.3.5 DLS 
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Figure 2.14: Graph showing DLS hydrodynamic diameter of 280, 22 and 45nm 
particles at 100, 10 and 1 µg/ml in water, RPMI and in RPMI with 0.1% BSA.  
Values represent the means of 3 experiments ± SEM (See appendix 8.1 for full set 
of data). 
 
One way analysis of variance (ANOVA) was preformed to investigate the DLS 
measurements further and revealed that there was a significant difference between 
the size (i.e. hydrodynamic diameter) in water, RPMI and RPMI with BSA for the 
280nm particles at 100µg/ml (P=0.00), with the largest particle size observed in 
RPMI.  There was a significant difference between the size of the 22nm Fe2O3 
particles in water, RPMI and RPMI with 1% BSA at 100µg/ml (p=0.00) and again 
the largest size was to be found when the NMs were measured in RPMI (with and 
without BSA).  ANOVA also found there was no significant difference between 
the size of the 45nm Fe3O4 NM in water, RPMI and RPMI with 0.1% BSA at 
100µg/ml (p=0.253).  The graph shows that there is a clear influence of particle 
concentration on the hydrodynamic size for all three particle types (22nm, 280nm 
and 45nm) and there is an effect of media on hydrodynamic size for the 22nm and 
280nm particle.  The higher concentration of 100µg/ml gives a higher Z average 
reading then the lowest 1 μg/ml reading.  This result was found in all media types.  
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2.3.6 Nanoparticle Tracking Analysis (NTA) 
 
Table 2.3: Hydrodynamic diameter of two particle types Fe2O3 (280nm) and 
Fe3O4 (45nm) at 10µg/ml (n=3) data obtained from NTA analysis as 
explained in 2.2.5 
 
Fe2O3 
280nm 
Mean Mode St dev Concentration (i.e. NTA 
estimation of number of 
particles/ml) 
  
1 216.00 216.00 45 4.58E+08   
2 291.00 241.00 92 4.85E+08   
3 263.00 274.00 76 5.82E+08   
Average 256.67 243.67 71.00 5.08E+08 6.52E+07 
 
Fe3O4 
45nm 
Mean Mode St dev Concentration (i.e. NTA 
estimation of  number of 
particles/ml) 
  
1 232 42 169 4.06E+08   
2 228 47 184 1.39E+08   
3 154 31 115 3.17E+08   
Average 204.67 40 156 2.87E+08 1.36E+08 
 
The NTA model generates an alternative model of the NM hydrodynamic 
diameter compared to DLS.  Upon further investigation of the NTA graphs the 
280 nm particles can be seen to be a monomeric sample, whereas it is clear there 
are aggregates or agglomerates present in the 45nm sample. This can be seen quite 
clearly in the graphical output from the NTA as seen in the below figure (2.15- 
2.16) 
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Figure 2.15: A graphical representation of the NTA data as described in table 2.3.  
NTA was carried out as mentioned in 2.2.1.2.  This figure shows the NTA analysis 
of 280nm Fe2O3 showing particle hydrodynamic diameter as a function of 
concentration and relative intensity.  Each panel shows the four typical images 
produced by NTA. The top left shows the size distribution from NTA 
measurements of the 280nm Fe2O3 particles. The top right panel shows a video 
frame of the live recording of the patterns made due to scattering of light by these 
particles. The bottom left panel shows particle size as a function of relative 
intensity and the bottom left panel shows a 3D representation of the particle size 
as a function of relative intensity.  The monodispersed 280nm Fe2O3 sample was 
found to have a diameter of 256. 67nm.  
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Figure 2.16: A graphical representation of the NTA data shown in table 2.3. This 
figure shows the NTA analysis of 45nm Fe3O4 particles showing the 
hydrodynamic diameter as a function of concentration and relative intensity. Each 
panel shows the four typical images produced by NTA. The top left shows the size 
distribution from NTA measurements of the 45nm Fe3O4 particles. The top right 
panel shows a video frame of the live recording of the patterns made due to 
scattering of light by these particles. The bottom left panel shows particle size as 
a function of relative intensity and the bottom left panel shows a 3D 
representation of the particle size as a function of relative intensity. The mode was 
found to be 42nm however peaks can also be seen at 76nm and agglomerates 
were tracked at the 100-700nm range. 
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2.3.7 Differential Centrifugal Sedimentation 
 
 
 
Figure 2.17: Differential centrifugal sedimentation graph showing particle 
hydrodynamic diameter of the 280nm Fe2O3 particles and the 45nm Fe3O4 
particles as a function of relative weight. DCS was carried out as explained in 
2.2.6. The results (n=3) modelled the 280nm particle size at 303.5nm and the 
45nm Fe3O4 NM gave a size of 174.8nm.  The 22nm particles produced an 
identical peak as that of the 280nm particles data shown in appendix (8.2). 
 
2.3.8 Zeta Potential 
 
 
 
Figure 2.18: Zeta Potential (mV) of iron oxide particles (280nm and 45nm) 
dispersed in water over pH range showing an IEP of at pH 2.75 for the 280nm 
particles and at pH 3.5 for the 45nm particles. 
 
280nm Fe2O3 
45nm Fe3O4 
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Figure 2.19: Zeta Potential (mV) of iron oxide particles (280nm and 
45nm) dispersed in RPMI over pH range showing an IEP of at pH 2 for 
the 280nm particles and at pH 2.9 for the 45nm particles. 
 
 
 
Figure 2.20: Zeta Potential (mV) of iron oxide particles (280nm and 
45nm) dispersed in RPMI+0.1% BSA over pH range showing an IEP of 
at pH 4 for the 280nm particles and at pH 4.1 for the 45nm particles 
 
 
Figure 2.18 - 2.20 shows the ZP versus pH in three different media types.  
Samples were prepared as previously described (2.2.5).  At every 2pH units (± 0.5 
U) the zeta potential was determined and plotted against pH to determine the IEP. 
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2.3.9 Sonication Study 
 
  
 
Figure 2.21 The effect of sonication time on hydrodynamic diameter of 
280nm Fe2O3 particles as determined by DLS performed as detailed in 
2.2.2. After 10 minutes sonication the particle had a Z average of 307nm 
(Pdi 0.24), 20 minutes 342nm(Pdi 0.32), 30 minutes 317nm (Pdi 0.24), 
40 minutes 321 nm ( Pd1 0.25) and after 50 minutes sonication 407nm 
(Pdi 0.24)  
 
2.3.10 Metal Analysis by SEM/EDX 
 
(a) 
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(b) 
 
(c) 
 
 
Figure 2.22: SEM/EDX profile for (a) 280nm (b) 45nm and (c) 22nm iron 
particles (n=1: n=3 in appendix 8.4.  Energy Dispersive X-Ray Spectroscopy 
was carried out on each of the three particle types in order to identify the 
elemental composition. This non destructive technique analysed three 
separate sections for each particle type to produce a representative view of 
the elemental composition of the particles. As can be seen from images Figure 
2.22 iron and oxygen is the main component of all the particles ranked by 
abundance. A large peak was also detected for silica and platinum. As sample 
preparation involved placing of sample on a glass slide and coating the 
sample with platinum this can account for presence of these elements.  
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2.4 Discussion  
 
Iron oxide NMs and particles were examined for the effect of time, sonication, 
particle concentration, ionic strength, pH, and the presence of FCS on their 
stability and characteristics.  This was accomplished using a range of techniques.  
Size analysis (DLS and DCS) of the 280nm and the 22nm Fe2O3 particles, 
suggested they were so similar it was not possible to distinguish between them; 
therefore the remaining study was conducted (after characterisation) with the 
280nm Fe2O3 and the 45nm Fe3O4 particles only.  
 
Physicochemical characterisation of these test particles in a representative 
dispersant is essential if any comparison to a potential biological effect is to be 
made.  The sizing results alone from the different experimental methods (DLS, 
NTA, image analysis, etc.) indicate that the effect of cell culture media on 
agglomeration is significant.  This is an important issue as little is known to date 
about the colloidal stability of iron NMs in cell culture medium.   
 
The images of NM suspension in vials give a good visual comparison of how 
stable the NMs and particle dispersions were.  These sedimentation studies show 
that the iron oxide particles settle rapidly out of solution when in water but with 
the addition of proteins they tend to form a more stable dispersion.  This can also 
be clearly seen in the light microscopy images of the cytospin samples.  The 
microscopy studies show the particles are polydispersed in nature and tend to 
agglomerate.  SEM found the diameters of agglomerates for the 280nm ranged 
from 230nm to 700nm and the 45nm particles ranged from 300nm to greater than 
1000nm.  SEM and TEM are used frequently to characterise NM size (diameter) 
and size distribution.  Traditionally analysing these characteristics from SEM and 
TEM images has been achieved manually counting and measuring every particle 
visually.  This is not only subjective but also labour intensive.  Using automated 
particle analysis programmes for nanoparticulate analysis has not always been an 
option as NM agglomerates tend to confuse the automated software programmes 
which will recognise agglomerates as one particle giving inaccurate particle size 
readings.  This would therefore overestimate NM size not allowing the difference 
between the individual and the population to be identified.  The user can use tools 
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in these software programmes to specify each particle size individually however 
in a large image this is time consuming.  Here, open source software called Image 
J was used for the particle analysis.  This software includes functions and 
algorithms (such as the water shed tool) as add in features of the programme that 
can be used to break agglomerates (which may occur in specimen preparation) 
into separate particles before analysis.  However this technique requires caution as 
it cannot be assumed to work for every image and particular attention must be 
paid to each image to supervise what the software recognises.  The results 
obtained using automated particle counting software gives an indication of 
particle size but for complete analysis a range of sizing techniques should be 
employed to gain more insight into the particles under investigation.  
 
DLS size analysis found the agglomeration rate and thus the size increased with 
particle concentration.  If a sample is too concentrated it may not be able to freely 
diffuse due to particle-particle interactions.  Thus the sample concentration is of 
importance when trying to elicit size.  In general these particle-particle 
interactions will not occur at concentrations below 0.1% by volume [125].  
However there is a significant difference in size between the 100μg/ml (.01%), 
10μg/ml (0.001%) and the 1μg/ml (0.0001%) dilutions at each particle type, with 
the 100µg/ml concentration having the greatest effect on the hydrodynamic size of 
the 280nm and 45nm particles in RPMI.  This suggests that there may be some 
concentration effects at a level below the 0.1% concentration.  NM hydrodynamic 
diameter was also affected by the type of media it was dispersed in.  In all cases 
the particle size was smaller in water and increased in RPMI, also the addition of 
BSA can be seen to have an effect on the size, in most cases causing a decrease in 
size, but still significantly higher than in water alone.  
 
Sonication was used as a method of dispersal as the particles did not go easily into 
solution.  To determine if the effect of time had any impact on the size/stability of 
the iron oxide particles, a sonication study was carried out and the results indicate 
that up to forty minutes of sonication did not have any adverse effects on size 
however in comparison after fifty minutes of sonication there was a slight increase 
in the hydrodynamic diameter.  Sonication was required for two main reasons (i) 
as mentioned above the particles did not easily go into solution (ii) to make sure a 
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homogeneous sample was always during experimentation.  As the size was not 
significantly impacted by sonication after ten minutes this was taken as the 
sonication time of particles in water for all future experiments.  
 
The IEP of the NMs was found to be in the range of pH 2 - 4.  The largest 
agglomerate size would be expected to be found at the IEP (i.e. where ZP=0).  
The further away the ZP deviates from the IEP the smaller the particle 
agglomerate would be due to increasing repulsive forces.  The results indicate that 
the iron oxide particles are moderately stable at a pH of 7 in water with a ZP of 
40mV (±7.59mV).  The ZP was also measured in cell culture media and in cell 
culture media with 0.1% BSA.  The ZP readings were much higher in RPMI and 
ultimately there was a shift to the left with the IEP found to be in the range of 
pH2.  It is important to note that instrument capabilities should be taken into 
account.  The DLS zeta technique is not optimized for cell culture media.  The 
media itself can lead to damage of the instrument cell in which the sample is 
cased and may lead to uncertainties in the analysis.  Consequentially the high 
value may not represent a true ZP value.  However it can also be considered that 
the higher ZP and low pH at which the IEP value was obtained for the iron 
particles in RPMI could be due to adsorption of ions onto NM surface.  Anions 
present in RPMI such as phosphates could act as ligands.  Therefore, during a 
titration experiment the more protons (acid) that are required to counteract 
adsorbed ions will lead to a lower IEP value.  This seems like an intuitive 
explanation of what may be occurring in the system.  These types of studies 
considering the impact of cell culture media on NMs are important at the initial 
stages of experimentation.  NMs with adsorbed species from cell culture media 
may exhibit novel surface properties which can influence NM behaviour in vitro 
in a way that may not be replicated in vivo.  For example, Chen et al. [148] reports 
the role of FCS in RPMI in influencing the stability, surface properties and 
intracellular uptake of magnetic NMs which they attribute to the adsorption of 
FCS onto the surface of MNPs. 
 
A simple study also investigated the size of the 22nm particles at different pHs 
(data shown in appendix 8.3).  At pH 7 (in water at 10µg/ml) they have a 
hydrodynamic size of 330nm however this increased significantly to 533nm at a 
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pH 3 and 1066nm at pH 2, thus supporting the fact that as the ZP reaches its IEP 
point the NM dispersion becomes less stable and more likely to agglomerate.  
This simple experiment shows the pH of the dispersants is an important factor to 
consider in any experimental set up. Although the particles above are stable in 
RPMI at a pH 7 which is the pH of the cell culture model system it can be seen 
that at a pH 4 they reach the IEP, suggesting the particles are not stable at this pH.  
This is an important consideration as the lysosomes of the cell operate at this pH 
and so NM may be less stable if they enter the cell lysosomes. 
 
Interestingly the NTA and DLS complement each other and each technique makes 
up for the deficiencies in the other.  Using a variety of techniques in this way is 
not an attempt at method validation but simply a requirement in NM 
characterisation.  The NTA models show an alternative view of the NM size.  
Upon further investigation of the NTA it can be clearly seen that there are 
agglomerates present, but as NTA separately tracks each individual particle the 
size distributions generated reflect the actual number of particles seen or the 
tracks processed and followed for a longer length of time.  As mentioned before, 
this is an advantage over PCS, a method where a large number of particles are 
analysed simultaneously and result in a z-average.  When using PCS if there are 
agglomerates present it will lead to a shift in the distribution to the right hiding or 
obscuring any smaller particles present in the sample, so this combined technique 
shows that there are agglomerates present and NTA allows us to determine in 
what range these particles are present and this is verified by SEM/TEM.  Care 
must be taken in interrupting this data, as it is easy to misinterpret data from the 
NTA as the automatic settings make it easy to analyse only tracks of interest 
rather than the entire sample leading to a bias in the particle estimation to the size 
of the stated particle rather than the actual particle size.  This is a minor issue that 
once identified can be easily remedied by adjusting the settings and preparing 
appropriate dilutions that allow both large and small particles to be identified and 
tracked, so agglomerates that are present will also be tracked as they move into 
the field of focus however unlike DLS they will not bias the overall results.  
 
EDX analysis showed output spectra that have characteristic peaks corresponding 
to the energy levels for iron.  As expected iron and oxygen is the most abundant 
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element present within the sample however a high amount of silica is also present.  
This can be explained by the sample preparation.  In order to analyse a sample on 
the SEM and thus on EDX, the sample is spun onto a glass slide on which the 
sample is introduced to the SEM. This glass slide was therefore the source of 
silica in this instance.  
 
Using a range of characterisation methods can give a more fully rounded 
indication of the actual nature of the NM.  Each technique adds an extra layer and 
depth of knowledge complementing each other, each will give its own unique 
model or view of the particles and together this combined approach can help to 
build an understanding of the complex nature of particles at the nanoscale.  For 
example, some methods are not suited for certain particles.  DLS and NTA 
analysis are based on size calculations for spheres and thus would not be suited as 
sizing technique for nanorods or nanowires.  Taking the 45nm Fe3O4 NM as an 
example; Fe3O4 NM was specified to have a nominal primary particle size of 
45nm.  DLS results find a Z average hydrodynamic value of 450nm at 10µg/ml, 
the Pdi of 0.3 indicating some degree of polydispersity.  NTA shows the sample to 
have a mode of 42nm but also shows many peaks right up to 500nm.  Upon 
further investigation of the NTA graphs it be clearly seen that there are aggregates 
present, but as NTA separately tracks each individual particle the size 
distributions generated reflect the actual number of particles seen whereas the 
DLS technique analyses particles simultaneously and result in a z-average.  When 
using DLS if there are aggregates present it will lead to a shift in the distribution 
to the right, hiding or obscuring any smaller particles present in the sample.  This 
combined technique shows that there are aggregates and agglomerates present but 
NTA shows exactly in what size range and agglomerates or aggregates were 
found to be present at 76nm and where tracked up to the 700nm size range.  SEM 
adds another level of understanding allowing us to see the individual 45nm 
primary particles but shows the configuration of these particles together.  Using 
Image J with the watershed tool plug in the individual particle size was found to 
be 54.07nm.  By comparing analytical techniques it can be seen that a range of 
techniques and not one standard technique is recommended for NM 
characterisation. 
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2.5 Conclusion 
 
This study shows it is not sufficient to rely on the manufacturers or suppliers 
stated physicochemical characteristics for NMs as this may vary from batch to 
batch.  It is important to have a range of techniques in order to elucidate the most 
important aspects of the particle characteristics.  In this newly emerging science of 
nanotoxicology this should not be mistaken for method validation. Nano specific 
measuring techniques are constantly evolving from methods employed in the non-
nano field.  Each technique will give its own unique model or view of the particle.  
In the absence of a ‘gold standard’ for nanoparticle characterisation this combined 
approach can help to build an understanding of the complex nature of particles at 
the nanoscale.  This work found that of the three particles supplied for the study 
there was no difference between the 280nm and the 22nm Fe2O3 particles in terms 
of size, size distribution and ZP.  Given the close similarity in appearance of these 
two particles it may be a case of mislabelling. It was not possible to confirm this 
however and the remaining study concentrated on the 280nm Fe2O3 and the 45nm 
Fe3O4 particles only. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
 
Chapter 3  Nanomaterial - Protein Interactions Consequences 
for Nanomaterial Toxicity 
 
3.1 Nanomaterial – Protein Interactions 
 
The molecular environment in which NMs are present influence their properties 
and potential toxicity.  Once NMs enter the body they immediately come into 
contact with biological fluids and thus will become coated in airway mucus, 
alveolar lining layer or blood components [78].  These fluids contain amongst 
other molecules an abundance of proteins and lipids.  Proteins can associate with 
the NMs and form a protein - NM interaction by adsorption. As opposed to 
absorption, adsorption is the adhesion of molecules (atoms or ions) from a liquid 
or gaseous state to a surface.  Evidence that NMs adsorb proteins onto their 
surface has been previously described [103, 149, 150] and after initial exposure 
and throughout their journey in the body NMs will encounter and interact with 
many different types of proteins depending on the initial exposure and their fate in 
the body [1].  This is an area of active research in the nanotoxicology community 
as currently there is limited information on how NMs interact with these 
biological components or the role of these interactions is influencing NM toxicity.  
Knowledge of protein interactions not only between the NMs and the protein but 
also between the NM-protein and the cell interface will allow for a greater 
understanding of how these materials behave in the body.  
 
3.1.1 The Protein Corona 
 
The specific proteins that adsorbed to the surface of a NM at any given time have 
been termed the protein ‘corona’ [151].  Studies investigating protein adsorption 
suggests that this interaction or this layer of proteins is what the cell ‘sees’ and 
thus if we are to understand or elucidate how the body will react to NMs, their 
cellular location, the pathway and process they undergo in the body, the proteins 
that associate with the NMs once in the body must be identified [103].  
Theoretically, the corona can be classified into what is termed the ‘hard’ or long 
lived corona and the ‘soft’ or short lived corona.  The long lived corona being 
made up of proteins that remain associated with the NM surface for a longer time 
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due to slow exchange kinetics with the surrounding environment.  The soft corona 
being made up of proteins that associates with the NMs for a short amount of time 
due to fast exchange kinetics with the surrounding environment [103, 152].  It is 
becoming increasingly clear that it is the long lived outer layer of adsorbed 
proteins – the stable hard corona that is of concern in nanotoxicology as the soft 
corona is transient and being weekly bound to the NM may not be of concern in 
toxicological terms [1, 103, 153].  It is not just the composition of the protein 
layer that is significant when elucidating the interaction of NMs with 
biomolecules and cells but it is important to realize that this is a dynamic 
association.  The factors that may affect the exchange times of proteins adsorption 
and the kinetics of this association/dissociation, may provide information on the 
NM’s interactions with biological surfaces/receptors and hence its fate in the 
body.  This again points to the importance of NM characterisation as the nature of 
the NM will influence the protein adsorption kinetics.  This includes factors that 
may not have necessarily been known, such as residues from the manufacturing 
process and the presence of endotoxin or controllable factors such as dispersants 
and buffers used in NM preparation and in toxicity testing [25]. 
 
3.1.2 The Corona as a Function of the Physicochemical Properties of 
Nanomaterials 
 
The physicochemical properties (such as size, surface properties, hydrophobicity, 
surface coatings) of NMs will determine the corona composition in different 
biological media [102, 154, 155].  For example, Cedervall et al. [102] found the 
degree of hydrophobicity of NMs influenced the amount and the type of proteins 
bound to its surface.  Lundqvist et al. [154] found that the size and surface 
modifications of polystyrene NMs significantly changes the nature of the bound 
proteins.  Furthermore, as mentioned in 3.1.1 the corona is not static, as different 
proteins have different affinities and different equilibrium constants to the particle 
surface.  These interactions can change over time [102, 149, 151].  The resident 
times (which can be from microsecond to days [25]) have been measured using 
techniques not commonly employed in nanotoxicology (e.g. isothermal titration 
calorimetry, size exclusion chromatography, surface plasmon resonance 
spectroscopy, etc.).  Considering toxicological investigations, the most abundant 
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proteins in a solution may not necessarily be of interest as it may be possible that 
less abundant proteins with a high affinity and/or specificity for a particular 
receptor may instead be of more relevance [103].  For example, the ability of 
opsonin proteins to bind (or not bind) to NMs will significantly alter how such a 
NM is processed in the body for example by promoting receptor mediated 
phagocytosis.  In blood more abundant proteins such as human serum albumin 
and fibrinogen might bind more favourably to the NM surface, however if 
proteins of lower abundance but with higher affinities and slower kinetics bind, 
they can over time displace proteins already present and alter the corona 
composition.  
 
3.1.3 Impact of Nanomaterial - Protein Interactions on Function of Proteins 
 
The ability of NMs to bind proteins may leave them unavailable for their normal 
biological functions. Conversely it has also been suggested that binding of 
proteins to NMs may have an impact on the structure of the proteins [103] and the 
protein’s biological function [154].  Many studies have reported the use on NMs 
to alter and control signalling and subsequent cellular responses ([156, 157]).  
Thus the implication of NM - protein binding is not only that the particle toxicity 
may be driven by their attached proteins but the possibility that NM-protein 
binding may impact the structure or the biological function of the protein.  
Investigating this is a challenging task as the protein concentration in body fluids 
can be up to 35% (0.35g/ml) [103], and plasma (which has 8% proteins) is made 
up of many different proteins which exist in varying concentrations.  Brown et al. 
[118] demonstrated that 14nm CB NPs adsorbed significantly more cytokines 
(TNF-α) than 260nm CB from solution and went on to find that TNF-α coated 260 
CB produced a greater expression of ICAM-1 in epithelial cells than TNF-α 14nm 
CB.  This work supported the hypothesis that one consequence of the NM - 
protein interactions may be that proteins mask the nanoparticle surface, thereby 
reducing NM reactivity and protein functionality. 
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3.1.4 Relevance of the Corona in Toxicological Studies 
 
When considering exposure, translocation and fate of NMs in the body we must 
consider that NMs have the ability to interact with a variety of different 
molecules.  Thus the protein corona, being a dynamic structure may vary 
depending on the NM properties but will also evolve depending on the route of 
exposure (e.g. inhalation, injection, ingestion and dermal adsorption), and on 
where in the body the NM translocates.  This suggests that NM toxicity may be 
driven by the exposure route due to the specific protein binding and that this is 
modified as the NMs move around the body.  As the biological identity of the 
NM is a consequence of the outer layer then it is important to investigate this 
corona to determine how flexible the corona is over time and in various different 
types and concentrations of proteins as it travels through the body.  In this way 
we can gain an understanding of how the body will react to NMs, their cellular 
location and the pathway/process they undergo in the body.  However the 
stability or flexibility of the corona over time and during movement between 
different body compartments remains unclear, including the relationship between 
proteins of high abundance and proteins of high affinity.  Although the long lived 
or hard corona is important when considering the fate of NMs in the body, there 
is a limited amount of studies available to demonstrate impacts of corona 
composition on fate, cellular interactions or toxicity [151].  To date studies have 
demonstrated the impact of cell culture media on NM toxicity [158].  It has been 
shown that carboxylated polystyrene NPs, when tested in vitro in the absence of 
FCS have an enhanced response on J774.A1 cell cytotoxicity and uptake than in 
the presence of FCS [114], suggesting that FCS may impart some protective 
influence.  Indeed cytotoxicity studies have shown the protective effect of 
serofendic acid (a component of FCS) against oxidative stress in monocytes [159] 
and neuronal cell types [160, 161].  It could be that this protective FCS effect is 
cell specific as previous studies have demonstrated that serum enhances the 
uptake of polystyrene NPs in hepatocytes [17].  With relation to NMs, corona 
studies have reported that binding of proteins from FCS to graphine oxide NMs 
[162] and blood proteins to CNTs [163] reduced the cytotoxicity of these NMs in 
human A549, monocytic leukemia and endothelial cell lines.   
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In this study the protein corona identity or ‘profile’ of iron oxide particles in 
human plasma and cell culture FCS was examined. To simulate exposure of NMs 
via inhalation followed by translocation to blood a protein corona first in lung 
lining fluid (LLF) was developed before transferring the NMs into serum or 
plasma.  Also investigated was the role of particle-protein interactions (i.e. the 
role of adsorbed proteins) in influencing the potential biological reactivity or 
toxicity of the NMs in macrophages.  As serum is present in cell culture media 
any effect it can have on the toxicity of NMs is essential to understand (especially 
when considering standardised nanotoxicology protocols).  Comparison of serum 
and plasma corona and its effect in a macrophage cell line can help with future in 
vitro /in vivo cytotoxic comparisons. 
 
3.1.5 Plasma 
 
The liquid component of blood is plasma and it contains several thousand 
different proteins.  Table 3.1 highlights the main components of blood plasma.  
Plasma proteins, most of which are synthesised in the liver, vary in abundance by 
twelve orders of magnitude [164].  A recent study by Shen et al. [164] described 
a method whereby 2392 proteins were identified from a single plasma sample.  
They found the relative abundances of these proteins covered a range of over 
eight orders of magnitude in concentration (< 30pg/ml to ∼30mg/ml).  Plasma is 
thus a complex proteome.  It has a vast dynamic range, a large abundance of 
albumin, there is a heterogeneity of glycoproteins [165] and protein compositions 
and expression varies between individuals.  These are just some examples of 
what makes plasma a very difficult biological sample to investigate.  Separation 
and identification of its components is therefore a difficult task.  Plasma functions 
in maintaining temperature and osmotic pressure, it is also essential in transport, 
signalling cascades and regulatory mechanisms [165].  For this reason it has a 
great diagnostic potential and its constituents (or lack thereof) provide biomarkers 
for disease diagnostics and so much work has been carried out since the 1900’s 
investigating analytical characterisation methods to separate and identify the 
various fractions of blood plasma.  
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Table 3.1: The table presents the most abundant components of blood plasma 
the types and percentage as well as the primary function of these main 
components (adapted from OpenStax College online source [166]).  
 
Component 
of blood 
Subcomponent 
Type and 
percentage 
Primary Physiological 
Function 
 
 
 
 
 
 
 
 
 
 
 
Plasma 
Water  
(92%) 
 
 
Fluid 
 
 
Transport medium 
 
 
 
 
 
 
Plasma Proteins 
(7%) 
 
 
 
 
 
 
 
 
Albumin 
(66kDa) 
 
(54-60%) 
 
 
Regulates 
osmotic pressure and 
pH, transporter, drug 
delivery. 
Globulins  
(155-160kDa) 
 
(35-38%) 
 
 
Maintain osmotic 
pressure. Defence 
mechanism and role in 
transport 
Fibrinogen  
(340kDa) 
(4-7%) 
 
Blood clotting and 
haemostasis 
Regulatory 
Proteins (>1%) 
Hormones and 
Enzymes 
Varied/regulation of 
body function 
Other Solutes 
(>1%) 
nutrients/gases
/wastes 
Numerous/varied 
 
3.1.6 Foetal Calf Serum  
 
FCS which is the liquid fraction of clotted blood from the fetal calf (minus cells, 
fibrin and clotting factors) is used in cell culture due to the large number of 
nutritional factors essential for cell growth and low level of antibodies.  Its 
function in cell culture is in providing essential growth factors for cells such as 
hormones, attachment and spreading factors, binding proteins, lipids, and minerals 
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[167]. The major component is BSA (bovine serum albumin) but it also contains 
amino acids, sugars, lipids and hormones.  Just like plasma it is a complex 
proteome and as such not every component has been identified, however it still 
remains the most effective growth product for cell culture  
 
3.1.7 Lung Lining Fluid 
 
A major entry route of NMs into the human body is the respiratory tract.  Many 
factors such as the size, shape and surface chemistry of the particles will be a 
factor in determining the fate of the particles in the lung but it is clear that size is a 
key parameter that determines if a particle will translocate across the alveolar 
capillary barrier [24].  In the alveolar region they can come into contact with lung 
lining fluid (LLF).  Although particles  <5μm in diameter undergo macrophage 
phagocytosis and mucocilliary clearance, UFP are not readily phagocytosed and 
thus can enter the pulmonary interstitium via the epithelium [168]. 
 
One line of defence against inhaled particles is LLF.  Kendall [168] found that 
when PM 2.5 is collected into normal lung lining liquid the particles aggregate 
into larger (>5 um) dense structures compared with samples collected in air or 
into saline.  Such aggregation will allow inhaled particles to become available for 
phagocytosis by AM where they can then be eliminated from the alveoli to the 
mucocilliary escalator or across the alveolar epithelium to the interstitium or 
circulating blood [169].   LLF has been reported to be diverse in its chemistry and 
composition.  This in part may be due to the inherent difficulty in obtaining a 
representative sample given the complicated sampling procedure (see 3.2.1) but 
LLF composition will also vary due to its source, local production and 
mechanisms such as active transport.  It is produced and secreted by type II 
alveolar epithelial cells and Clara cells [169].  As inflammatory cells (e.g. 
macrophage, lymphocyte, and neutrophils) line the alveolar space they will be 
found in the LLF.  In most cases (from human samples) 80% of these cells found 
in LLF were alveolar macrophages [170]. 
 
The majority of the non cellular components include proteins, such as cytokines 
and immunoglobulin, surfactant-like lipids and phospholipids, complement 
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factors and enzymes.  The largest component is made up of phospholipids (80%), 
the most common being phosphatidylcholine.  The phospholipids function in 
reducing surface tension during breathing.  The 10% protein fraction is mostly 
composed of surfactant proteins (SP) A, B, C and D. SP C and B aid the 
phospholipids in decreasing surface tension during breathing, the SP A and D are 
large (43 kDa) hydrophilic proteins which are important in allowing particles to 
be taken up by macrophages [171, 172].  In particular they have carbohydrate 
recognition domains which allow them to bind to pathogens and set off an 
immune response [171].  Thus binding or loss of large amounts of this protein (as 
has been shown to occur upon NM exposure [118]) could lead to ineffective 
clearance of particles in the lungs.  
 
3.1.8 In Vitro Cytotoxicity of Iron Oxide Nanoparticles  
 
Further to the aims of this work a murine macrophage cell line was the chosen 
model.  The adherent murine macrophage cell line J774A.1 (obtained from the 
European Collection of Cell Cultures) displays a number of characteristics of 
primary macrophages, including adhesion and antibody dependent phagocytosis.  
It has cell – bound receptors for immunoglobulin and complement [173].  It also 
produces interleukin-1 and lysosome.  This cell line has been used as a model 
system in many nanotoxicity studies (macrophages as described in 1.2.1.3 are part 
of our innate immune response – they are specialised host defence cells which 
allows fast recognition and clearance of foreign material).  This innate nonspecific 
response is essential to our immune system protecting us from 98% of pathogens 
we encounter [67].  Macrophages are commonly used as models in many in vitro 
studies looking at their ability to actively uptake foreign particles and respond 
with cytokine signalling cascades or production of ROS [81, 83, 95, 174].  
Macrophage phagocytosis will be discussed in more detail in Chapter 5. 
 
Iron, as an essential metal, has vital biochemical functions (e.g. electron transfer, 
oxygen transfer, etc.) and it is regulated in mammals due to its toxic potential 
upon accumulation.  Bioavailability in the body is limited due to its ability to be 
oxidised to an insoluble form in solution [175].  Iron not bound to protein or 
stored efficiently will bind non-specifically to many cellular components and can 
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catalyse production of free radicals which can happen if iron degrades via the 
Fenton reaction (H202+Fe2+Fe3
+
 and Ho
- 
+ HO(.-) [176]).  So iron toxicity can 
occur if homeostasis is not maintained or if it occurs in excess in the body thereby 
exceeding the capacity of transferrin to bind it.  Non transferrin bound iron will be 
internalised into tissues (primarily but not exclusively in the liver and heart [175]) 
and as mentioned previously up to 3500mg (section 2.1.4) can be stored in the 
body of which 0.2mg/g is in the liver and liver toxicity can occur with iron leaves 
reach 4mg/g [141] or when iron (bound as serum ferritin) reaches levels greater 
than 1,000μg/L iron overload occurs [177].  This is a cause for concern, as excess 
iron in the body has been linked to heart failure, diabetes, arthritis, cirrhosis, liver 
cancer [177] and more recently has been linked to Alzheimer’s and Parkinson’s 
disease [178, 179]. 
 
Studies have found iron oxide NMs did enhance human endothelial cell 
permeability through the production of ROS, for example, Apopa et al [180] 
found that after exposure (50µg/ml iron NMs) to human endothelial cells within 
10 minutes uptake into the cells cytoplasm occurred and found cell permeability 
increased after 10 minutes peaking at 30 minutes after exposure.  Brunner et al. 
[64] found MTT conversion and DNA content significantly reduced in human 
mesothelioma cells after exposure to 3.75 ppm iron oxide but with a rodent 
fibroblast cell line affected after 30 ppm iron oxide  The variability of in vitro iron 
oxide NMs toxicity data may be due to the large variety of iron oxides NMs 
available (e.g. naked, dextran or citrate stabilised, silica or gold coated) however 
literature still reports variable findings for naked particles as recently reviewed by 
Soenen et al. [181]. 
 
Accumulation of NMs in organs in this way may produce inflammatory as well as 
cytotoxic effects through oxidative stress ROS [182-192]. The immune system 
model is particularly important as macrophages are responsible for particle 
clearance at sites of exposure and the role of ROS has been implicated in J774.A1 
mouse macrophage cytotoxicity after exposure to iron oxide nanoparticles [192].  
 
Renwick et al. [95] did find that metal oxides (TiO2) impaired J774.A1.2 
macrophage cells in a dose dependant manner and found smaller 29nm particles 
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were more effective in impairing phagocytosis than a 250nm counterpart.  More 
recently Zhu et al. [146] reported iron oxide NM exposed intratracheally in a rat 
model caused inflammation and increased micro vascular permeability in cells.  
They went on to study the kinetics of this distribution in a rat model [147] where 
they saw that the particles were passed through the alveolar-capillary barrier and 
distributed into organs such as the liver spleen and kidney.  Although ‘inert’ NMs 
have been reported to produce ROS due to their ability to target mitochondria 
with iron NMs there is an extra concern as iron oxides being metal NMs can 
release ions, and so iron NM toxicity can arise from the formation of reactive 
species as mentioned above via the Fenton reaction.  It is unclear if these ions are 
solely responsible for all toxic effects or if there are separate ion and NM effects 
as it is difficult to distinguish between these two types of effects in vitro.  Iron 
oxide NM toxicity is related to solubility however some studies do find that 
toxicity cannot be explained by ionic effects alone [64] which does point towards 
a NM specific cytotoxicity.  It is unknown if the NM effects are induced first or in 
conjunction with the dissolved ion effect, or indeed if there is a synergist or 
potentiating effect.  
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3.1.9 Chapter 3 Aims 
 
 To prepare iron oxide NMs with a plasma, FCS and LLF long lived ‘hard 
corona’ and to use protein characterization techniques to investigate 
protein binding 
 
 Examine how the NM size, surface area, composition and charge influence 
the affinity and degree of protein binding. 
 
 Investigate the impact of protein-NM interactions on influencing toxicity 
of the NMs by investigating the effects of iron oxide particles with their 
associated corona on  exposure on J774.A1 macrophage cells with respect 
to:  
 
o Lactate dehydrogenase (LDH) release and mitochondria function 
o IL-1β, TNF-α, IL-10 and MCP-1 release. 
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3.2 Materials and Methods 
 
3.2.1 Materials  
 
Fe2O3 (280nm) and Fe3O4 (45nm) were received and prepared as detailed in 
2.2.1.  Before embarking on this study the particles were examined, looking at the 
effect of sonication, particle concentration, ionic strength, pH, and the presence 
of FCS on the stability of Fe NM in media.  The particles were extensively 
characterised as reported in Chapter 2.   
 
Human plasma was obtained from the Irish Blood Transfusion Board, aliquoted 
into 1ml eppendorfs, and stored at -80
o
C until required.  FCS (Sigma, UK) was 
aliquoted into 1ml eppendorfs and stored at -80
o
C until required.  
 
LLF was obtained from male Sprague Dawley rats using the method of Baughman 
et al. [193], briefly; rats of 3 months old were euthanized by intraperitoneal 
injection of pentobarbitone.  The lungs were removed and lavaged with 4 x 8ml 
volumes of sterile saline.  The lavageate was pooled into a single tube which 
underwent a series of centrifugation steps.  After a final centrifugation step at 
60000g for 45 minutes the supernatant was discarded and the remaining pellet was 
resuspended in 10ml sterile PBS.  This surfactant-enriched fraction, termed LLF, 
was aliquoted into 1ml volumes and stored at -80
o
C until required.  The neat 
plasma, serum or LLF was removed from the freezer and allowed to thaw on ice 
at room temperature and centrifuged at 16000g for 2 minutes at 4°C and the 
supernatant was removed.  The supernatant was removed into a new low protein 
binding eppendorf and the pellet was discarded.  The protein content of the 
plasma, serum and LLF was determined using the BCA protein assay, according 
to the manufacturer’s instructions.  
 
3.2.2 Cell Culture 
 
All reagents were obtained from Sigma (UK) unless otherwise stated. Ampoules 
of J774.A1 were removed from the -170°C liquid nitrogen container and thawed 
by placing the ampoule into warm water briefly.  Cells were then re-suspended in 
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5 ml of pre-warmed routine culture medium (RPMI 1640 supplemented with 10% 
heat inactivated FCS; L-glutamine (diluted from 100x stock solution) and 1% 
penicillin/streptomycin) and centrifuged at 9000g for 5 minutes.  The supernatant 
was removed and the pellet of cells was re-suspended in 3 ml of pre-warmed 
routine culture medium.  The cell suspension was then transferred into 20 ml of 
pre-warmed routine culture medium in a 75cm
2
 tissue culture flask.  Cells were 
incubated for 24 hours in an incubator with a humidified atmosphere (90%) and 
set at 37
o
C and 5% CO2 to allow the cells to adhere to the bottom of the flask.  
When the cells were observed by a phase contrast microscope to be 70% 
confluent, they were subcultured into a new 75cm
2
 culture flask.  To ensure the 
cells had overcome the lag growth phase they were subcultured at least three 
times before being used in a bioassay.  Cells were sub-cultured via scraping.  The 
cells were scraped from the flask surface, aspirated and dispensed into a new flask 
in a 1:4 ratio.  The final medium volume per culture flask was 25 ml.  
 
3.2.2.1 Cell Counting 
 
Cells were re-suspended with pre-warmed routine culture medium.  A volume of 
cell suspension (100μl) and trypan blue solution (100μl) were added together and 
mixed thoroughly.  A volume of 20µl was pipetted into the cell counting chamber 
(Bürker-Türk haemocytometer) and the number of cells counted using a phase 
contrast microscope.  Cell concentration was calculated using the formula: Cell 
concentration (cells/ml) = average number of cells in one large square * the 
dilution factor * 10
4
.
 
 
3.2.2.2 Cell Plating  
 
A cell suspension of 5*10
5
 cells/ml in routine culture medium was prepared.  A 
volume of 100µl of the cell suspension was dispensed into each well of a 96 well 
plate.  Peripheral wells of the 96-well tissue culture plate were left blank to be 
used as negative controls.  Cell suspensions were carefully mixed prior to plating 
to ensure equal numbers of cells in each well.  Cells were incubated for 24 hours 
to achieve 60-70% confluency in each well.  This incubation period assures cell 
recovery, adherence, and progression to exponential growth phase.  Each plate 
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was examined under a phase contrast microscope to assure that cell growth was 
relatively even across the plate.  
 
3.2.2.3 Cell Preservation 
 
The cells were rinsed in routine culture media freed by scraping from the culture 
flask and counted.  They were then re-suspended in pre-warmed routine culture 
medium and centrifuged.  The supernatant was removed and the pellet was re-
suspended in pre-warmed routine culture medium (half the final freezing volume).  
Routine culture media with 10% DMSO was added slowly to the cells so that the 
solvent would equilibrate across the cell membranes.  Cells were then brought to 
the final freezing volume (containing 10% dimethyl sulfoxide (DMSO)) and 
transferred into ampoules at the appropriate density.  The ampoules were stored in 
a -80°C freezer for at least 24 hours.  After 24 hours, the tubes were placed in the 
liquid nitrogen container. 
 
3.2.2.4. Cell Treatments 
 
Particles were received as a dry powder and were weighed using an analytical 
mass balance in a special ventilated safety cabinet (Sartorius Model: SWC900) 
and suspended in sterile water at a concentration of 1mg/ml.  The NMs were 
sonicated at 200W for 10 minutes using a bath sonicator (Grattan).  J774.A1 
macrophages were treated with the NMs in RPMI at concentrations ranging from 
3.9µg/ml to 500µg/ml (corresponding to 2.4 and 312µg/cm
2
 respectively).  A 
volume of 100µl of each particle suspension was pipetted into triplicate groups of 
wells on a 96-well plate.  Supernatants were removed, centrifuged and stored at -
80
0
C until required.  Plates also contained a positive control which was triton x 
100 at 0.1% and a negative control of media only.  One hundred microlitres of 
0.1% triton x 100 in RPMI was added to the remaining adherent cells and the 
plate was incubated for a further 10 minutes, to obtain a measure of 100% lysis in 
the LDH assay.  Wells containing no cells and particle treatment were also 
prepared to investigate any interference of the particles in the assay. 
 
 
72 
 
 
3.2.3 Imaging of Macrophages with Particles  
 
A six well plate was seeded with cells at a concentration on 5*10
5
 per well and 
incubated for 24 hours to allow confluent growth and attachment to the wells.  
After 48 hours they were exposed to 280nm Fe2O3 (500 or 125µg/ml) in a range 
of BSA (0, 0.1, 0.5 and 1% BSA) and imaged over various time points (4, 18, 24 
and 48hrs) under a phase contrast microscope with a Canon camera (40D) 
attached to capture images. 
 
3.2.4 Preparation of Hard Corona Coated particles 
 
The layer of strongly associated proteins (the hard corona) was created using 
plasma, serum, or LLF by a series of incubation and washing stages.  The 
particle/protein solutions were prepared in low protein binding eppendorf tubes 
with the various biological fluids in order to achieve final particle mass 
concentrations of 100µg/ml and solutions of LLF (10µg/ml), plasma (10 and 
55%) or serum (10%).  A standard ratio of iron oxide particle dispersion in 
protein solution was 1:9 as has been reported in similar studies [149, 194]. The 
particle-protein samples were briefly vortexed (~30 seconds).  The particles were 
then incubated in a shaking heating block for one hour at 37
o
C. After incubation 
the particle suspensions were centrifuged at 12000g for 20 minutes to ensure all 
NMs were separated from the soft corona.  The supernatant was removed after 
each centrifugation step.  This process was repeated until no further protein 
remained in the supernatant as determined by using both a Pierce® BCA Protein 
Assay Kit (Thermo Scientific) and a Micro BCA Protein Assay Kit (Thermo 
scientific) as per the manufacturer’s instructions.  This produced NM dispersions 
with a strongly bound layer of associated biomolecules.  In addition, particles 
once coated in LLF were again (using the same procedure) coated in plasma or 
serum in order to investigate the effects of LLF precoated particles on the protein 
corona composition. In this way seven different test samples were created as per 
table 3.2. 
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Table 3.2: The conditions under which the hard corona was created for each 
particle.  
 
1 10% P 100µg/ml particles incubated in plasma and PBS (final 
conc.10% plasma) 
2 55% P 100µg/ml particles incubated in plasma and PBS (final 
conc.55% plasma) 
3 10% S 100µg/ml particles  incubated in serum and PBS (final 
conc.10% serum) 
4 LLF 100µg/ml NMs incubated in LLF and PBS (final conc.10µg/ml 
LLF) 
5 LLF/ 
10%P 
Particles incubated as per LLF, after incubation centrifuged and 
supernatant removed. Then incubated with 10% plasma in PBS. 
6 LLF/ 
55%P 
Particles incubated as per LLF, after incubation centrifuged and 
supernatant removed. Then incubated with 55% plasma in PBS  
7 LLF/ 
10%S  
Particles incubated as per LLF, after incubation centrifuged and 
supernatant removed. Then incubated with 10% serum in PBS. 
 
 
3.2.5 Characterisation of the Particle-Protein Complex 
 
Characterisation of the particles alone included (a) dispersion studies (b) size 
measurements (DLS and NTA) (c) image analysis (SEM TEM) (d) 
charge/stability using ZP and (e) metal analysis (EDX). DLS measurements and 
ZP were used initially to study the hydrodynamic diameter to obtain an indication 
of size and stability of the particles in water and in PBS.  Particles were then 
remeasured after coating with the biological fluid (10% plasma, 55% plasma, 10% 
serum, LLF, precoated in LLF and then in 10 and 55% plasma and 10% serum).  
In this way the DLS (Malvern Zetasizer Nano) was used to give an indication of 
the thickness of an adsorbed layer on the NM surface.  Polydispersity index (Pdi) 
was obtained to gain an indication of the particle aggregation/flocculation 
behaviour.  An increase in Pdi represents an increase in agglomeration.  
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Differential Centrifugal Sedimentation (DCS) was employed to investigate the 
size shift between the coated and uncoated particles.  NMs in solution were 
injected into a spinning disc containing a sucrose gradient.  One hundred 
micrograms per millilitre of either particle or the coated particles were injected 
into a CPS disc centrifuge.  Using specific parameters (disc speed, density and 
particle absorbance) for each NM tested the sample settled through the gradient 
according to the size of the particles and the mean size from the resulting peaks 
indicated the average size of the NM.  In order to get an accurate reading of the 
complex the internal density of the sample and particle absorbance must be 
known.  This was set at 5.24g/cm
3
 (Fe2O3) and 5.17g/cm
3
 (Fe3O4) and particle 
absorbance at 0.5nm.  Particles with their corona were also measured using DCS 
as described above and the resulting shift in the peak was used to calculate the 
corona or ‘shell’ layer size using a core - shell two - density model as previously 
reported by Monopoli et al.[151].  The hard corona shell size (thickness) can be 
calculated using the core-shell two-density model involving the particle material 
and the adsorbed protein/biomolecule densities.  In practice this was 
accomplished with the software supplied by CPS instruments after inputting three 
values these are (i) the assumed coating density (ii) the NM core density (as 
specified above) and (iii) the NM core diameter.  The density of hydrated protein 
crystals is 1.23g/cm
3
 and blood plasma is 1.025g/cm
3
 thus the intermediate value 
of 1.125g/ml was taken as the coating density of our plasma in this model ([151, 
195] for this model.  The theory behind this model can be found in Pitek et al. 
[195].   In summary to identify the true size and the corona thickness from this 
technique a simple core-shell two-density model involving the particle material 
and adsorbed protein/biomolecule densities as reported in Monopoli et al. [151].  
This information supported the DLS data to give a more accurate estimation of the 
adsorbed layer thickness. 
 
3.2.6 Protein Separation and Identification 
 
To investigate which proteins strongly associated with the particles, one 
dimensional sodium dodecyl sulphate (SDS) gel electrophoresis and mass 
spectroscopy (MS) was used. 
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3.2.6.1 SDS PAGE Reagents 
 
(a) Resolving and Separating Gels  
A 10% separating gel and a 4% stacking gel were prepared using the following 
reagents: 3.095mls Milli Q water, 3.5mls Tris-HCL (pH 8.8) 10% SDS (dissolved 
in MilliQ water), 3mls acrylamide/bis (29:1) and before pouring 10% (v/v) 
ammonium sulphate and 5ul TEMED.  The stacking gel was prepared using the 
following reagents 2.82mls MilliQ water 1.575mls Tris-HCL (pH 6.8), 500ul 
acrylamide (29:1) solution, 50ul 10% SDS, 50ul 10% ammonium sulphate and 5ul 
TEMED.  This was enough for 2 gels, 1.0 mm thick. 
 
(b) Electrophoresis Buffer 
Electrophoresis stock buffer was prepared by dissolving 144g glycine, 30g trizma 
base 10g SDS in 1L dH2O.  Prior to use a 1x buffer was prepared by diluting the 
stock 1:10 in dH20. 
 
(c) Preparation of Samples (Removal of Hard Corona) 
The NM and the hard corona complexes were separated as previously described 
[104, 151] as follows: denaturating agent 1.25M dithiothreitol (DTT - Sigma, UK) 
was added to a loading buffer in a 1:10 dilution.  The loading buffer (New 
England Biolabs) contained 62.5mM Tris-HCl (pH 6.8 at 25°C), 2% (w/v) SDS, 
10% glycerol and 0.01% (w/v) bromophenol blue.  A 40µl volume of each sample 
was added to 20µl of the loading buffer/DTT solution in a low binding eppendorf 
tube and incubated at 100
o
C for three minutes.  In this way the denatured corona 
proteins coated in SDS surfactant gain a negative charge. Ten microlitres of each 
sample was loaded on a 10% resolving gel and a 4% stacking gel.  
 
(d) Electrophoresis  
The resolving gel was poured between two glass plates of a Bio-Rad casting 
apparatus and topped with a layer of isopropanol and left to polymerise (for one 
hour).  After polymerisation the isopropanol was poured off and the stacking gel 
was dispensed between the casting plates.  A 10 well comb was then inserted 
between the glass plates and left to set for 30 minutes.  Once set the comb was 
removed and the gel and the glass plates containing the gel were washed with 
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MilliQ water to eliminate bubbles.  The gels were immersed in electrophoresis 
buffer in a Bio-rad electrophoresis tray prior to addition of 10µl of sample to each 
well.  Samples were separated by electrophoresis at 130 mA until the dye had run 
to the bottom of the gel (one hour) at which time the gel was removed and stored 
for future reference. 
 
(e) Staining 
The resulting gels were stained using either a silver staining kit (Cosmo Bio, 
Japan) or a mass spectroscopy compatible silver staining kit (GE Healthcare 
International) according to the manufacturer’s instructions.  
 
3.2.6.2 Mass Spectroscopy 
 
After imaging the gel bands (Image Quant LAS 400 Biomolecular Imager - GE), 
the gel lanes were processed and analyzed with MS to identify the constituent 
proteins. The lanes were excised from the gel using a scalpel and trypsin digested 
to the method of Monolopi et al. [151] before analysis using a LTQ ESI MS/MS 
(Thermo Fisher) interfaced with an LTQ Orbitrap (ThermoFinnigan, CA).  The 
resulting spectra were searched using Sequest Uniprot/Swiss-Prot database 
(www.expasy.org- Accessed October 2012 and February 2013). 
 
3.2.7 Lactate Dehydrogenase Assay  
 
LDH is a soluble enzyme found in the cytosol.  As cell membranes are damaged 
LDH is released from the cell, thus determining LDH content of cell culture 
media gives an indication of cell membrane integrity and a measure of 
cytotoxicity.  LDH, if present, will catalyse the conversion of pyruvate to lactate 
with concomitant inter-conversion of NADH and NAD+.  Secondly, diaphorase 
was added which uses the newly formed NADH and H
+
 to catalyse the reduction 
of a tetrazolium salt – formazan.  Then formazan can be quantified 
calorimetrically as it absorbs strongly at 490-520nm.  Thus the amount of 
formazan measured in the cell culture media is proportional to the amount of LDH 
released into the medium as a result of cytotoxicity.  Thus the assay measures 
LDH release to determine cell death in response to exposure to NMs.  
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From a confluent flask of cells, the cell culture medium was discarded into a 
beaker containing Virkon.  The cells were harvested using a cell scrapper and the 
flask was rinsed with 10mls of cell culture medium.  The suspension was poured 
into a 30ml sterile universal container.  Under sterile conditions 50-100µl of the 
cell suspension was removed a cell count was conducted.  In a 96 well plate 100 
µl of cell suspension was added per well, giving a final cell number of 5*10
5
.  
After 24 hours the media was removed from the cells the cells were washed twice 
with 100ul pre warmed PBS buffer.  The cells were then exposed to a range of 
500-3µg/ml particles in serum free media. 
 
The plate was incubated for 24 hours.  Following exposure the culture media was 
transferred 1.5ml eppendorfs and centrifuge for 30 minutes at 1500g to remove 
any particles.  The supernatants were stored at -80
o
C until required.  Media with 
0.1% triton x 100 was then added to the adherent cells, and the plate was 
incubated for a further 10 minutes at 37°C, 5% CO2.  The remaining cell 
suspension was transferred to 1.5ml eppendorfs, centrifuged and stored until 
required.   
 
A stock solution of 1mg/ml nicotinamide adenine dinucleotide (NADH – Sigma, 
UK) in 0.75nM sodium pyruvate (Sigma, UK) solution was made fresh and used 
to create a standard range from 2000-0 LDH activity (units/ml).  In a 96 well plate 
60µL of each standard was plated to create the standard curve.  A volume of 
50µl/well of NADH (1mg/ml)/pyruvate (0.75mM) was added to the remaining 
wells.  This was incubated at 37°C, 5% CO2 for 5 minutes.  To this 10µl of each 
sample was added to the wells containing NADH.  This was incubated for a 
further 30 minutes at 37°C, 5% CO2.  A volume of 50µl 2,4-
dinitrophenylhydrazine (Sigma, UK) solution was added to each well.  The plate 
was incubated at room temperature in the dark for 20 minutes.  A volume of 50µl 
4M NaOH was added to each well, placed on a plate shaker for 5 minutes at room 
temperature.  The absorbance at 550nm was measured using MRX plate reader 
(Dynatech Labs, UK).  The percent total LDH leakage was calculated using the 
formula = ((sample abs-media control abs)/ (triton X positive control abs – media 
control abs))*100. 
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3.2.8 WST-1 Assay 
 
The WST-1 assay is a cell proliferation assay based on the principle that viable 
cells will reduce the tetrazolium salt (WST-1) to formazan by cellular 
mitochondrial dehydrogenases.  Formazan is a coloured dye (dark yellow) that 
can then be detected by absorbance at 420-480nm with 440nm being the optimal 
absorbance range.  The absorbance directly correlates to cell number.  
 
Cells were seeded at a density of 5*10
5
 final concentrations in cell culture media 
inclusive on test particles at 125µg/ml-32µg/ml.  Wells were seeded with 100µl 
cells per well in a 96 well plate.  After 24 hours 10µl of WST-1 proliferation 
agent (Roche, Germany) was added and the plate was incubated for four hours at 
37°C and 5% CO2.  After 4 hours the plate was removed from the incubator and 
placed on a plate shaker for one minute.  The absorbance was measured at 440nm. 
Controls included cells in medium without NMs with WST-1 reagent (negative 
control) and cells with triton and WST-1 reagent (positive control).  Controls also 
included also included medium without cells with WST-1 reagent, NM in medium 
without cells and WST-1 reagent and cells with NM only. 
 
3.2.9 Cytokine Estimations using FACS Array Analysis 
 
Supernatants obtained during the LDH assays (see 3.2.7 and 3.2.2.4) were used to 
estimate the release of the following cytokines from treated cells; IL-1β, TNF-α, 
IL-10 and MCP-1.  Supernatants analysed by FACS include (a) cells exposed to 
Fe2O3 particles (b) cells exposed to Fe2O3 particles with LLF corona (c) cells 
exposed to Fe2O3 particles with plasma corona (d) cells exposed to Fe2O3 particles 
with serum corona.  Analysis was carried out on a BD FACS Array™ 
Bioanalyzer, using a BD cytometric bead array mouse/rat soluble protein master 
buffer kit.  
 
3.2.10 Statistical Analysis 
 
Data from all experiments were analysed using the Minitab 15 statistical package 
using a general linear model analysis of variance.  Significance was set at 5%.
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3.3 Results 
 
3.3.1 Imaging of J774.A1 Macrophages Exposed to Fe2O3 Particles. 
 (a) 4 Hours 
(i)   (ii)                                       (iii)                                       (iv)  
    
(b) 18 Hours 
(i)   (ii)                                       (iii)                                       (iv)  
    
Figure 3.1: Light microscopy (20x) images of J774.A1 macrophages after 
exposure to Fe2O3 particles for (a) 4 hours and (b) 18 hours, where (i) control (ii) 
exposure to 0.5mg/ml (iii) exposure to 125µg/ml and (iv) exposure to 125µg/ml in 
RPMI with 1% BSA.  These images show how the particles associate with the 
cells within 4 hours.  No very obvious effect on particle uptake can be seen due to 
the addition of BSA.  If there were such an effect this would be difficult to 
visualize by light microscopy.  Images at other time points can be seen in the 
appendix 8.6.  
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3.3.2 Hard Corona Analysis 
(a)                                                                   (b) 
   
 
Figure 3.2: The total protein content of the serum (43.286mg/ml), plasma 
(64.83mg/ml) and LLF (30.52µg/ml) was measured using a BCA protein assay. 
After hard corona preparation as described in 3.2.4 the protein-NM complexes 
were studied free of excess protein (i.e. the hard corona).  The above graphs 
show the percentage free protein remaining in (a) Fe2O3 particle supernatant and 
(b) Fe3O4 particle supernatant after 1-4 washes as determined by BCA assay, as 
measured during hard corona preparation. Values represent the mean +/- SD 
(n=3). After four washes the free protein present in the supernatant diminished to 
less than 1% of the original protein content for most samples.  It was therefore 
concluded that any proteins remaining in the system were associated with the 
iron oxide particles and were not free in solution.  These remaining proteins 
attached to the particles were deemed the hard corona.  This method of 
repeatedly centrifuging (washing) the protein-NM complex is a commonly 
reported method of eliminating the soft corona [151, 195].  
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3.3.3 DLS Analysis 
 
Table 3.3: Hydrodynamic diameter, polydispersity index (Pdi) and zeta 
potential for 280nm Fe2O3 particles and 45nm Fe3O4 particles measured in 
water, PBS and with their associated long lived or ‘hard’ protein corona 
(where P=plasma, and S=serum and LLF= lung lining fluid) as determined 
by DLS. Values represent the mean +/- SD (n=3). 
 
 
Fe3O4 (45nm) Z average (nm) St 
Dev.(nm) 
Pdi ZP (pH 7.5) mV 
Water 544.00 9.19 0.44 -24.8mV 
PBS 791.00 n/a 0.55 -20mV 
10% P 1212.00 n/a 0.65 -0.5mV 
55% P 1204.00 n/a 1 -0.2mV 
10% S >1000 n/a 1 .5mV 
LLF >1000 n/a 1 -1.0mV 
LLF/10%P 865.90 37.32 0.26 n/a 
LLF/55%P >1000 21.21 0.50 n/a 
LLF/10%S >1000 78.93 0.38 n/a 
 
The DLS measurements show the Fe2O3 NM to be 297.4 nm and the Fe304 NM to 
be 544nm. The ZP measurements, which are an indication of particle charge and 
suspension stability, find that both particles have a value above 20mV. Both 
particles showed an increase in hydrodynamic diameter in PBS and after 
incubations with 10 and 55% plasma compared to deionised water. The largest 
increase in hydrodynamic diameter was observed for both particles with the LLF 
Fe2O3 (280nm) Z average (nm) St Dev. 
(nm) 
Pdi ZP (pH 7.5) 
mV 
Water 297.40 1.80 0.28 -21.8mV 
PBS 461.00 16.80 0.38 -9.52m 
10% P 560.70 13.50 0.35 -12mV 
55% P 543.60 5.60 0.39 -12.2mV 
10% S 362.30 12.60 0.29 -14.6mV 
LLF 822.70 95.40 0.50 -16.2mV 
LLF/10%P 1384.00 134.60 0.88 n/a 
LLF/55%P 442.40 8.60 0.23 n/a 
LLF/10%S  475.20 58.70 0.30 n/a 
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corona.  The hydrodynamic diameter for LLF/10%S was similar to 10%S for 
both particles, with a value of 362.30nm/475.20nm for Fe2O3 and over 
1000nm/1000nm for Fe3O4).  LLF pre-treatment followed by incubation in 
plasma resulted in a Z average that was similar to plasma alone, but smaller than 
LLF alone.  For the 45nm particle in LLF/10% P had a smaller Z average than for 
10% P alone, but for 55% P compared to LLF/P55% there was no difference. 
 
The Pdi was generally lower for the 280nm particles than the 45nm particles.  
PBS and plasma increased the Pdi by a small amount for the 280nm particles, but 
serum had no major effect on the Pdi.  LLF almost doubled the Pdi and this was 
increased further by the 10% plasma, but reduced by the 55% plasma.  
LLF/10%S treated 280nm particles had a similar Pdi to the water dispersed 
particles.  Plasma, serum and LLF all increased the Pdi of Fe3O4 significantly, but 
when pretreated with LLF and then serum or plasma the Pdi was reduced, most 
extensively with 10% plasma. 
 
3.3.4 Corona Characterisation using DCS 
 
Table 3.4: Differential centrifugal sedimentation (DCS) measurements (n=3) 
showing particle hydrodynamic diameter as a function of relative weight for (a) 
Fe2O3 and (b) Fe3O4 particle when dispersed in water and PBS and the particle-
corona complexes free from excess plasma, serum and LLF 
 
 (a) 
 
 
 
 
 
 
 
 
 
 
280nm Fe2O3 Size (nm) Shell Diameter 
water 303.5  n/a 
PBS 323.9  n/a 
10%P 311 13nm 
LLF/10%P 290.3 38nm 
55%P 320.5 3.5nm 
LLF/55%P 275.3 59nm 
10%S 268.5 69.5 
LLF/10%S 309.5 15nm 
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 (b)  
 
 
 
 
 
 
 
 
 
The particle-corona complexes were prepared as described in materials and 
methods (3.2.5). A volume of 100μg/ml NM was injected into a differential 
centrifuge.  The sample settled according to the size of the particles and the mean 
size from the resulting peaks was used as the average size of the sample (these are 
the results displayed above in column a). The hard corona shell size (as seen in 
column b) was calculated using a core-shell two density model as described in the 
materials and methods (3.2.5). This method has been used in previous studies 
[151, 195]. The results show that the particle corona thickness varied according to 
dispersant/corona and particle type.  For Fe2O3, the greatest corona depth was 
10%S > LLF/P55% > LLF/10%P > LLF/10S% > 10%P > 55%P. For the Fe3O4 
NM the greatest corona dept was 10%P > 55%P > LLF/10%P > LLF/10%S > 
LLF/55%P > 10%S. 
 
 
 
 
 
45nm Fe3O4 Size (nm) Shell diameter 
water 174.8  n/a 
PBS 197.0  n/a 
10%P 151.3 63nm 
LLF/10%P 154.6 57nm 
55%P 151.9 61.5nm 
LLF/55%P 186.9 10.5nm 
10%S 217.0 n/a 
LLF/10%S 174.7 25.5nm 
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3.3.5 SDS PAGE Investigation of Protein Corona Profile 
(a) SDS-PAGE gel lanes showing binding patterns of proteins associated with the 
10% plasma hard corona of iron particles before and after incubation with LLF.  
For comparison purposes these gels have been cropped. The full gel image from 
which this lane is cropped can be seen in the appendix (section 8.7 (a) and (b)) 
 
280nm                                                          +       +              -         -
 
45nm                                                  -       -               +       + 
Precoated in LLF                                -       +              -        + 
                                                                 
 
(b) SDS-PAGE gel lanes showing binding patterns of proteins associated with the 
55% plasma hard corona of iron particles before and after incubation with LLF. 
The full gel image from which these lanes are cropped can be seen in the 
appendix (section 8.7 (d) and (e)) 
 
280nm                                                           +        +           
_           _
 
45nm                                                             -         -             +      + 
Precoated in LLF                                           -         +            -       + 
                                                                                       
 
Figure 3.3: SDS-PAGE gels obtained to investigate the binding patterns of iron 
particle-protein interactions (a) 10%P and LLF/10%P hard corona (b) 55%P and 
LLF/55%P hard corona.  
Molecular weight ladder 
Molecular weight ladder 
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Table 3.5: Results from Mass Spectroscopy analysis showing the most prevalent 
proteins in the 280nm iron particle plasma hard corona before (a) and after (b) 
precoating in LLF.  The full list of all proteins identified can be found in the 
appendix 8.8. 
(a) 
Fe2O3  
10% P MW Acc No 
XC 
Score PEP %C 
Peptide 
Ion 
(hits) 
Function as 
defined by 
Uniprot 
Apolipo- 
protein B-100 515.28 P04114 350.29 
1.11 
E-15 12.80 35 
Functions as a 
recognition 
signal for the 
cellular binding 
and 
internalization 
of LDL particles 
by the apoB/E 
receptor. 
Complement 
C3 187.03 P01024 260.30 
2.00 
E-13 24.60 27 
C3 plays a 
central role in 
the activation of 
the complement 
system. 
Serum 
albumin 69.32 P02768 110.30 
2.40 
E-11 20.70 12 
good binding 
capacity for 
water, Ca
2+
, 
Na
+
, K
+
, fatty 
acids, hormones, 
bilirubin and 
drugs. Its main 
function is the 
regulation of the 
colloidal 
osmotic pressure 
of blood. Major 
zinc transporter 
in plasma, 
typically binds 
about 80% of all 
plasma zinc. 
Apolipoprotei
n (a) 500.99 P08519 60.27 
2.86 
E-09 18.20 6 
Apo(a) is the 
main constituent 
of lipoprotein(a) 
(Lp(a)) 
Complement 
C4-A 192.65 P0C0L4 50.27 
3.07 
E-07 3.60 5 
C4 plays a 
central role in 
the activation of 
the classical 
pathway of the 
complement 
system 
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(b) 
Fe2O3 
LLF/10% P MW Acc No 
XC 
Score PEP %C 
Peptide 
Ion 
(hits) 
Function as 
defined by 
 Uniprot 
Complement 
C3  187.03 P01024 440.30 
1.55
E-14 39.00 48 
(see figure 3.4 
(a)) 
Serum 
albumin  69.32 P02768 230.29 
6.91
E-12 45.50 25 
(see figure 3.4 
(a)) 
Apolipo 
protein B-100  515.28 P04114 190.29 
9.58
E-11 7.30 19 
(see figure 3.4 
(a)) 
Filamin-A  280.56 P21333 170.28 
7.63
E-11 12.40 17 
Anchors 
transmembra
ne proteins to 
the actin 
cytoskeleton 
and serves as 
a scaffold for 
a range of 
cytoplasmic 
signalling 
proteins 
Myosin-9  226.40 P35579 120.28 
1.09
E-09 9.60 12 
Cellular 
myosin that 
appears to play 
a role in 
cytokinesis, 
cell shape, and 
specialized 
functions e.g. 
secretion and 
capping. 
 
Table 3.5 reports the protein identified in (a) the Fe2O3 10%P corona and (b) the 
Fe2O3 LLF/10%P corona by Mass Spectroscopy (LTQ ESI MS/MS interfaced with 
an LTQ Orbitrap along with the reported molecular weight (MW-kDa).  The 
Accession number (Acc No) is a unique identifier given to a protein sequence and 
in this case it refers to entries at the Sequest Uniprot/Swiss-Prot database 
(http://www.uniprot.org/).  The Xcorr value (XC Score) is the cross-correlation 
value from the search. In other words the scoring method reporting the number of 
fragmented ions in common between the experimental spectrum and the 
theoretical spectrum.  The PEP or (posterior error probability) is the probability 
that the observed peptide match is incorrect (a chance event). If the PEP of a 
peptide spectrum is 1% it means there is a 99% chance that peptide has been 
correctly identified. Thus the lower the number the higher the probability of a 
‘true’ match.  The percentage sequence coverage (%C) and the number of 
peptides confirmed by mass spec analysis are shown.  
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SDS-PAGE gel lanes showing binding patterns of proteins associated with a iron 
particles with a 10% serum hard corona before and after incubation with LLF. The 
full gel from which these lanes are cropped can be seen in the appendix section 
8.7 figure (f) and (g)) 
280nm                                             +       +      
_         _
 
45nm                                     -       -             +      + 
Precoated in LLF                            -       +             -      + 
                                                                            
 
Figure 3.4: SDS-PAGE gels obtained to investigate the binding patterns of iron 
particle-protein interactions (a) 10%S and LLF/10%S hard corona.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Molecular weight ladder 
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Table 3.6 Results from mass spectroscopy analysis showing the most prevalent 
proteins identified in the 280nm iron particle serum hard corona profile (before 
(a) and after (b) incubation with LLF ) - the full list of all proteins identified can 
be found in the supporting information (appendix 8.8) 
 
(a) 
Fe2O3   
10% S Acc No. MW 
XC  
Score P EP % C 
Peptide 
Ion 
(hits) 
Function as defined 
by  
Uniprot 
Serum 
albumin P02768 69.32 60.19 
2.71 
E-12 10.80 7  
(see figure 3.4 (a)) 
 Apo- 
lipoprot
ein A-I  P02647 30.76 10.20 
4.20 
E-10 6.00 1  
Participates in the 
reverse transport of 
cholesterol from 
tissues to the liver for 
excretion  
Desmog
lein-1  Q02413 113.67 10.20 
3.98 
E-05 1.50 1 
Involved in the 
interaction of plaque 
proteins and 
intermediate 
filaments mediating 
cell-cell adhesion. 
 
Cystatin
-A  P01040 10.99 10.19 
6.70 
E-06 18.40 1 
This is an 
intracellular thiol 
proteinase inhibitor. 
Has an important role 
in  cell-cell adhesion 
in the lower levels of 
the epidermis 
Fibrone
ctin P02751 262.46 10.17 
8.90 
E-04 .80 1 
Fibronectins are 
involved in cell 
adhesion, cell 
motility, 
opsonization, wound 
healing, and 
maintenance of cell 
shape 
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(b) 
Fe2O3 
LLF/ 
10% S Acc No MW 
XC  
Score P EP % C 
Peptide 
 Ion 
(hits) 
Function as 
defined by 
Uniprot 
Serum 
albumi
n  P02768 69.32 170.28 
1.27
E-09 35.80 18  
(see figure 3.5 
(a)) 
Apolip
oprotei
n A-I  P02647 30.76 40.20 
3.81
E-10 17.60 4  
(see figure 3.5 
(a)) 
 Ig 
gamm
a-1 
chain 
C 
region P01857 36.08 30.24 
9.62
E-12 17.58 3  
None listed 
Ig 
kappa 
chain 
C 
region  P01834 11.60 20.25 
4.71
E-12 32.08 2  
None listed 
 
Glycer
aldehy
de-3-
phosp
hate 
dehydr
ogenas
e  P04406 36.03 20.20 
4.45
E-09 11.34 2  
playing a role in 
glycolysis and 
nuclear functions 
 
The SDS-PAGE gels lanes seen in figure 3.3 and 3.4 show proteins of the iron 
oxide NMs with a 10% plasma hard corona (10%P) before and after incubation 
with LLF (LLF/10%P); the 55% plasma hard corona (55%P) before and after 
incubation with LLF (LLF/55%P) (Figure 3.3) and a 10% serum hard corona 
(10%S) before and after incubation with LLF (LLF/10%S).  They were obtained 
to investigate the binding patterns of 280nm and 45nm Fe particle - protein 
complexes free from excess proteins.  The proteins were separated as described in 
3.2.6.  The molecular weights of the proteins in the standard ladder are reported 
on the left for reference.  
 
After staining using a mass spectroscopy compatible staining procedure, selected 
lanes (280nm Fe2O3 in 10% plasma, and after pre incubation in LLF lanes) were 
trypsin digested to remove the protein and analysed using MS.  The above tables 
(3.3 and 3.4) show the five most abundant proteins identified by MS. All 
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recorded proteins can be found in the appendix 8.8. The MS findings indicated 
that the quantity of proteins that make up the hard corona vary, not only in type, 
but in quantity between plasma and serum.  The most abundant protein found in 
the 10% plasma corona was apolipoprotein B-100, apolipoprotein (a) and 
complement proteins.  After preincubation with LLF the amount of complement 
and serum albumin that made up the corona doubled.  This indicated that the LLF 
resulted in greater adsorption of proteins onto the NM surface at the 10% plasma 
concentration.  This data is also supported by the DLS /DCS and SDS PAGE 
binding patterns.  This suggests that as NMs and particles translocate to 
secondary target sites in the body its biological identity is not static but may 
change over time and recent studies [151] have shown that the protein 
concentration impacts on the evolution of the protein corona over time, so that the 
corona evolves as it passes from one biological fluid to another [153].  Bands 
were also observed at 90kDa (plasminogen), 30kDa (apolipoprotein A) and at 
20kDa.  The same binding pattern was seen at the higher plasma concentration, 
but the intensity of the bands varies especially at 50kDa.  These bands were 
different from those observed using 10% serum which was seen to bind many 
different proteins of a lower molecular weight.  
 
The three most abundant proteins isolated from the Fe2O3 in 10% plasma and in 
LLF/10%P were apolipoprotein B-100, complement C3 and albumin, but the 
relative order of abundance was different. In the 10% plasma corona the most 
abundant proteins of the corona also included apolipoprotein (a) and complement 
C4-A, while in LLF/10%P the most abundant proteins included filamin-A and 
myosin-9.  For the Fe2O3 particles in 10% serum or LLF/10%S the most abundant 
proteins included albumin, which is not surprising since this is the most abundant 
protein in serum.  The remaining composition of the corona was different from 
the plasma corona in that it included apolipoprotein A-1, desmoglein-1, cystatin-
A and fibronectin.  While in LLF/10%S the corona included apolipoprotein A-I, 
alpha-1-antitrypsin, Ig gamma-1chain C region and Ig kappa chain C region. 
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3.3.6 Cytotoxicity Results 
 
   
(a)                 (b) 
 
Figure 3.5: (a) Percentage (of positive control) LDH release and (b) 
viability assessed by WST-1 of J774.A1 macrophages after exposure to 
Fe2O3 280nm and Fe3O4 45nm particles for 24 hours. Values represent 
the means of 3 experiments ± SEM .  The asterisk denotes a significant 
difference from the negative control (p < 0.05).  
 
This work reports that there was no significant release of LDH from the 
macrophage cell line treated with the 280nm Fe2O3 particles after four hours 
exposure compared to cells in media only (data shown in appendix 8.9).  There 
was also no significant release of LDH for the cells exposed to the 45nm particles 
after 4 hours compared to media alone, except at the highest concentration of 
500µg/ml (data shown in appendix 8.10).  Both Fe2O3 and Fe3O4 induced a dose 
dependent increase in LDH release after 24 hours (Figure 3.5).  The concentration 
at which the cytotoxicity became significant compared to the control was 62.5 
µg/ml for both the Fe2O3 280nm and Fe3O4 45nm particles (24 hours exposure).  
ANOVA (95% significance level) indicates there was no significant difference in 
* 
* 
* 
* 
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percentage LDH release between the 2 particle types (p=0.752).   Figure 3.3.6 (b) 
shows the effect of particle exposure on cell mitochondrial function.  Again, the 
percentage viability of the cells after exposure to Fe2O3 280nm and Fe3O4 45nm 
particles after 24 hours exposure showed a dose dependent increase in 
cytotoxicity.  Again there was no difference between the two particle types (P > 
0.05) and the concentration at which there is a significant difference from 
untreated cells is at 62.5µg/ml.  
 
3.3.7 Impact of Corona on Cytotoxicity  
 
(a) 280nm 
 
 
(b)45nm
 
Figure 3.6: Percentage (of positive control) LDH release from J774.A1 
macrophages after exposure to (a) Fe2O3 280nm particles (b) from 
* 
* 
* 
*  * * 
* * 
* 
* 
* 
* 
* 
* 
* 
* 
* * 
* 
* 
* * * 
* 
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Fe3O4 45nm particles with and without i ts associated 10%P, 10%S and 
LLF corona after 24 hour exposure. Values represent the means of 3 
experiments ± SEM.   
 
The results from figure 3.6 show that following exposure to 280nm Fe2O3 there 
was no significant difference (P=0.123) in the % LDH release between the plain 
particles (i.e. those without a hard protein corona) and those coated with LLF.  
There was a significant difference between in the % LDH release from cells 
exposed to the plain and LLF coated particles than those exposed to serum 
(P=0.001) and plasma (P=0.001) coated particles as denoted by the asterisks.  
Indicating that the serum and plasma coated particles mitigate toxicity.  There 
was also a significant difference between the serum and plasma coated particles 
(P=0.45) with serum coated causing more LDH release than plasma coated 
particles.   The 45nm particles produced similar findings to the 280nm particles, 
in that there was no significant difference (P=0.197) in the % LDH released from 
cells exposed to plain uncoated particles and those coated in LLF.  As with the 
280nm particles the % LDH measured was significantly higher (p=0.001) in cells 
exposed to plain and LLF coated NMs than those exposed to plasma and serum 
coated NMs.  Unlike the 280nm particles there was no significant difference 
(p=0.911) between serum and plasma coated particles with respect to % LDH 
release.  
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3.3.8 Cytokine Analysis  
 (a)  (b)  
 
(c)  (d)  
 
Figure 3.7: Cytokine profile measured from supernatant of J774.A1 
cells exposed to Fe2O3 with and without associated LLF Plasma and 
serum corona (a) MCP-1 (b) TNF-α (c) IL-1β and (d) IL-10.  Data 
expressed as a mean ± SEM, n = 3. The effect of the particles with their 
serum corona has a significant impact (at 95% significant level) on 
cytokine release with these particles showing increased release 
compared to the control for MCP-1, TNF-α ,IL-1β and IL-10 at all 
concentrations tested (250, 62 and 3µg/ml).  The table underneath 
 
Fe2O3 
no corona 
Fe2O3 
LLF 
Fe2O3 
10%P 
Fe2O3 
10%S 
MCP-1,      
IL-1β,  
   
 
TNF-α      
IL-10  
   
 
 
 
95 
 
denotes the treatments were the cytokine levels were significantly greater 
than the control at the 3 concentrations.  
 
(a)  (b)  
 
(c)  (d)  
 
 
Fe3O4 
No  
corona 
Fe3O4 
LLF 
 
Fe3O4 
10%P 
 
Fe3O4 
10%S 
 
MCP-1,      
IL-1β,  
 
(only at 250ug/ml) 
 
 
TNF-α      
IL-10  
  
  
 
Figure 3.8: Cytokine profile measured from J774.A1 cells exposed to 
Fe3O4 with and without associated LLF, Plasma and serum corona (a) 
MCP-1 (b) IL-1β (c) TNF-α and (d) IL-10.  The table underneath 
denotes the treatments were the cytokine levels were significantly 
greater than the control at three concentrations . 
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3.4 Discussion  
 
This study investigated the effect of the iron oxide particles and iron oxide NMs 
with a protein hard corona on a J774.A1 ‘macrophage like’ murine cell line in 
relation to cytotoxicity and ability to stimulate pro-inflammatory cytokine release.  
The particles were characterised before and after protein coating using differential 
centrifugal sedimentation, dynamic light scattering and zeta potential 
measurements. Semi quantification of the hard corona composition was carried 
out using one dimensional gel electrophoresis and mass spectrometry.  
 
Initially three types of particles were investigated, two Fe2O3 particle (280nm and 
22nm) and one Fe3O4 (45nm) particle which was an ultra superparamagnetic iron 
oxide (USPIO) NM.  The three particle types were examined for the effect of 
sonication, particle concentration, pH, and the presence of FCS on their stability 
in media, using a range of techniques.  This study on the physical and chemical 
analysis of the 280nm and the 22nm Fe2O3 particles, as well as their cytotoxicity 
(LDH release see appendix 8.10) suggested that they were so similar that it could 
not distinguish between them.  Therefore the remaining studies continued with 
the 280nm Fe2O3 and the 45nm Fe3O4 particles only.  
 
The images of the cells after particle expose (Figure 3.1 and those found in the 
appendix 8.6) show that within four hours particles appear to associate with the 
cells and after 48 hours cell death appears to occur.  Cell death can clearly be seen 
to occur after exposure to the higher concentration (500µg/ml) of particles.  The 
light microscopy imaging, the LDH release data and the WST-1 assay all 
indicated that the 280nm Fe2O3 and the 45nm Fe3O4 particles were of relatively 
low toxicity to the macrophage cell line at 4 hours.  By 24 hours both particles 
induced toxicity to a similar extent despite their difference in chemistry and size. 
 
Naked particles induced a dose dependent increase in LDH release for both 
particle sizes These results concur with published literature on naked iron oxide 
NM toxicity (example review by Soenen et al. [181]) which indicate that these 
types of NMs are tolerated at high levels [47, 144]. The data presented in this 
thesis does show this using two separate endpoints.  However given the large 
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variety of testing methods/endpoints and the types/sources of naked iron oxide 
NMs published in the existing literature it is difficult to develop an overall 
consensus on iron oxide NM toxicity in macrophage cell lines.  This work adds to 
the published literature and overall suggests that the hard corona of particles has 
an effect on cytotoxicity as assessed by LDH released in a J774.A1 cell line.  
LLF had no significant impact on this toxicity, while serum and plasma reduced 
the toxicity significantly, perhaps this may be because the plasma and serum coat 
the particles surface in a way that LLF does not.  The low protein content of LLF 
may be a crucial factor here.  Indeed SDS gels of the LLF coated particles 
(appendix 8.11) shows only one major band was obtained.  This is an interesting 
result indicating that exposure via inhalation is an important route to consider for 
future toxicological studies and that the addition of serum into pulmonary cell 
culture models may, firstly not be relevant and secondly might lead to an 
underestimation of the potential toxicity of the particles. 
 
The applications and current uses of these particles are discussed in Chapter 2.  
For these particles to be useful in the biomedical field they need to be stabilised 
or functionalised by the application of a coating [181].  In this study the particles 
were used in their non-functionalised form in order to investigate the ‘naked’ 
particles, in this way the study was not complicated with the issue of coating or 
coating degradation on toxicity.  The coating effect on iron oxide NM 
cytotoxicity and cellular uptake in different cell media has been previously 
described [158, 181] and such issues may be responsible for many inconsistencies 
in the published literature on iron oxide NM toxicity.  The large variety of iron 
oxide particles, cells types used in cytotoxicity studies and the variety of 
cytotoxicity protocols available, is also no doubt an issue of concern when 
elucidating iron oxide NM toxicity.  
 
Due to the nature of the iron oxide particles used in this study, care had to be 
taken when optimising the cytotoxicity assays.  Contamination of samples by 
particles before spectroscopic analysis can lead to an increase in the absorbance 
readings.  Particles have been shown to interact with colour generating dyes in 
colorimetric assays for example, as has been found when employing the MTT 
assay when examining CNT cytotoxicity [196, 197].  After a preliminary 
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examination of the particles this was found to be true for the particles employed 
in this study  (data shown in appendix 8.5), therefore before analysis the 
supernatant was removed from each test well in the 96 well plates and 
centrifuged to remove any particles.  Failure to take such precautions may result 
in a higher estimation of cell viability or LDH release.  It was also considered that 
particles may adsorb LDH; such binding can of course confound endpoint 
measurements leading to an underestimation of cytoxicity as it will not be present 
in the supernatant for detection.  For this reason it is important to use a variety of 
endpoints.  
 
This study’s focus was on the long lived protein corona, those proteins that 
remain strongly bound to the NMs.  During preparation of the long lived corona 
samples, a BCA protein assay was carried out on each wash to investigate the 
concentration of remaining protein and it was seen that after 3-4 washes less than 
1% of the total protein was detectable in the washes.  It must be considered that 
this method however has limitations in that the complexes must be heavier than 
any unbound proteins in order to be separated successfully.  Given that iron oxide 
has a density of 5.24g/cm
3 
(blood serum=1.025g/cm3)
 
in this case the complex 
does suit this method of separation. 
 
Immediately after preparation of the particles or NM corona, the particle – 
protein complex was characterised using DLS, ZP and DSC.  According to DLS 
measurements all the particle types showed an increase in hydrodynamic 
diameter in PBS compared to deionised water.  This has been reported previously 
for other particle types [198-200] and for iron oxide particles [137].  For both 
particles there was a further increase in the hydrodynamic diameter after 
incubation in plasma (10% and 55%).  It is interesting to note that DLS 
measurements also show that incubation in 55% plasma contributed to a smaller 
increase in the hydrodynamic diameter than after incubation in the 10% plasma.  
This was observed for both particle types and was also confirmed by DCS data.  
The largest increase in Z average was seen in the LLF corona.   
 
These DLS characterisation results find that NMs with their associated long lived 
hard corona showed an increase in the hydrodynamic diameter compared to the 
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particles dispersed in water; however the Pdi measurements remained similar, 
suggesting that this increase was not due to agglomeration, but due to the 
additional adsorbed layer.  However the LLF coated and precoated particles had a 
high Pdi and very low ZP indicating they were not stable in solution and tended 
to be highly agglomerated.  LLF has been previously reported to have this effect 
on particulate matter [168].  
 
The ZP measurements, which are an indication of particle charge and suspension 
stability, showed that the particles were stable in water.  The ZP value of the 
particles decreased by up to 50% measured with their associated proteins.  A 
decrease in the zeta potential may be explained in one of two ways: (i) the 
‘slipping plane’ (the point at where the ZP is obtained) being moved further away 
from the particles and hence reducing the zeta potential, or (ii) the drag caused by 
the presence of the coating on the particles reducing the mobility of the particles 
(and hence also reducing the ZP).  
 
By examining the difference in peak shift between the naked NMs and NMs with 
a protein corona in the DCS data, information on the external protein coating was 
obtained.  Using the core-shell two density model the shell thickness (i.e. that of 
the protein coating) was reported.  This information supported the DLS data to 
give a more accurate estimation of the adsorbed layer thickness.  For the 280nm 
iron oxide NMs, there was an increase in shell size after treatment using every 
coating and after precoating in LLF followed by serum or plasma.  For the 280nm 
particles the 10% plasma corona shell was determined to be 13nm.  It is 
interesting that this dropped to 3.5nm for the 55% plasma corona.  After 
preincubation in LLF the corona, for both 10 and 55% plasma and 10% serum, 
increased to 38nm, 59nm and 69.5nm respectively, suggesting that the LLF in 
some way adds to the hard corona.  It was seen that the shell size varied 
according to dispersant/corona and particle type.  For Fe2O3, the greatest corona 
depth was LLF/S10% > LLF/P55% > LLF/P10% > 10%P > 10%S > 55%P.  
 
For the 45nm particles a slightly different trend was observed compared to the 
280nm Fe2O3 particle where the protein shell coating in plasma (both 10 and 
55%) appeared to be larger before precoating with LLF.  This interesting 
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observation was confirmed by DLS results and visually by the SDS PAGE gels, 
where it can be observed that after precoating the 45nm particles with LLF and 
then plasma there appeared to be less protein in the gel lane than with the 55% 
plasma coating alone.  The 10% serum corona did not produce a measurable shell 
corona thickness.  However, after precoating with LLF there was a 25.5nm 
coating observed.  The protein shell thickness was not calculated for the LLF 
coated particles as the protein density was unknown.  For the Fe3O4 NM the 
greatest corona dept was 10%P > 55%P > LLF/10%P > LLF/10%S > LLF/55%P 
> 10%S. 
 
Each sample (280nm Fe2O3, 45nm Fe3O4, NMs with a plasma and serum corona, 
and NMs preincubation with LLF) was further investigated using SDS PAGE so 
as to examine the hard corona protein profile.  The SDS gels revealed that there 
was no obvious alteration in the binding patterns of the 280nm plasma and serum 
corona after preincubation with LLF.  The binding patterns were almost identical 
to the non-preincubated particles however they did show higher band intensity 
after preincubation.  The observation for the 45nm iron oxide particles was 
similar to that of the 280nm however the 45nm iron oxide NMs with its 
associated 55% plasma hard corona did show there was more protein binding 
compared with the same particles which was first precoated using LLF followed 
by a 55% associated corona.  This was not observed for the 10% plasma corona 
suggesting that the LLF in some way hindered protein adsorption at higher 
concentrations.  
 
The observation that the hard corona can significantly vary in composition 
depending on the concentration of protein and the coating (plasma, serum or 
preincubated in LLF) is an interesting observation which potentially has 
implications for interpretation of in vitro experimental data.  The different coating 
protocols also provide an opportunity to prepare the particles for in vitro studies 
that better model the exposure scenario in vivo.  The ability to track the evolution 
of a protein corona in a real life scenario (lungs to blood) is an important element 
of this study.  It is interesting to note that both opsonic proteins (i.e. proteins that 
enhance phagocytosis such as complement proteins and immunoglobulins) and 
dysopsonic proteins (i.e. proteins that are less recognisable to macrophages such 
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as apolipoproteins and albumin) were detected by MS in the corona adding yet 
another layer of complexity in elucidating how particles are processed once in the 
body (i.e. the retention time in the blood/clearance by macrophages). 
 
NMs studied in vitro in cells lines with FCS concentrations may not correlate to 
actual real life exposure scenarios where the NMs are in a high plasma 
concentration and come into contact with many types of biological fluids.  
Considering this, the macrophage response to iron oxide particles and NMs in a 
plasma, serum and LLF corona was investigated.  The plasma concentration at 
10% and 55% and serum concentration at 10% corona as chosen in order to 
compare the in vivo and in vitro situation. As inhalation is a likely route of 
exposure to NMs, the corona of NMs first preincubated in LLF and then incubated 
in either plasma or serum was also investigated further as it has previously been 
shown that NMs can translocate from the lungs to the blood [201]. 
 
This study also examined the ability of the iron oxide particles (with and without 
their corona) to stimulate the release of the acute phase cytokines IL-1β, TNF-α, 
the cytokine IL-10 and chemotactic protein MCP-1 from J774.A1 macrophages.  
This was a study made in connection to the LDH assay and so the cytokine profile 
was measured from the supernatant saved from the LDH assay.  Both the 280nm 
and the 45nm iron oxide particles with their associated serum corona showed a 
significant difference from the negative control (at all 3 concentrations tested) in 
terms of cytokine release with an increase in release for MCP-1, TNF-α, IL-8 and 
IL-10.  In general it would be expected that the amount of proteins (cytokine) 
produced is an indicator of the number of viable cells present and that an increase 
in protein production occurs in correlation to the increasing particle dose until a 
point (LC50) at which point the protein production would decrease. The
 
results 
from the LDH assay revealed that the serum coated particles produced a lower 
LDH response; this means there are more intact cells available to produce 
measurable quantities of cytokines.  In the absence of normalised data these 
results should be viewed not as a separate experiment but taken together with the 
LDH data.  Higher quantities of viable cells may explain the higher cytokine 
levels not only in the proinflammatory cytokines but also in the anti-inflammatory 
cytokine inhibitor IL-10.  Thus it may not so much be an indication of an 
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inflammatory response (which is heavily dependent on cytokine and chemokine 
release) but validates the LDH assay.  As both particles with their associated 
serum corona showed a significant difference from the control in terms of 
cytokine release, with an increase in release for MCP-1, TNF-α, IL-8 and IL-10, it 
was expected then that this may also be the case for particles with a plasma 
corona however a higher cytokine release was not seen consistently for this 
treatment at all concentrations.  However it should be noted that at 250µg/ml both 
45nm Fe3O4 and the 280nm Fe2O3 particles with a plasma corona did produce a 
significant increase in MCP-1 and TNF-α.  
This work ultimately shows that the biological identity of particles is a result of 
their attached proteins.  Bound proteins may aid binding to receptors expressed in 
cells thus facilitating endocytosis into cells.  Although this was not examined 
within the scope of this thesis it is possible to hypothesise that greater interaction 
with receptors would lead to a greater intracellular dose that might enhance 
toxicity.  However, studies have also demonstrated ([114, 158]) an ability of NMs, 
when tested in vitro in the absence of FCS, to have an enhanced response on cell 
cytotoxic response and uptake over NMs in presence of FCS and more recent 
studies emerging have linked the protein corona to reduced cytoxicity [162, 163].  
This study shows the ability of the protein corona to reduce the cytotoxicity of 
iron oxide particles to the J774.A1 cell line.  The more proteins making up the 
corona, (as identified by MS) the less % LDH release was found in vitro.  It can 
be speculated that NMs and particles with their associated corona, do not interact 
as much with the cells as NMs and particles in the absence of a corona.  It may be 
that the naked iron oxide NMs which caused the higher LDH release are more 
prone to associating with cells in order to bind biomolecules to their plain surface 
in a bid to lower their surface reactivity. 
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3.5 Conclusion 
 
Although it is difficult to correlate the impact of any individual protein identified 
in the protein corona to cytoxicity this study has shown that binding of serum and 
blood plasma proteins to iron oxide particles reduces cytoxicity to macrophages.  
It was found that the particle - protein interactions vary according to protein type 
(serum or plasma or LLF) the concentration and on precoating in LLF.  It is 
interesting to note that not only the type of biological material, but the 
concentration of that material impacts on the protein binding profile of the 
corona.  
 
There is a clear difference in the biological identity of the iron oxide particles in 
plasma, serum and in LLF and this illustrates the implications for interpretation of 
data from in vivo cell culture tests that do not take the protein corona into 
consideration.  Clearly the protein corona is an important element to consider in 
experimental design so that a better insight into particle/protein interactions can 
be obtained in a biological system.  Thus this work implies that the biological 
consequences of NM-cell interactions cannot be examined without considering 
the biological environment and may explain the contradictory toxicity results 
proposed thus far observed for iron oxide NMs.  Such studies provide an 
opportunity to devise particle preparation protocols that mimic the corona 
composition in vivo to better study cellular responses in vitro. 
 
Why NMs appear to have an affinity for one protein compared with another and 
why these affinities vary according to the protein concentration is unknown.  This 
is a worthwhile opportunity for future studies, particularly focusing on FCS, as 
this may lead to standardised experimental conditions that can advance the 
nanotoxicological field, leading to a more harmonised approach to NM and 
particle toxicity investigations. This work has been repeated using other particle 
types as a comparison.  
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Chapter 4 The Effect of the Silica Particles and Nanomaterial  
                               Protein Corona on Macrophage Cytotoxicity 
 
4.1 Introduction 
 
NMs exhibit a relatively high surface area to volume ratio compared to larger 
particles.  The small size of NMs restricts the space available for intermolecular 
bonds causing them to become strained and more reactive, hence leading to a 
relatively higher surface reactivity.  Consequences of the high surface reactivity 
include a tendency to adopt spherical shapes where possible, to agglomerate and 
in biological fluids NMs to associate with proteins and other biomolecules [202].  
This behaviour that not only lowers their high free energy state but can also 
determine their potential fate (organ distribution) in the body.  In 3.1.1 the term 
protein corona was introduced to describe the specific set of proteins in a 
biological media which associate with NMs.  These protein interactions, the type, 
degree and amount are essential to investigate in nanotoxicology, as the presence 
of proteins on the NM surface will determine their in vivo response [25].  For 
example the presence of opsonins in the NM corona will promote phagocytosis 
whereas the presence of dysopsonins will inhibit phagocytosis and promote 
circulation of NMs in the body [151].  Recently emerging research shows that 
NMs adsorb proteins from a biological matrix in a manner that is correlated with 
the specific NM physicochemical properties [154, 203].  Although this is a 
growing area of interest in nanotoxicology recent studies focus more on the 
corona characterisation [25, 104, 204] and adsorption kinetics [149, 204] and less 
on the toxicological significance of the protein corona.  The emerging studies 
looking at the toxicological impact of the protein corona [150, 162, 163] have 
reported that binding of proteins to NMs does tend to reduce the cytotoxic 
potential of NMs.  Previous work in this thesis (Chapter 3) does find that iron 
oxide particles with a plasma and serum protein hard corona were less cytotoxic 
than naked particles, as determined by the LDH release.  These types of findings 
have important consequences for nanotoxicity studies again highlighting the need 
for well characterised NMs and standardised experimental conditions.  
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In Chapter 2 it was discovered, after extensive characterisation, that there was no 
difference in the physicochemical characteristics of the 22nm and 280nm iron 
oxide particles that were used to examine if particle size can influence the affinity 
and degree of protein-particle binding.  Therefore in order to re-examine this 
hypothesis of the thesis the work expanded to incorporate silica NMs. Four silica 
particles and NMs (200nm and 50nm neutral silica and 200nm and 50nm amino 
modified silica) were examined to determine their responses in the same 
macrophage cell line (J774.A1).  Their ability to bind proteins from plasma serum 
and LLF were investigated in the same manner as that carried out for iron oxide 
particles in Chapter 3.  These particles have previously been used in corona and 
toxicity studies [151, 205] and were characterised as part this work.  
 
4.1.2 Silica Nanomaterials 
 
Owing to the relative ease with which stable monodisperse silica NM can be made 
they are one of the most widely available NMs in the marketplace today (as can 
be seen in table 1.1).  In the order of 1.5 million tonnes of silica NMs are 
produced annually and this represents a  market value of around €2.7 billion [14].  
A study commissioned by the European Commission on the types and uses of 
NMs (which shall be summarised briefly herein with regards to silica) reports that 
silica NMs find uses as function fillers in polymers, electronics and the cosmetic 
industry and to a lesser extent in paints and coatings and food additives [14].  The 
function of silica NMs depends on the form it is manufactured in.  For example 
colloidal silica are generally spherical particles and are mainly used in the paper 
industry as coatings for ink jet paper, the electronics industry for polishing 
computer chips and in the food and textile industry.  Silica NM manufactured as 
‘precipitated silica’ (5-100nm) are used primarily in the manufacture of rubber 
and as anti-caking agents in the food and healthcare industries (e.g. toothpastes, 
detergents and cosmetics).  Fumed silica is a type of silica that is in the size range 
of 5 and 100 nm and is used in the rubber and plastic industry, as an antifoaming 
agent in the food industry (e.g.  in the manufacture of decaffeinated coffee and 
tea) [14]. 
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It is important to emphasise synthetic amorphous silica should be distinguished 
from crystalline silica.  Crystalline silica (or quartz) has been classified as a class 
1 carcinogen by IARC [206].  Amorphous silica has been in use since the 1920’s 
and some studies report amorphous silica to be relatively inert or benign.  
 
Animal (mouse model) data shows treatment with low doses (20-80mg/kg) 
produces no observed effects on animal health and with the LD50 in this model 
reported to be greater than 1000mg/kg [207].  High doses have been reported to 
induce inflammation, cytotoxicity and tissue damage in the lungs [208].  However 
other in vivo data shows a dose and time dependent inflammatory response 
(neutrophilic inflammation and macrophage accumulation) to intratracheally 
instilled 14nm silica NM at concentrations of 0.3-100µg/mouse measured 3 days 
after exposure.  A recent in vitro study reports that amorphous silica NMs (15 and 
46nm) have a greater effect on A549 cells (measured as ROS generation) than a 
5µm crystalline silica particle [208].  Overall in vivo studies show SNP cause 
reversible lung inflammation, (granuloma formation) that does not progress to 
cause lung fibrosis and most of the in vitro studies report results of size and dose-
dependent cytotoxicity as well as increased reactive oxygen species levels [209].  
 
Given the quantities in which silica NMs are produced, the limited (or 
incomplete) data available on the adverse health effects, coupled with the growing 
number of applications in the healthcare and food industries more scrutiny and 
critical analysis of the existing data is warranted.  Ideally all toxicological 
data/publications should also include detailed characterisation of the physical 
chemical properties of the material [210].  
 
Although uptake mechanisms were not under investigation in this study it is 
important to note that a range of uptake behaviours have been reported for NMs 
(including silica NMs (SiO2 NMs)) as mentioned in 1.2.1.  SiO2 NMs (which 
agglomerated to size of 5 μm in diameter in cell culture media) have been shown 
to enter the cytoplasm of cells (A549 cells) [19].  Silica NMs less than 100 nm in 
size have been found to induce endocytosis-dependent ROS (HaCaT cells), while 
conversely the affinity of silica NMs for the cells lipid bilayer allows the potential 
for passive uptake in vesicles [211].  Of course the corona that forms on their 
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surface once in contact with biological fluids is one factor that can effect these 
interactions and Lesniak et al. [150] found that silica NMs exposed to cells 
(HeLa; hCMEC/D3 and A549) in the absence of serum have a stronger adhesion 
to the cell membrane than those in medium with serum.  These different exposure 
conditions were found to affect both the rate of uptake and the intracellular 
location of the silica NMs.  
 
The same experimental design used previously for iron oxide NMs (outlined in 
Chapter 3) was employed in order to investigate the corona composition of SiO2 
NMs in FCS (as used for in vitro cell culture) and in human blood plasma.  
Inhalation as a route of exposure was again of particular interest in this study and 
so in order to simulate exposure via inhalation followed by translocation to blood 
a protein corona first in LLF then in serum or plasma was prepared.  This study 
therefore expands on the previous work with iron oxides not only by allowing 
direct comparison of two NM types but also by investigating the effect of size and 
surface modification on the corona development.  Comparison of serum and 
plasma corona in this way and investigation of its cytoxicity can help with in 
vitro/in vivo cytotoxic comparisons.  
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4.1.3 Chapter 4 Aims 
 
 To prepare silica NMs with a hard plasma, serum and LLF corona, and to 
use protein characterization techniques to investigate protein binding. 
 
 Examine how particle size, composition and charge influence the affinity 
and degree of protein binding. 
 
 Investigate the role the protein-particle interaction has in influencing 
toxicity of the NMs by investigating the effects of NM-protein exposure 
on J774.A1 macrophage cell line with respect to LDH release and cytokine 
release and compare these results to those results already obtained for 
Fe2O3 and Fe3O4 particles and nanoparticles. 
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4.2 Materials and Methods: 
 
4.2.1 Materials 
 
Silica nonporous particles (Kisker, Germany) were obtained in two sizes (200nm, 
50nm) and had either an unmodified surface (neutral) or animated (positive) 
surface and a density of 2.6g/cm
3.  
They were provided dispersed in deionised 
water.  The NH2 modified particles were further NH2 modified after zeta potential 
experiments revealed the particles were not strongly positive.  Surface 
modification of silica NMs involved the addition of aminopropyltrimethoxysilane 
(APTMS) to a concentration of 10mg/ml NMs.  The pH was adjusted to pH5 with 
acetic acid and the mixture was stirred for 4 hours at 400rpm.  Finally the particles 
were purified from excess APTMS by centrifugation and re-suspension in ethanol 
and water.  The particles were then diluted in filtered sterile MilliQ water to 
1mg/ml.  Silica NMs were diluted as required in either sterile deionised water or 
filtered sterile PBS or RPMI before analysis.  Before exposure each sample was 
sonicated at 200W for five minutes using a bath sonicator (Grattan). 
 
4.2.2 Cell Culture and Treatments  
 
The adherent mouse macrophage cell line J774.A1 was used as a model system 
and was routinely cultured as described in 3.2.2.   J774.A1 macrophages were 
treated with the NMs in RPMI at concentrations ranging from 0.9µg/ml to 
200µg/ml (corresponding to 2.4 and 125µg/cm
2
 respectively).  The LDH and 
WST-1 assay were carried out as described in 3.2.7.  Briefly for the WST-1 assay, 
after incubation the supernatant from each well was removed and replaced with 
culture medium containing WST-1 in a 1:10 ratio.  The plates were incubated for 
4 hours at 37°C.  Before reading, the plates were centrifuged at 250g for 3 
minutes, the supernatants were removed and transferred to a new 96 well plate 
and read using a multiwall plate reader at a wavelength of 450nm.  Data was 
expressed as the percentage viability of treated cells compared with the medium 
only control.  
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For the LDH assay 0.75 mM aqueous sodium pyruvate (containing NADH 
1mg/ml) was pipetted into each well of a 96 well plate and incubated at 37
º
C for 5 
minutes.  A volume of 10µl of cell supernatants were added to the wells in 
triplicate and mixed on a plate shaker.  The plates were incubated for 30 minutes 
at 37
º
C.  Fifty microlitres of 2,4-dinitrophenylhydrazine (dissolved in 1M HCL) 
was added to each well and incubated at room temperature for 20 minutes.  Fifty 
microlitres of 4 M NaOH was added to each well, mixed and allowed to stand for 
5 minutes. The absorbance was read at 540nm as described in 3.2.7.  The LDH 
content of the supernatants was expressed as a percentage of the 100% lysis. 
 
4.2.3 Preparation of Hard Corona Coated Nanomaterial 
 
The NMs were mixed in low protein binding eppendorf tubes with plasma, serum 
or LLF as described in order to prepare the hard corona as described in 3.2.4.  
 
4.2.4 Characterisation of Nanomaterial-Protein Complex 
 
Characterisation of the particles alone included (as described in 3.2.5) size 
analysis measurements (DLS) and charge/stability using ZP. Image analysis 
(SEM) was also carried out and previously reported by Brown et al (in 
publication). DLS measurements were used initially to study the hydrodynamic 
diameter and zeta potential to get an indication of size and stability of the particles 
in water and in PBS.  Particles were then remeasured once coated (see 3.2.4) in 
proteins (10% plasma, 55% plasma, 10% serum, LLF, precoated in LLF and then 
in 10% plasma, 55% plasma or 10% serum).  The difference between the results 
gives information on corona layer thickness and in this way the DLS was used to 
determine the thickness of an adsorbed layer.  Pdi was also measured to access 
particle aggregation/flocculation behaviour. An increase in Pdi represents an 
increase in agglomeration.  The NM stability and charge in water and PBS was 
determined using ZP measurements (Malvern Zetasizer Nano) as described 
previously in 2.2.4.  Protein separation and identification of the hard corona was 
carried out using SDS-PAGE and MS as described in 3.2.6.  
 
 
111 
 
4.2.5 Cytokine Estimations using FACS Array Analysis 
 
Supernatants obtained during LDH assays were used to estimate the release of the 
following cytokines from treated cells; IL-1β, TNF-α, IL-10 and MCP-1.  
Analysis was carried out on a BD FACS Array™ Bioanalyzer, using a BD 
cytometric Bead array mouse/rat soluble protein master buffer kit as per 
manufactures instructions. 
 
4.2.6 Statistical Analysis 
 
Data from all experiments were analysed using the Minitab 15 statistical package 
using a general linear model analysis of variance.  Significance was set at 5%. 
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4.3 Results 
 
4.3.1 DLS Characterisation 
 
Table 4.1 Hydrodynamic diameter, polydispersity index (Pdi) and zeta 
potential for SiO2 200nm and 50nm particles measured in water, PBS and 
with their associated long lived protein corona (where P=plasma, and 
S=serum and LLF= lung lining fluid) as determined by DLS. Values represent 
the mean ± SEM (n=3). 
 
 
 
 
SiO2 200nm Z average (nm) St Dev.(nm) Pdi ZP (pH 7.5) 
mV 
Water 174.40 1.58 0.06 (-)25.0 
PBS 186.60 2.73 0.08 (-)23.2 
10%P 211.60 3.23 0.24 (-)12.0 
55%P 272.80 7.37 0.31 (-)9.8 
10%S 207.70 4.30 0.12 (-)10.4 
LLF >1302.00 93.80 0.50 (-)13.4 
LLF/10%P 267.40 5.77 0.28 n/a 
LLF/55%P 236.10 8.84 0.22 n/a 
LLF/10%S 261.40 8.58 0.46 n/a 
SiO2 50nm  Z average (nm) St Dev. (nm) Pdi ZP 
(pH7.5) 
mV 
Water 54.16 0.06 0.12 (-)21.00 
PBS 64.08 0.99 0.16 (-)23.90 
10%P 109.80 3.55 0.27 (-)11.10 
55%P 116.40 1.75 0.42 (-)11.20 
10%S 122.70 0.08 0.29 -12.40 
LLF 1142.00 101.00 0.32 -8.02 
LLF/10%P 209.50 5.16 0.41 n/a 
LLF/55%P 203.60 2.92 0.36 n/a 
LLF/10%S 464.70 38.80 0.43 n/a 
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Table 4.2 Hydrodynamic diameter, Pdi and zeta potential for NH2 modified 
SiO2 200nm and 50nm particles measured in water, PBS and with their 
associated long lived protein corona as determined (where P=plasma, and 
S=serum and LLF= lung lining fluid) by DLS Values represent the mean ± 
SEM (n=3). 
SiO2 NH2 200nm Z average (nm) St Dev. (nm) Pdi ZP (pH 7.5) 
mV 
Water 239.20 4.05 0.04 38.20 
PBS 262.40 3.16 0.07 (-)1.20 
10%P 313.40 5.30 0.25 (-)10.70 
55%P 396.90 7.54 0.31 (-)10.30 
10S%  241.10 5.60 0.19 (-)12.30 
LLF 2256.00 55.15 1.00 (-)23.80 
LLF/10%P 270.00 2.19 0.34 n/a 
LLF/55%P 278.30 17.38 0.36 n/a 
LLF/10%S 306.40 5.60 0.31 n/a 
 
SiO2 NH2 50nm Z average (nm) St Dev. Pdi ZP (pH 7.5) 
mV 
Water 145.50 1.71 0.20 30.00 
PBS 159.00 0.10 0.23 0.04 
10%P 302.10 1.78 0.35 (-)8.13 
55%P 223.00 7.60 0.24 (-)8.66 
10%S 362.60 12.20 0.30 (-)9.67 
LLF 546.90 11.11 0.45 2.71 
LLF/10%P 935.00 17.88 0.31 n/a 
LLF/55%P 646.00 19.46 0.40 n/a 
LLF/10%S >1000 58.50 0.31 n/.a 
 
The particles were characterised before and after addition of their protein corona. 
The hydrodynamic diameter measurements were determined by DLS and are 
listed in table 4.1. It can be seen that both the 200nm and the 50nm particles 
dispersed in water had a size similar to that reported by the manufacturers. The 
SiO2 200nm and 50nm and the SiO2 NH2 200nm were all found to have a very 
low Pdi value in both water and PBS suggesting they were not agglomerated or 
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stable.  However the SiO2 NH2 50nm particles appeared to agglomerate more than 
the non amino modified particles and when dispersed in water were found to be 
145.5nm.  They were also found to agglomerate in PBS with a hydrodynamic 
diameter of 159nm.  The DLS results show that all particles with their associated 
hard corona show an increase in the hydrodynamic diameter.  For all particles this 
was seen most markedly in the LLF corona where the hydrodynamic diameter was 
the largest. For all the particles (expect the 200nm NH2 silica particles) the 
hydrodynamic diameter of the particles were smaller than those pre-incubated in 
LLF and then in plasma or serum. The ZP measurements show all particles are 
more stable or less agglomerated in water and PBS without their corona. The 
measured ZP values showed the difference in surface chemistry between the two 
types of particles. The ZP of both the 200 and 50nm NH2 modified particles were 
positive but it is interesting to note that the ZP of the amino modified NMs in PBS 
or with their associated corona was lower than that of the particles in water alone.  
 
4.3.2 Hard Corona Analysis 
 
 (a)  (b)  
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(c)  (d)  
 
Figure 4.1: The above graphs show the percentage of free protein 
remaining in the (a) SiO2 200nm particle supernatant, (b) SiO2 50nm 
NM supernatant, (c) SiO2-NH2 200nm particles and (d) SiO2-NH2 50nm 
particle supernatant after 1-4 washes.  Protein was determined by the 
BCA assay in each wash step , as measured during hard corona 
preparation. Values represent the mean +/- SD (n=3). As can be seen 
after 4 washes no free protein was detectable in the supernatant for 
most samples. It was therefore concluded that any proteins remaining in 
the system were associated with the iron particles and not free in 
solution.  These remaining proteins attached to the particles were what 
formed the hard corona 
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4.3.3 SDS PAGE Investigation of Protein Corona Profile 
 
SDS-PAGE gel lanes showing binding patterns of proteins associated with the 
10% plasma hard corona of silica particles before and after incubation with LLF.  
Full gels from which these lanes were selected are in the appendix 8.7 figure (c,b)  
200nm SiO2                              +   -       +     -               -     -        -      - 
200nm SiO2- NH2                                  -    +      -     +               -    -         -      -  
50nm SiO2                                              -    -       -     -               +    -         +     -        
50nm SiO2- NH2                                    -    -       -     -                -    +        -      + 
Precoated in LLF                                  -    -       +    +               -     -        +     +         
                                           
 
SDS-PAGE gel lanes showing binding patterns of proteins associated with the 
55% plasma hard corona of silica particles before and after incubation with LLF.  
Full gels from which these lanes were selected in the appendix 8.7 figure (d and e)  
200nm SiO2                    +    -        +     -             -       -       -     - 
200nm SiO2- NH2            -    +        -      +             -      -       -     - 
50nm SiO2                        -    -         -       -             +     -      +     -        
50nm SiO2- NH2               -    -         -       -             -      +      -    + 
Precoated in LLF                                   -    -         +     +             -      -      +    +  
                                                  
 
Figure 4.2: SDS-PAGE gels obtained to investigate the binding patterns 
of silica particle-protein interactions (a) 10%P and LLF/10%P hard 
corona (b) 55%P and LLF/55%P hard corona.  
Molecular weight 
ladder 
Molecular weight 
ladder 
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SDS gel lanes showing binding patterns of proteins associat ed with the 
10% serum hard corona of silica particles before and after incubation 
with LLF. The full gels from which these lane images were taken can be 
seen in the appendix( 8.7 (f) and (g)) 
 
200nm SiO2                                 +     -         +    -                     -    -          -      - 
200nm SiO2- NH2                       -      +         -    +                    -     -         -      - 
50nm SiO2                                   -      -          -    -                    +     -         +     -   
50nm SiO2- NH2                         -      -          -    -                     -     +         -     + 
Precoated in LLF                       -      -         +    +                    -      -        +     +  
                                       
 
 
Figure 4.3: SD-PAGE gel lanes obtained to investigate the binding 
patterns of silica particle-protein interactions associated with the 10% 
serum hard corona and before and after pre coating in LLF (10%S and 
LLF/10%S). 
 
Figure 4.2 and 4.3 show the SDS-Page protein profile of each corona and 
demonstrates interesting differences in the protein binding patterns not only in 
different concentrations of the same biological fluid (i.e. 10% and 55% plasma) 
but also between plasma and serum.  The most common bands across all silica 
particle types and biological fluids were observed at 60kDa and 20kDa.   The 
charge of the particle charge did not appear to affect the protein profile of the 
plasma corona however the SDS-PAGE gels do reveal a difference in the binding 
patterns of the 50nm plain and amino modified particles in the serum corona.  The 
binding patterns do seem to alter depending on particle size (200nm or 50nm) 
most notably with the 10% plasma corona and to a lesser degree for the 55% 
plasma corona and the 10% serum corona. When the particles were pre-coated 
with LLF and then in plasma the binding pattern remained similar in that both 
Molecular weight 
ladder 
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concentrations, however the intensity of these binding patterns are higher.  In 
particular there is a 20kDa band which shows a stronger intensity after 
preincubation with LLF.  This was seen predominately for the 10% and 55% 
plasma corona.   
 
Table 4.3: Proteins of the 200nm silica plasma hard corona (before (a) and 
after (b) precoating in LLF) as identified by MS- the full list of all proteins 
identified can be found in the supporting information (appendix 8.8) 
 
Table 4.3 (a) 
SiO2 
(200nm1
10%P) 
MW Acc No 
XC 
Score 
% C PEP 
Pep. 
Ion       
(Hit) 
Function as defined 
by Uniprot 
Apolipop
rotein B-
100  515.28 P04114 480.32 16.31 
2.55
E-14 48 
Recognition signal for the 
cellular binding and 
internalization of LDL 
particles by the apoB/E 
receptor. 
Comple
ment C3  187.03 P01024 398.30 35.30 
9.99
E-15 43 
C3 plays a central role in 
the activation of the 
complement system. 
 
Histidine
-rich 
glycopro
tein  59.54 P04196 160.31 37.71 
6.66
E-11 58 
Binds a number of ligands 
(heme, heparin, heparin 
and plasminogen).  
Implicated in regulating 
immune complex, 
pathogen clearance, cell 
adhesion, angiogenesis, 
coagulation and 
fibrinolysis. Mediates 
clearance of necrotic cells 
through enhancing the 
phagocytosis of necrotic 
cells.   
Comple
ment C4-
A  192.65 
P0C0L
4 130.29 12.44 
8.61
E-12 13 
C4 plays a central role in 
the activation of the 
classical pathway of the 
complement system.. 
 Serum 
albumin  69.32 P02768 110.28 21.51 
6.44E
-09 12 
Good binding capacity 
for water, Ca
2+
, Na
+
, K
+
, 
fatty acids, hormones, 
bilirubin and drugs. Main 
function is regulation of   
osmotic pressure of 
blood.  Major zinc 
transporter in plasma, 
typically binds about 
80% of all plasma zinc. 
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Table 4.3 (b) 
SiO2 
(200nm) 
LLF/10%P  MW Acc No 
XC  
Score % C PEP 
Pep 
Ion         
(Hits) 
Function as 
defined by 
Uniprot 
Apolipoprote
-in B-100  515.28 P04114 
590.3
1 21.60 
1.00E
-30 59 
As above (table 
4.3(a)) 
 Complement 
C3  187.03 P01024 
300.3
1 28.40 
5.55E
-15 30 
As above (table 
4.3(a)) 
Serum 
albumin  69.32 P02768 
200.3
2 46.10 
8.88E
-15 21 
As above (table 
4.3(a)) 
Histidine-rich 
glycoprotein  59.54 P04196 
100.2
8 26.30 
1.69E
-11 11 
As above (table 
4.3(a)) 
Hemoglobin 
subunit beta  15.99 P68871 70.21 44.90 
7.97E
-12 7 
Involved in 
oxygen 
transport from 
the lung to the 
various 
peripheral 
tissues. 
 
Table 4.3 reports the protein identified in (a) SiO2 200nm10%P corona and (b) the 
SiO2 200nm LLF/10%P corona by Mass Spectroscopy (LTQ ESI MS/MS along 
with the reported molecular weight (MW-kDa).  The table reports the Accession 
number (Acc No) is a unique identifier given to a protein sequence (refers to 
entries at the Sequest Uniprot/Swiss-Prot database (http://www.uniprot.org/)).  
The Xcorr value (XC Score) is the cross-correlation value from the search. The 
posterior error probability (PEP) or is the probability that the observed peptide 
match is incorrect (a chance event). The percentage sequence coverage (%C) and 
the number of peptides confirmed by mass spec analysis are shown.  
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Table 4.4: Tables show the most prevalent proteins in the 200nm silica particle 
serum hard corona profile (before (a) and after (b) incubation with LLF), as 
identified by MS.  The full list of all proteins identified can be found in the 
supporting information (appendix 8.8). 
 
Table 4.4(a) 
 
SiO2 
(200nm) 
10%S 
Corona MW Acc No 
XC 
Score 
PEP 
 %C 
Pep 
Ion 
(Hits) 
Function as defined 
by Uniprot 
Serum 
albumin  
69.3
2 P02768 60.21 
8.79
E-10 12.32 8 
As above (table 
4.3(a)) 
 
Apolipop
rotein B-
100  
515.
28 P04114 30.18 
2.29
E-06 0.88 3 
As above (table 
4.3(a)) 
 
Apolipop
rotein A-I  
30.7
6 P02647 30.17 
2.45
E-08 11.24 3 
As above (table 
4.3(a)) 
Heat 
shock 
protein 
HSP 90-
alpha  
84.6
0 P07900 28.25 
3.12
E-10 5.74 3 
Molecular chaperone 
that promotes the 
maturation, structural 
maintenance and 
proper regulation of 
specific target 
proteins involved for 
instance in cell cycle 
control and signal 
transduction. 
Thrombo
spondin-4  
105.
80 P35443 20.25 
1.29
E-07 3.54 2 
Adhesive 
glycoprotein that 
mediates cell-to-cell 
and cell-to-matrix 
interactions. 
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Table 4.4(b) 
 
SiO2 (200nm) 
LLF/10%S 
Corona 
MW Acc No XC 
Score 
PEP %C Pep  
Ion 
(Hits) 
Function as 
defined by 
Uniprot 
Serum albumin  69.32 P02768 90.29 
1.14 
E-10 22.20 12 
As above 
(table 
4.3(a)) 
Thrombospond
in-1  129.30 P07996 20.25 
6.00 
E-14 3.10 2 
Adhesive 
glycoprotei
n that 
mediates 
cell-to-cell 
and cell-to-
matrix 
interactions. 
Hemoglobin 
subunit alpha  15.245 P69905 20.22 
4.70 
E-11 21.80 2 
As Above 
(table 
4.3(a)) 
Apolipoprotein 
A-I  30.76 P02647 20.19 
4.77 
E-06 11.20 2 
As Above 
(table 
4.3(a)) 
 Complement 
C3  187.03 P01024 20.17 
2.78 
E-08 2.50 2 
As Above 
((table 
4.3(a)) 
 
Table 4.4 reports the protein identified in (a) the SiO2 200nm 10%S corona and 
(b) the SiO2 200nm LLF/10%S corona by Mass Spectroscopy (LTQ ESI MS/MS 
along with the reported molecular weight (MW-kDa).  The table reports the 
Accession number (Acc No).  The Xcorr value (XC Score) (PEP) the probability 
that the observed peptide match is incorrect (a chance event). The percentage 
sequence coverage (%C) and the number of peptide Ions as previously described.  
 
For all particles there were five main bands derived from the 10% plasma corona.  
The strongest band was seen in the 60kDa range.  MS results suggest these are 
serum albumin and histidine rich glycoprotein.  For the two weaker bands at 50-
40kDa range, MS suggests these are apolipoprotein A4, actin and Ig mu chain 
proteins., A band at 30kDa also exists which MS suggests is apolipoprotein A-1 
and a strong band at 20kDa which was not identified by Mass Spectroscopy.  As 
can be seen from figure 4.2 the 10% plasma corona for all particle types varies a 
lot from the 55% plasma corona where there is stronger band intensity at the 
50kDa range and more bands in the higher kDa (100-250) range, in particular the 
20kDa band for all particle types is not as strong as with the 10% plasma corona 
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suggesting less proteins are bound to the particles in this region at this plasma 
concentration.  For all particles this 20kDa band is much stronger in all particle 
types after pre-incubation in LLF.   
 
Observation of the binding patterns of the serum corona for the 4 particle types 
shows there are far lower molecular weight proteins compared to the plasma 
corona.  The 50nm SiO2 (both plain and amino modified) particles in their serum 
corona both bind far more proteins (as indicated by quantity of bands) than their 
200nm counterparts.  This intensity is stronger still after precoating in LLF.  
However the intensity of the bands in the serum corona overall are not as strong 
as those obtained for the plasma corona gels and MS results identified far less 
proteins in the serum corona of the 200nm SiO2 plain NM than the plasma corona 
as can be seen in table 4.3 and 4.4) 
 
Mass spectroscopy results of the 10% plasma corona and the precoated in LLF 
10% plasma corona of the 200nm SiO2 particles show that both coronas have 
similar profiles made up of four main proteins.  These proteins were 
apolipoprotein B-100, complement C3 and C4-A, histidine rich glycoprotein and 
serum albumin.  The abundance of these proteins varies before and after 
precoating in LLF.  The 10% plasma corona found an order of: apolipoprotein B-
100 > complement C3 > histidine rich glycoprotein > complement C4-A > serum 
albumin.  Whereas the 10% plasma corona after precoating in LLF showed a 
slightly different order; apolipoprotein B-100 > complement > serum albumin> 
histidine rich glycoprotein, complement 4-A was not observed in this protein 
corona make up.  There was a larger diversity of proteins identified by MS in the 
hard corona of the precoated SiO2 200nm particles (both serum and plasma) than 
the uncoated particles.  The differences in the corona profile based on particle 
characteristics have also been reported in our previous study for iron oxide NMs.  
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4.3.4. Cytotoxicity Results 
 
4.3.4.1 WST-1 
 
(a)      (b) 
  
 
Figure 4.4: WST-1 assay. Percent viability of J774.A1 cells after 
exposure to silica NM (a 200 and 50nm and (b) NH2 modified 200nm 
and 50nm, after 24 hours exposure (n=3).  Data is expressed as the % 
mean ± SEM.  The WST-1 assay revealed no significant difference 
between the 200nm Si02NH2 and the 50nm Si02NH2 NMs to impact 
mitochondrial function.  The 200nm and 50nm SiO2 particles were 
significantly different only at the lowest concentrations of 3.9µg/ml 
and 7.8µg/ml (P<0.001). 
 
 
 
 
124 
 
4.3.4.2 LDH Assay 
 
(a)              (b) 
   
 
Figure 4.5: Percentage LDH release (expressed as % of positive 
control) in J774.A1 cells after exposure to (a) 200 and 50 nm SiO2 
particles and (b) Si02NH2 after 24 hours exposure. (n=3, data is 
expressed as the % mean ±SEM).  
 
The LDH assay shows all particles at all concentrations a significant 
increase in LDH release from J774.A1 cells compared to control cells 
with no treatment after 24 hour exposure.  No dose response effect was 
found (general linear model ANOVA) for the 200nm SiO2 or for the 
50nm SiO2-NH2 particles.  LDH release from cells treated with the 50nm 
SiO2 at 200µg/ml was significantly greater compared to lower 
concentrations (31.25µg/ml (P<0.05), 15.62µg/ml (P<0.001) and 
7.8µg/ml (P<0.05)).  Analysis of LDH release following exposure to the 
200nm SiO2 NH2 particles found a significantly greater LDH release for 
the 200µg/ml compared to the cells treated with 125µg/ml-7.8µg/ml 
(P<0.001).  No other dose dependent effects were found.  
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4.3.5 Impact of Corona on Cytotoxicity  
 
(a) 200nm SiO2     (b) 50nm SiO2 
  
 
(c) 200nm SiO2 (NH2)    (d) 50nm SiO2 (NH2)  
  
 
Figure 4.6: Percentage (of positive control) of LDH release from 
J774.A1 cells after exposure to SMN with associated corona in (a) 
200nm and (b) 50nm. (c) 200nm amino modified and (d) 50nm amino 
modified (n=3, data is expressed as the % mean ±SEM). 
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ANOVA (general linear model) indicates there was no significant difference in 
the percentage LDH release after exposure of J774.A1 cells to 200nm SiO2 
particles and the percentage LDH release from exposure to the SiO2 particles with 
a plasma (P=0.215) and serum (p=0.7780) corona after 24 hours.  However there 
was a significant difference between the 200nm SiO2 particles and the 200nm 
SiO2 particles with a LLF corona (P<0.01) suggesting these particles with their 
LLF corona are more toxic than the naked particles.  The 200nm SiO2 particles 
with a plasma corona appear to be less cytotoxic than the particles with a serum 
(P<0.05) or LLF (P<0.001) corona.  
 
There was a significant difference between the LDH release after exposure to 
50nm SiO2 particles and those with a plasma corona (P<0.001) indicating the 
50nm particles were more cytotoxic.  There was also a significant difference 
between LDH release seen after exposure to the 50nm SiO2 particles in a plasma 
and a LLF corona (P<0.001) indicating the particles in a LLF corona was more 
cytotoxic than the particles in a plasma corona. There was no significant 
difference in the LDH release from the 50nm SiO2 particles in a LLF corona 
(P=0.3107) and a serum corona (P=0.695).   
 
Statistical analysis of the data also shows the only significant difference observed 
after exposure to 200nm SiO2 NH2 was between the naked particles and the 
particles in a LLF corona (P<0.01) the naked particles being the more toxic in the 
J774.A1 cell line. However after exposure to the 50nm SiO2NH2 NMs the naked 
particles were significantly more toxic to the J774.A1 cells than any other 
treatment (10%P, 10%S and LLF) (P<0.001).  A significant difference was also 
found between these particles in a plasma and LLF corona (P<.001) and these 
particles with a serum and LLF corona (P<0.001).in both cases the particles in 
their LLF being more cytotoxic than the particles in their serum or plasma 
corona.  
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4.3.6 Cytokine Analysis 
(a)  (b)  
(c)  (d)  
 
Silica 
200nm 
no 
corona 
Silica 
200nm 
LLF 
Silica 
200nm 
10%P 
Silica 
200nm 
10%S 
Silica 
50nm 
no  
corona 
Silica 
50nm 
LLF 
Silica 
50nm 
10%P 
Silica 
50nm 
10%S 
 
MCP-1,      
    IL-1β,      
   
 
TNF-α      
   
 
IL-10   
 
 
      
Figure 4.7: Cytokine profile measured from J774.A1 cells exposed to 
silica NMs with and without associated LLF, plasma and serum corona 
at 65.2µg/ml (a) MCP-1 (b) IL-1β (c) TNF-α and (d) IL-10. Data 
expressed as a mean ± SEM, n = 3.  The table underneath denotes the 
treatments were the cytokine levels were greater than the negative 
control.  
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Figure 4.8: Cytokine profile measured from J774.A1 cells exposed to 
amino modified silica NMs with and without their associated LLF, plasma 
and serum corona where (a) MCP-1 (b) IL-1β (c) TNF-α and (d) IL-10.  
Data expressed as mean ± SEM, n = 3.  The table underneath denotes the 
treatments were the cytokine levels were significantly greater than the 
control. 
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4.4 Discussion  
 
This study investigated the effects of silica particles and NMs and their associated 
protein corona on a macrophage murine cell line in relation to their cytotoxicity.  
It was reported in Chapter 3 that the cytotoxicity of iron oxide particles was 
influenced by the presence of a protein corona.  That study did not address if the 
charge or size of the NM influenced the profile of the protein corona and thus this 
study expands further to investigating silica NMs of two sizes (200nm and 50nm) 
which were either neutral or positively charged by amino modification.  
Following the same experimental set up as in Chapter 3 (to investigate the 
particles with plasma, serum and LLF) a 10% and 55% plasma and a 10% serum 
concentration was used to prepare the corona.  This was chosen to best compare 
an in vivo and in vitro exposure.  Just as in Chapter 3 the corona of NMs first 
preincubated in LLF and then incubated in either plasma or serum was also 
prepared and investigated.  
 
In order to investigate the impact of the protein corona on the particles properties, 
the particles were characterised before and after protein coating.  The 
hydrodynamic diameter measurements as determined by DLS found that both the 
200nm and the 50nm particles dispersed in water had a size similar to that 
reported by the manufacturers.  There was a slight increase in hydrodynamic size 
in PBS (of 12 and 10nm respectively for the plain particles; 23nm and14nm for 
the amino modified silica particles).  This was different from what was observed 
with the iron oxide particles where DLS data suggests the iron oxide particles 
agglomerated more in PBS than was seen for the silica particles.  The silica 
particles were found to have a very low Pdi value in both water and PBS.  The 
amino modified 50nm silica NMs appeared to agglomerate more than the non 
amino modified particles and when dispersed in water were found to be 145.5nm 
with a Pdi of 0.2.  They were also found to agglomerate in PBS with a 
hydrodynamic diameter of 159nm, the Pdi was 0.23.  Once the particles were 
analysed with their associated hard corona a large increase in the hydrodynamic 
diameter was observed.  The particles appeared to agglomerate when incubated 
with LLF, as indicated by the high Pdi value.  Previous studies [168] have shown 
that LLF modifies the surface chemistry of particles promoting enhanced 
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agglomeration and this work appears to support this.  The hydrodynamic diameter 
of the particles in a plasma and serum corona are smaller than those pre-incubated 
in LLF and then in plasma and serum corona.  It may be the case that the LLF 
caused particle agglomeration which results in a larger hydrodynamic diameters 
however the Pdi of the particles dispersed with a plasma and serum corona before 
and after LLF coating remained somewhat stable (0.1 - 0.4).  This suggests that 
the particles with their associated LLF corona in some way allows for more 
biological molecules from serum and plasma to bind to the NM.  The SDS-PAGE 
gels showing the plain silica NM with their associated hard corona appear to 
verify this, showing that there is more protein bands present in the samples after 
preincubation with LLF.  This increase in particles size observed in LLF and in 
LLF with serum or plasma corona which was observed for all but one particle 
treatment.  The 200nm NH2 silica particles with its 10% P coating was 313.4nm 
and after LLF preincubation was 270nm.   
 
The NH2 modified particles had a low or neutral value when initially characterised 
and so they were further NH2 modified as for this study the charge was a key 
variable to investigate.  Again as was found for the previous work with iron oxide 
particles this shows that relying on manufacturers specifications for NM 
characteristics without independent characterisation may lead to an erroneous 
conclusion.  The measured ZP values showed the difference in surface chemistry 
between the two types of particles.  It should be noted that although ZP is not a 
direct measure of the surface charge of the particles, it can be used to indicate 
stability and tendency to agglomerate.  All particles appear to be more stable in 
water and PBS without a corona as the NM with a corona resulted in a decrease in 
ZP.  The ZP of the non modified particles was, as expected, positive but it is 
interesting to note that the ZP of the amino modified NMs in PBS or with their 
associated corona was reduced, indicating the surface was extensively covered 
with the protein thereby masking the positive NH2 groups.  It could also mean the 
protein/lipid coating somehow moved the shear plane (i.e. the point where the ZP 
is measured) away from the particle surface.  
 
As mentioned previously the observations of the particles with their LLF corona 
show the hydrodynamic diameter increased compared to all other measurements 
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(i.e. in water, PBS and with their serum and plasma corona).  This increase was 
associated with a large increase in Pdi and a relatively low ZP indicating that the 
particles were agglomerating and/or obtaining a layer of molecules to their 
surface.  However, results from triplicate experiments with LLF were not 
reproducible as there were very low count levels (i.e. low levels of scattered light) 
leading to poor quality data, thus this DLS data alone does not clarify if the LLF 
prevents/allows for further protein adsorption to the surface of the silica NMs or if 
the sample is agglomerating. 
 
This study demonstrates that the protein profile of the corona (as seen on the SDS-
PAGE binding patterns) shows interesting differences in the protein binding 
patterns not only in different concentrations of the same biological fluid (i.e. 10% 
and 55% plasma) but also between plasma and serum.  The most common bands 
across all silica particle types and biological fluids were observed at 60kDa and 
20kDa.  This 20kDa band was not observed with the SDS PAGE gel analysis of 
the iron oxide corona.  For all particles the 55% plasma corona does show more 
bands in the protein profile than the 10% plasma corona and the serum corona 
shows a very different binding pattern from the plasma corona.  This was also 
observed for the iron oxide particles.  Overall the effect of particle charge did not 
appear to affect the protein profile of the plasma corona however the SDS-PAGE 
gels do reveal a difference in the binding patterns of the 50nm plain and amino 
modified particles in the serum corona.  The binding patterns do seem to alter 
depending on particle size (200nm or 50nm) most notably with the 10% plasma 
corona and to a lesser degree for the 55% plasma corona and the 10% serum 
corona.  When the particles were pre-coated with LLF and then in plasma the 
binding pattern remained similar in that both concentrations of plasma (10 and 
55%) seemed to bind the same type of protein regardless of NM size or type 
(neutral or positive).  This may be due to LLF causing agglomeration with the 
particles and thus any size specific effects could be mitigated.  However, the 
intensity of these binding patterns are higher, in particular there is a 20kDa band 
which shows a stronger intensity after preincubation with LLF.  This was seen 
predominately for the 10% and 55% plasma corona.  No obvious difference was 
observed in the 10% or 55% plasma corona binding patterns for the 200nm SiO2 
and SiO2-NH2 particles either before or after incubation in LLF in the types of 
132 
 
proteins identified although the intensity of the bands do suggest the particles 
precoated in LLF do bind more protein.  The 50nm (both neutral and positive) 
also appeared to have stronger bands after pre-coating in LLF indicating more 
protein adsorption after incubation in LLF.  This was also indicated by the DLS 
results where it can be seen that the hydrodynamic diameter increased after pre-
incubation with LLF. 
 
This work was concerned with the protein profile of the corona and does not 
address how the corona is formed as the mechanisms of protein adsorption are 
beyond the scope of this thesis.  There are many mechanisms by which proteins 
may adsorb to the particle surface and of course it will depend on the biological 
environment and the nature of the NM in question.  For example, it has been 
reported that proteins containing amino acids with thiol, sulfide, and disulfide 
groups may interact strongly forming covalent bonds with metallic NMs [103]. 
Perhaps a similar mechanism is occurring here and it may in some way explain 
the strong preferential binding of proteins such as complement and 
immunoglobulin which have thiol groups in their native confirmation, although 
non covalent bonds may also occur.  In particular this study finds the most 
common protein in the corona (besides serum albumin) were apolipoproteins.  
Other studies also show a high abundance of apolipoproteins in the corona (see 
review [212]).  These proteins do have accessible free thiol groups in their 
structure [213].  
 
The WST-1 assay revealed there was a significant difference in viability between 
the 200nm and 50nm SiO2 particles but only at the 2 lowest concentrations (at 3.9 
and 7.8µg/ml).  At these two concentrations the viability of the cells after 
exposure to 200nm silica was not significant from the negative control suggesting 
the 50nm plain particles were more cytotoxic than the 200nm particles at this low 
concentration.  There was no significant difference between the 200nm Si02NH2 
and the 50nm Si02NH2 NMs to impact mitochondrial function.  
 
The LDH assay shows all particles at all concentrations had a significant increase 
in LDH compared to cells with no treatment.  It is interesting to note that the 
corona associated with the silica particles had a different effect on the LDH 
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release in J774.A1 macrophages compared to the iron oxide particles.  It was still 
the case that the plasma and serum corona reduced cytoxicity, however there were 
some exceptions: there was no significant difference in the percentage LDH 
release after exposure to 200nm SiO2 particles and those with their plasma and 
serum corona but there was a significant difference between the plain and the LLF 
coated particles suggesting the particles with their LLF corona are more toxic than 
the plain non coated particles.  There was a significant difference between the 
LDH release after exposure to 50nm SiO2 particles and those with a plasma 
corona but no significant difference in the LLF particles and those with a serum 
corona.  Upon exposure to the animated particles this work also reports that a 
significance difference in LDH release upon exposure to 200nm SiO2 NH2 and 
those in with a LLF corona and exposure to the 50nm SiO2NH2 were more 
cytotoxic to the J774.A1 than the same particles with a plasma serum and LLF 
corona.  The findings demonstrate the nature of the corona can influence the 
subsequent toxicity of the particles, the most pronounced effect can be seen for 
the 50nm NH2 modified silica NM where the serum and plasma and LLF corona 
significantly reduced the particle toxicity to macrophages.  This work again points 
to recommendations for future in vitro assays to consider the corona profile when 
developing assays that are relevant for comparison to cellular responses in vivo.  
 
The suggestion that different dispersants can enhance or reduce toxicity is not a 
novel observation and a recent study with these same particles (Brown et al., 
2013, in publication) reports that the use of different dispersants can influence 
particle toxicity.  This study builds on this premise and addresses the corona 
proteins (i.e. those proteins that are strongly associated with the particles and 
likely to be the proteins (in vitro or in vivo) recognised by cells).  This adds a new 
layer of understanding to the previously demonstrated ability of NMs, when tested 
in vitro in the absence of FCS, to have an enhanced response on cell cytotoxic 
response and uptake that NMs in presence of FCS [114, 158].  A simplistic 
approach of relating specific proteins in the protein corona to an effect in vitro/in 
vivo may lead to erroneous comparisons but this work does ultimately indicates 
that for both types of silica at two sizes the particles with their associated plasma 
corona masked the cytotoxicity in a J774.A1 cell line.  This seems 
counterintuitive as the particles were found to bind many proteins that serve to 
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mark the particles as opsonins (complement C3 and C4A for example).  It can be 
hypothesised that binding of these proteins to the NM surface may lead to a 
conformational change in their structure causing them to become inactive.  In the 
previous study (Chapter 3) it was speculated that NMs with their associated 
corona having a lower surface energy are not likely to interact as much with cells 
as NMs in the absence of a corona.  It could be possible that particles without 
their corona (i.e. those which caused the higher LDH release) are more prone to 
associating with cells in order to bind biomolecules to their plain uncoated surface 
in a bid to lower their free energy state.  However this work indicates a more 
complex situation as particles with a LLF corona do appeared to increase LDH 
release in some treatments (cells exposed to 200nm silica but not 50nm silica).  
This was not previously found for iron oxide particles.  This is an interesting 
result indicating that exposure via inhalation is an important route to consider for 
future toxicological studies and that the addition of serum into pulmonary cell 
culture models may not be relevant and might lead to an underestimation of the 
potential toxicity of the particles.  
 
To further investigate the effect of the corona on silica particles cytotoxicity, 
cytokine stimulation after exposure to J774.A1 macrophages was examined.  
MCP-1, IL-1β, TNF-α and IL-10 levels were determined by multiparametric 
FACS analysis.  This is a common tool used to assess the number of cytokines 
release by single cells.  As in Chapter 3 where iron oxide particles were 
investigated this study was also made in connection with the LDH assay and so 
the cytokine profile was measured from the supernatant saved from the LDH 
assay.  Cytokine release within the cell is a highly regulated process and thus it is 
difficult to make a simple correlation between cytokine levels and potential 
cytoxicity.  The results here show that all particles with all treatments stimulated 
secretion of MCP-1, Il-1β and TNF-α. The 200nm silica particles with and 
without their corona, produced quantities of MCP-1, Il-1β , TNF-α and IL-10 at 
quantities significantly higher than the control.  This was in direct contrast to the 
smaller size 50nm particles where only the particles with a serum corona caused a 
significant increase in TNF-α and IL-1β and was also dissimilar to the 200nm 
amino modified silica particles ,where only the serum corona particles caused an 
increase in TNF-α production.  The 50nm amino modified particles also produce 
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significant quantities of TNF-α and Il-1β without any hard corona and with a LLF 
corona produced more quantities of TNF-α , Il-1β   and IL-10 compared to the 
control. It is difficult to compare the magnitude of the measured cytokine release 
directly amongst all these samples as each cytokine will not act in a similar 
manner (for example, the rate of diffusion of different cytokines from cells may 
vary [214]).  Also in the absence of normalised data these results should be 
viewed not as a separate experiment but taken together with the LDH data.  It is 
possible to gain information by looking at the trends and seen and it can be seen 
that there are high MCP-1 and TNF-α levels and low IL-10 anti inflammatory 
release this was also seen for iron oxide NM exposure to J774.A1 cells.  
136 
 
4.5 Conclusion 
 
Previous work detailed in Chapter 3 found that that proteins such as albumin, 
immunoglobulin and complement make up the hard corona profile of iron oxides 
in biological fluids.  The research also demonstrated the effect of LLF to alter this 
hard corona.  This study shows that silica particles behave in a similar manner and 
after investigation of the serum and plasma hard corona it was found that albumin, 
apolipoproteins and complement (just as with iron oxide particles) make up their 
hard corona.  The presence of LLF also altered the protein profile corona of silica 
NMs.  Although the serum and plasma coronas of both particle types (iron and 
silica) had proteins in their corona in common this work also demonstrate that 
each particle type and size has a unique protein corona profile.  The ability of 
NMs to bind these types of proteins is important as complement and 
immunoglobulin binding can lead to particle opsonization which in particular for 
J774.A1 macrophages can promote receptor mediated phagocytosis in vivo.  
Although this work did not find that binding of these proteins caused an enhanced 
cytotoxic response, it did find that the toxicity (LDH release in J77 4.A1 cells) is 
altered by the specific corona in particular the plasma and serum corona of the 
50nm amino modified silica particles had the most profound effect in mitigating 
toxicity.  
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Chapter 5  Chemotactic Response in Macrophages after                                
Exposure to Serum Activated with Nanomaterials. 
 
5.1 Chemotaxis  
 
The movement of any cell that is directed by extracellular gradients of diffusible 
chemicals (chemoattractants) is known as chemotaxis [215].  In the absence of a 
gradient chemoattractants can increase the non directional migration of cells and 
this is known as chemokinesis.  Chemotactic cell migration was first described by 
Leber in 1888, in 1936 Clarke et al., demonstrated the phenomenon in vivo and by 
1962 Boyden et al., discovered it was the mechanism that allowed for leukocyte 
recruitment describing an in vitro technique for assessing the chemotactic activity 
of ‘soluble substances on motile cells’[216, 217]. Chemotaxis is involved in many 
fundamental physiological processes such as immunity, embryogenesis and 
migration of neurons.  When chemotaxis is impaired, it can cause diverse diseases 
such as cancer metastasis, angiogenesis and inflammatory diseases [215].  
Although most cells in tissues are stationary, leukocytes are motile and migrate 
actively through the walls of blood vessels into surrounding tissues (see figure 
5.1) [67].  The recruitment of leukocytes from blood vessels into tissues by 
chemotaxis plays a fundamental role in the in vivo response to infection [67] and 
any impaired ability of leukocytes to move in this manner could impair the 
inflammatory response [218].  Conversely any activation of the chemotactic 
response could lead to non specific inflammation causing an autoimmune 
response.  
 
Figure 5.1: Transendothelial migration of cells. Image adapted from  
Toetsch et al. [218] showing the leukocyte adhesion cascade; rolling 
(mediated by selectins), activation (mediated by chemokines) and 
migration as directed by chemotaxis.  
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5.1.2 Complement Activation Cascade  
 
There is a large and diverse group of chemoattractants that can guide chemotactic 
transendothelial migration of macrophages such as lipids, peptides, complement 
proteins and chemotactic cytokines (chemokines).  Most chemoattractants operate 
via the guanine nucleotide-binding protein (G protein) coupled seven-
transmembrane-spanning receptor (see figure 5.3) [217].  Complement proteins 
(or more specifically the proteolytic fragments of complement proteins) are 
chemoattractants that consist of over 30 proteins.  They are produced primarily by 
hepatocytes (but can also be produced by macrophages and intestinal epithelial 
cells) and circulate in the body in an inactive form [219].  These proteins are 
connected as part of a biochemical cascade.  Once the first protein in the pathway 
is activated it initiates a complement proteolytic cascade.  There are three main 
activating pathways in the complement cascade; the classical, lectin and 
alternative pathways (see figure 5.2).  Activation of the cascade leads to multiple 
interconnections among complement proteins, immune cells and mediators which 
go on to initiate inflammatory and opsonization responses.  Thus in this way the 
complement activation cascade forms part of the body’s non specific innate 
immune response, providing the mechanism to protect against infections and 
support the repair of damaged tissues [220]. 
 
Figure 5.2 Adapted from [219] and [221] showing the classical, lectin 
and alternative pathways of the complement activation cascade. The 
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proteins upstream of C5 are essential for opsonization and immune 
complex clearance. All pathways of complement activation converge  at 
the cleavage of C3 and C5 to ultimately trigger the assembly of the 
membrane attack complex (MAC), which forms pores in lipid bilayer 
membranes resulting in cell lysis.  
 
As can be seen in figure 5.2 the classical pathway is activated when 
antibody/antigen complexes interact with the first complement component (C1). 
C1 is cleaved and the cascade is initiated ultimately leading to the formation of C3 
protein.  It is at this point that the classical, lectin and alternative pathway 
converge.  Native C3 is not a functional molecule however it becomes 
biologically active once cleaved (by C3 convertase) into C3a, C3b, and C5.  C5 is 
subsequently cleaved (by C5 convertase) to form C5a and C5b.  This proteolysis 
of C3, C5 as well as C4 gives rise to N-terminal positively charged fragments 
C3a, C4a and C5a, collectively known as anaphylatoxins [217].  Anaphylatoxins 
cause smooth muscle contraction, histamine release from mast cells, enhanced 
vascular permeability and they also mediate chemotaxis and inflammation [222].  
The most potent of these is C5a which at the  nanomolar level permits chemotaxis 
of neutrophils, eosinophils, basophils, monocytes and macrophages [217].  
 
Further downstream of the cascade the addition of C6, C7, C8 and C9 components 
to the C5b results in the formation of the membrane attack complex (MAC).  This 
C5b-9 MAC molecule can create transmembrane channels that lead to cell lysis 
[223]. The C3b protein can be covalently attached to target surfaces leading to 
opsonization once receptors on the surface of phagocytes recognize and bind to 
the C3b molecule on the surface of the pathogen (i.e. phagocytosis).  So, it can be 
seen how the complement system ‘complements’ the innate and adaptive immune 
system and why its regulation is essential for prevention of disease.   
 
NM mediated complement activation is important in the clearance mechanism of 
particles by macrophages.  Complement activation allows for surface opsonization 
allowing for phagocytosis and MAC assembly.  The process is facilitated by 
chemotactic attraction, i.e. the production of chemoattractant C activation 
products (such as C5a in serum proteins present in the alveolar surface) results in 
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chemotactic migration of alveolar macrophages [224].  There are a wide range of 
studies which look at the ability of particles and fibres to activate the production 
of chemotactic factors and the alternative complement pathway [225-228].  
Warheit et al. [229] found that asbestos fibers could activate complement in vitro 
in rat serum and cell free rat lung lavage and in a follow up study by the same 
author (1988) showed that complement was activated in vitro (rat serum and 
lavaged proteins) by many other fibers and particles including iron-coated 
chrysotile asbestos, fiberglass, wollastonite fibers, carbonyl iron and zymosan 
[224].  These early studies showed that complement activation facilitates 
macrophage recruitment to sites of fibre/particle deposition. 
 
The ability of NMs to activate the immune system is of interest not only in 
nanotoxicology but also in the complementary field of nanomedicine.  The 
interaction between NMs and their ability to activate the complement system is 
regulated by many factors and pathways (figure 5.2) and although regulatory 
proteins can inhibit convertase activity their protective effects can be overcome by 
uncontrolled complement activation which may lead to hypersensitivity reactions 
or anaphylaxis.  Indeed this has already been reported with regulatory approved 
nanomedicine (for example Dioxil
TM
) [230].  However complement activation can 
also be used to the advantage of nanomedicine and NMs which are used for 
internal administration.  A study in 2007 by Reddy et al. [231] exploits the ability 
of NMs to cause complement activation to facilitate the delivery of vaccines, 
reporting that the uptake of the NM by dendritic cells, activation of T-cells and 
generation of the antigen-specific immune response was dependent on 
complement activation by the NM.  Thus it can be seen that the ability of NMs to 
activate complement may be either beneficial or adverse depending on its 
application.  
 
Governa et al. demonstrated that crystalline silica can induce the generation of a 
C5a-like protein when exposed to human plasma, which is chemoattractant for 
leucocytes [232].  Renwick et al. compared the ability of ultrafine and fine CB 
and TiO2 particles to affect alveolar macrophage chemotaxis by examining the 
ability of isolated macrophages obtained from rats instilled with 125ug and 
500µg/ml particles to migrate towards a C5a gradient (serum activated with 
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zymosan) [174].  They found that at 500µg/ml both the ultrafine TiO2 and CB (but 
not the fine TiO2 or CB) caused a significant increase in macrophage chemotaxis 
compared with a saline control suggesting that this increased sensitivity to a C5a 
chemotactic gradient could make the ultrafine particles exposed macrophages 
more likely to be retained in the lungs, hindering their clearance by the normal 
mucocilliary route.  
 
More recently Barlow et al. demonstrated high doses of CB NMs did have the 
capacity to cause chemotactic factor generation in foetal calf serum after 
incubation with the serum for 2 hours at 37
º
C [228].  This was reported as a 1.8-
fold increase in macrophage migration towards the treated serum compared with 
untreated serum.  It was also reported that this effect was partially inhibited by 
antioxidant intervention.  The same author also reports [233] that exposure of 
epithelial type II cells to CB nanoparticles resulted in significant release of 
macrophage chemoattractant (compared to the negative control, fine carbon black 
and TiO2 and TiO2 NM) as measured by macrophage migration towards cell 
conditioned medium.  
 
CNTs have also been found to activate the human serum complement system via 
the classical pathway, for example, Salvador-Morales et al. found that human 
serum exposed to CNTs at 37
º
C for one hour activated serum to the same extend 
as a positive control of serum exposed to Zymosan [225]. Interestingly surface 
modification of these CNTs altered their interactions with complement proteins 
and Anderson et al. [234] demonstrated that modified CNTs (resulting in CNTs 
with linear poly(ethylene glycol) amphiphiles) trigger the lectin complement 
activation pathway as opposed to the classical pathway.  Besides the surface 
modification of NMs other factors such as polymer coating and surface charge are 
important factor for complement activation. 
 
A review by Dobrovolskaia et al. [235] suggested that NMs with a charged or 
reactive surface group (polypropylene sulphide nanoparticles, lipid nanocapsules, 
polycation-based nanoparticles and polystyrene nanospheres) are more able to 
activate complement than neutral particles. In addition, it was demonstrated that 
NM coatings affected the ability of NM to activate complement with poly 
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ethylene glycol (PEG). Poloxamine coatings reduced complement activation, but 
dextran coatings were associated with an increase in nanoparticle-mediated 
complement activation [235]. 
 
The findings detailed in Chapter 3 and Chapter 4 suggest that complement 
proteins  (C3, C4 C4a and C5) are present in the protein plasma and serum corona 
profile of both iron and silica particles.  This was an interesting finding as 
complement proteins in this C3 and C4 form can lead to particle opsonization and 
in particular for J774.A1 macrophages can promote receptor mediated 
phagocytosis in vivo.  Cleavage of these C proteins can generate N-terminal 
positively charged fragments, C3a, C4a and C5a (anaphylatoxins) mediating 
chemotaxis and inflammation.  However, the research in this thesis indicates that 
the protein corona reduced or mitigated toxicity 
 
5.1.3 Macrophage Migration 
 
Migrating macrophages can be identified in vitro by filopodia which are 
extensions of about 0.1– 0.2µm in diameter and up to 20µm in length [67].  In 
vitro, migrating macrophages can be observed to move in a cyclic form starting 
with an extension of the leading edge of the cell (protrusion of filopodia), 
adhesion of this leading edge to the matrix, contraction of the cytoplasm and 
finally release from contact sites at the tail end [236].  Filopodia support 
membrane-enclosed cytoplasm termed lamellipodia. Migration occurs by 
modification of the extracellular matrix and in macrophages this cytoskeletal 
rearrangement is driven by the actin cytoskeleton.  Thus in this way the actin 
within the lamellipodia of macrophages, in association with structural and 
regulatory proteins, allows for cell locomotion.  This controlled cell locomotion 
allows cell movement and the shape changes required for chemotaxis.  Therefore 
it has a key role in locomotion, phagocytosis, and the regulation of cell shape 
[67].  Although the exact regulatory intracellular signalling mechanism of 
macrophage migration is beyond the scope of this thesis, in recent years there has 
been an increase in the understanding regarding the signalling pathways from 
outside the cell and the actin rearrangement in the cell as well as the roles of the 
many individual proteins in each step of the cell migration process. 
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Figure 5.3 The G-protein-coupled receptor mediated signalling network 
showing, binding of chemoattractant to the G- protein receptor leading 
to chemotaxis and J774.A1 macrophages stained for actin (assembly of 
actin at the leading edge drives the cell forward ) adapted from Jin et 
al. [215] . 
 
Chemotactic factors (such as complement) regulate cell migration via a family of 
G protein coupled receptors (GPCRs) and tyrosine kinase receptors.  The binding 
of chemoattractant to GPCR induces the dissociation of the G-protein into Ga and 
Gbc subunits [215].  Gbc activates proteins in the Ras family, which regulate the 
formation of lamellipodia and filopodia and ultimately lead to actin polarization 
(see figure 5.4) 
 
5.1.4 Chemotactic Assays 
 
There are many chemotactic models that can be employed to measure chemotaxis 
in vitro (this subject has been reviewed by many authors, (e.g. Toetsch et al. 
[218], Li et al. [237] and Kramer et al.[238]).  The transwell or static model (see 
144 
 
figure 5.4) has historically been a widely used and is a popular tool to quantify 
migration of cells exposed to different chemoattractant concentrations.  As it was 
first introduced by Boyden it is often referred to as the Boyden chamber assay 
[216].  The chamber contains two compartments that are separated by a porous 
filter membrane.  The size of the cells being examined determines the required 
pore size of the membranes.  Cells are seeded in the medium in the upper part of 
the chamber and can migrate in the vertical direction through the pores of the 
membrane into the lower compartment.  Chemoattractants diffuse from the 
bottom compartment to the upper compartment through the membrane generating 
a gradient.  The cells on the upper filter can then be removed with a cotton swab 
and the cells that migrate to the bottom of the filter can be stained and quantified.  
Since the introduction of this method in the 1960’s by Boyden there have been 
continual improvements of this technique (becoming simplified or the 
introduction of disposable 96 plate formats, etc.) and other similar versions of this 
static method have been introduced (such as the micropipette based assay, 
Zigmond chamber and Dunn chamber) that work in a similar manner to produce 
chemical concentration gradients by free diffusion.  
 
These types of static assay have limitations in that they require large amounts of 
reagents and cells.  The transwell migration kits that are now commercially 
available for examining a large amount of samples can be expensive and the 
optimal time of migration for the cell type needs to be pre-determined.  The 
practice of using a cotton swab to remove non migrated cells on the filter can be 
difficult and prone to error in that it heavily relies on the technique used by the 
individual.  Thus this technique may not be quantifiable and if it is can vary in 
outcome.  The chemokinetic (speed at which cells migrate) and chemotactic 
effects (direction in which cells migrate) may not be distinguishable.  There is no 
way to incorporate the effects of shear stress on the cells under investigation and 
there is no reliable way to sustain and control the chemoattractant gradient.  
 
More recently microfluidic models/techniques have been employed in chemotaxis 
assays.  These models involve the use of micro fabricated chips consisting of 
channels of fixed dimensions.  Cells are seeded in these channels and the 
treatment can be applied under a control flow.  As such these models are designed 
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to better mimic the body’s microvasculature.  These types of models allow for 
stable chemical concentration gradients and as they are miniaturised allow the use 
of small amounts of reagents and cells.  These microfluidic models also allow for 
the control of shear stress making them a valuable physiologically relevant model 
for this work.  The chips can also be visualised in real time allowing the cells to 
be visualised and chemotaxis to be analysed over time.  In this work the transwell 
system was used to investigate macrophage response to NM treated serum, some 
experimental work with the microfluidic system was also carried out to see how 
this system might add more to the knowledge base.  
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5.1.5 Chapter 5 Aims 
 
 To determine whether activation of chemoattractant factors in serum can 
occur following NM exposure. 
 
 To determine if NMs differ in their ability to activate chemoattractants in 
serum as indicated by increased macrophage migration towards the 
particle-treated serum in vitro using a transwell assay and experimentally 
using a microfluidic assay. 
 
 To investigate the ability of NMs coated in various physiological relevant 
protein coatings (plasma, serum and LLF) to activate chemoattractants in 
serum, using both a transwell and experimentally using a microfluidic 
assay. 
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5.2 Materials and Methods 
 
5.2.1 Serum Activation 
 
Non heat inactivated FCS was treated in a manner similar to that described by 
Barlow et al. [228] and Renwick et al. [174].  Serum was exposed to 62.5µg/ml 
NM and to NM with associated corona (prepared fresh as described in 3.2.4).  
Barlow et al., reports the use of 10mg/ml carbon black for serum activation 
(followed by a 6 hour incubation with macrophages) however here we choose a 
more relevant exposure dose of 62.5µg/ml.  Previous work (Chapter 3) indicated 
that NMs exposed to macrophages at this concentration were cytotoxic 
(significant release of LDH compared to control) and thus this was the 
concentration chosen for activating the serum.  The serum was incubated with the 
NM at 37
◦
C for two hours to promote activation of complement.  After two hours 
the serum was incubated for further thirty minutes at 56
◦
C to ensure that no further 
complement activation occurred.  Following incubation, the samples were 
centrifuged at 12,000 g for fifteen minutes to remove the particles.  The 
supernatants and particles were stored at -80
◦
C until required.  A positive control 
of C5a-rich serum was prepared using the same conditions by incubating the FCS 
with 10mg/ml Zymosan (Sigma, UK).  A negative control of FCS incubated with 
PBS was also prepared.  All samples were diluted to 10% in serum free RPMI for 
use in the chemotactic assay, 10% zymosan activated serum has been routinely 
used in other chemotaxis studies [174, 228] 
 
5.2.2 Chemotactic Model/Assay 
 
The particles used in these experiments were iron oxide NM (280nm Fe2O3 and 
45nm Fe3O4 and silica NMs (200nm and 50nm). These particles have been 
previously characterised and described as detailed in Chapter 3 and Chapter 4.  
 
The transwell system (as described in 5.2.3) was used first in order to investigate 
cell migration of J774.A1 cells in response to NM activated serum.  This high 
throughput method allowed for multiple sample screening.  The microfluidic 
system was also used to further investigate the chemotactic response under more 
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physiologically relevant conditions.  This method (as described in 5.2.4) 
employed the use of cells grown in channels on a substrate chip.  Using such a 
method therefore allows the cells in this channel to be temperature controlled and 
subject to a constant controllable sheer force.  Such an experimental set up 
therefore better resembles the body’s vasculature making these experiments more 
physiologically relevant [218].  Due to the complexity and cost inherent with 
microfluidic investigation a triplicate sample size was not possible for this 
experiment as such this was more of an experimental/investigative research.  
Nonetheless it is relevant as this assay complements the transwell model allowing 
real time investigation of cell migration under sheer stress conditions.  In addition 
cells from each experiment were fixed and stained for further microscopic 
analysis as described in 5.2.3 
 
5.2.3 Transwell Chemotactic Assay  
 
J774.A1 cells were cultured until 80-90% confluent and serum starved (this 
increases the sensitivity of the cells and enhances migration response) overnight at 
37
o
C, 5% CO2.  Cells were washed multiple times with PBS to remove any bound 
serum, counted and adjusted to a concentration of 1*10
6
 in serum free RPMI cell 
culture medium.   Transwell plates (Corning, USA) were obtained in a 24 well 
plate format with inserts containing a 5µm polycarbonate filter (see figure 5.4).  
Prior to the experiment the transwell plates were incubated for one hour with 
serum free media (600µl per well and 100µl per insert) prior to cell addition in 
order to improve cell attachment.  This was carried out according to the 
manufacturer’s protocol which suggested an initial equilibrium period may 
improve cell attachment [239].  The serum free medium was removed before the 
addition of cells.  
 
Each well of the plate was seeded with 600µl of chemoattractant (i.e. particle 
treated serum prepared as described in 5.2.1).  The inserts were aseptically placed 
into each well of the receiver plate making sure no air was trapped between the 
bottom of the insert and the solution in the well.  The inserts were seeded with 
100µl of cells in serum free media.  The plates were incubated for thirty minutes 
at 37
o
C in 5% CO2.  After thirty minutes the plate was removed and the sides 
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were gently tapped to ensure no bubbles were present and replaced in the 
incubator.  The cells were incubated for a further five and half hours. A six hour 
time point was chosen based on previous published  research using the same 
method [228] and based on the transwell protocol recommended by the transwell 
plate manufacturer [240]. After a six hour total incubation, the media was 
removed from the inserts and the front facing top side of the filters were swabbed 
using a sterile cotton swab in order to remove any remaining attached cells on the 
filter that did not migrated through the inserts.  The cell viability of the cells that 
did migrate was determined using a cell proliferation assay (Celltiter 96, Promega, 
UK).  This proliferation assay was a colorimetric assay used to determine the 
number of viable cells.  MTS reagent (120µl) was added to the bottom of each 
well and the plates were incubated for a further 2 hours (37
o
C in 5% CO2).  The 
absorbance of the formed formazan product (which is soluble in tissue culture 
media) was measured at 490nm (Epoch Bio-Tek, UK).  The results were reported 
as percentage of negative control. 
 
 
Figure 5.4 Transwell plate used in chemotaxis assay image (adapted 
from [239]) with line diagram showing set up of the chemotaxis 
chamber. 
 
5.2.4 Microfluidic Experimental Assay 
 
A Vena ECTM platform (Cellix, Ireland) was used to mimic the situation 
observed in the body’s blood vessels.  The substrate tissue culture treated chip 
(see figure 5.5 insert) was UV sterilised for 30 minutes prior to cell seeding.  
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J774.A1 cells were cultured on the substrate chip in a 35mm Petri dish at a 
concentration of 1*10
6
 cells per ml for 24 hours at 37
o
C at 5% CO2.  The substrate 
was removed from the media and with the aid of sterile tweezers clamped to a 
custom microscope frame (figure 5.5).  A VenaEC biochip (see figure 5.5 insert) 
was place on top of the substrate to create two parallel channels which mimic 
microcapillaries (figure 5.5).  
 
 
 
Figure 5.5: Substrate chip and EC Vena biochip assembly on 
microscope frame (source www.cellix.com accessed November 2012) 
insert showing how substrate and biochip are assembled to create two 
cell lined channels.  
 
The customised microfluidic system consisted of an epifluorescent microscope 
(Zeiss/Axivovert) with a mercury lamp light source, which was enclosed in a 
temperature controlled chamber.  The microscope frame was placed on the stage 
of the microscope and in order to circulate the sample through the channels each 
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port on the bio chip was connected via inlet and outlet cables (Cellix, Ireland) 
through which the activated serum samples suspended in RPMI were pumped.   
The samples were circulated using the Mirus™ Nanopump (Cellix, Ireland).  In 
this way the cells within the microfluidic channels were exposed to the activated 
serum in a controlled flow, from static flow to shear stress rates of 0.5Pa.  The 
microscope was coupled to an AxioCam digital camera which allowed live 
imaging of the channels on the biochip. For each activated serum sample (and 
controls) a new chip was set up in this manner.  After a maximum of 5 minutes 
the chip was removed and the cells were fixed and stained.  The media from each 
exposure was saved and stored at -80
o
C for further cytokine analysis. This assay 
therefore mimics the condition of the cells in the blood vessels in that they are 
maintained, treated and imaged under flow conditions. The assay provides an 
indication of cell activation and motility. However as the cells are treated under 
constant flow of medium and so there is no gradient established. Thus this 
microfluidic experiment builds upon the previous transwell assay allowing more 
information on activation and motility to be gathered in real time rather than 
directly comparing chemotactic techniques.  
 
5.2.4.1 Cell Staining / Confocal Imaging- Experimental Assay 
 
The substrate was removed from the chip, washed 3 times in PBS and fixed with 
3.7% paraformaldehyde in PBS at room temperature for 30 minutes.  They were 
washed in PBS and permeabilized with 0.1% triton for 3 minutes at room 
temperature.  The substrate with the fixed cells was then washed three times with 
PBS before staining.  The cells on the substrate chip were stained with Alexa 
Fluor Phalloidin (448 Excitation/Emission: 495/518nm) (1:200 dilution) to 
visualise the actin cytoskeleton morphology and Hoechst (1:800 of 1μg/ml stock) 
to visualise the nuclei, for 1.5 hours at room temperature in the dark.  The cells 
were then washed three times with PBS before being mounted on glass slides 
using a drop of mounting medium (Darko, USA).  The cells were examined using 
a Zeiss Laser Scanning Microscope (LSM) 510 system (Carl Zeiss Jena, 
Germany) with a 63× oil immersion objective.  The LSM was equipped with 4 
laser sources.  The samples were excited at 488nm laser wavelengths and imaged 
with emission with band pass filter of 450 – 560nm 
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5.2.4.2 Cytokine Analysis- Transwell and Experimental Chemotactic Assay 
 
Supernatants of cell culture media saved from the microfluidic chemotaxis assay 
were investigated to estimate the release of the following cytokines from 
macrophages; IL-1β, TNF-α, IL-10 and MCP-1.  Analysis was carried out on a 
BD FACS Array™ Bioanalyzer, using a BD cytometric Bead array mouse/rat 
soluble protein master buffer kit as per manufactures instructions.  
5.2.5 Data Analysis 
 
Statistical analysis on the transwell data was carried out using the Minitab 15 
statistical package using a 2 way ANOVA.  Significance was set at 5%.  For the 
experimental microfluidic data images were obtained from each recording at 
specific regular time points.  Non Migrated cells in one field were counted and a 
graph of percentage cell migration was generated.  
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5.3 Results 
 
5.3.1 Transwell Chemotactic Assay 
(a) 
 
Figure 5.6: (a) Macrophage migration after 3 and 24 hours in the 
transwell chemotaxis assay (as described in 5.2.2) towards NM treated 
serum.  All results are reported as percentage of negative control.   The 
negative control was serum treated with PBS and the positive control 
was serum treated with zymosan (or zymosan activated serum (ZAS), as 
described in 5.2.1.  Data expressed as mean ± SEM, n = 3.  Asterisks 
denote a significant increase compared to the negative control (* p < 
0.05). 
 
Study of the ratio of migrating cells compared to the total number of cells or a 
negative control is a common method of determining chemotactic signaling.  Here 
we observed that serum which was activated with particles (62.5µg/ml for 2 
hours) (Fe2O3, Fe3O4, 200nm silica and 50nm silica) caused a significant increase 
in cell migration compared to both the negative and positive control.  Previous 
studies (e.g. [228, 241]) use high concentrations of particles for serum activation, 
here however a more relevant dose of 62.5µg/ml was used as discussed in 5.2.1.  
The findings show that NMs when exposed to serum at 62.5µg/ml induced the 
generation of a complement factors or complement like factors which produce a 
* 
* 
* 
* 
* 
* 
* 
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significant increase in macrophage chemotaxis in vitro compared to unactivated 
control of serum.  There was no difference between the ability of the iron oxide 
and silica particle activated serum to induce macrophage migration at a 3 hour 
time point.  
 
5.3.2 Impact of Corona on Chemotaxis as Determined by Transwell Assay 
 
(a) 
 
(b) 
 
 
Figure 5.7: Macrophage migration towards particle treated serum as 
determined by transwell assay.  Measurements were taken at (a) 3 hours 
and (b) 24 hours.  The negative control consisted of serum incubated 
with PBS.  Results are reported as percentage of negative control.  The 
positive control included serum exposed to zymosan. Data expressed as 
mean ± SEM, n = 3.  Asterisks denote a significant increase compared 
to the positive control (* p < 0.05). 
* 
* * 
* 
* 
*  
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The results shown in figure 5.7 indicate that serum activated with Fe2O3 and 
Fe3O4 caused the highest amount of migration.  This was even significantly higher 
than the amount of migration measured by zymosan activated serum samples.  
Overall both the iron oxide and the silica NMs (with and without their corona) 
activated serum sample had a significant increase in migration compared to the 
negative control.  A second aim of this study was to investigate the ability of NMs 
coated in various physiological relevant protein coatings (plasma, serum and LLF) 
to activate chemoattractants in serum.  The transwell experiments show that the 
particles with their associated corona varied in their ability to cause chemotaxis 
and interestingly, there is a significant difference between the ability of the silica 
particles with their plasma hard corona and particles with the serum hard corona 
to induce chemotaxis after 3 hours (but not 24 hours).  Serum activated with silica 
(200 and 50nm) particles in their plasma corona caused a higher amount of 
migration than the serum activated with silica particles in their serum corona.  
After 24 hours, the serum activated with Fe2O3 and silica (200nm and 50nm) 
particles in LLF caused a decreased amount of cell displacement than the plain 
particles without their LLF corona.  
 
5.3.3 Experimental Microfluidic Assay Analysis 
 
Figure 5.8 (a-e) shows the analysis of microfluidic data obtained from 
microfluidic chemotaxis assay as described in 5.3.4 (a) after exposure to Fe2O3 
particle activated serum (b) Fe3O4 particle activated serum (c) silica (200nm) 
particle activated serum and (d) after exposure to silica (50nm) particle activated 
serum and (e) the negative control of cells exposed to serum activated with PBS.  
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Figure 5.8(a) 
 
 
 
 
Figure 5.8(a) Microfluidic analysis of cells exposed to Fe2O3 particle activated 
serum Graph showing percentage of migrating cells after exposure to serum 
activated with Fe2O3 with and without their plasma, serum and LLF corona with 
table showing percentage loss at 10 seconds, 100 seconds and 200 seconds.  
 
The microfluidic data was obtained from the experimental microfluidic 
chemotaxis assay as described in 5.3.4 after exposure to Fe2O3, Fe2O3 in its 
plasma corona, Fe2O3 in its serum corona and Fe2O3 in its LLF corona.  The 
figure represents the percentage of migrating cells after exposure to the serum 
activated by the particles with and without their plasma, serum and LLF corona.  
Live imaging of the cells in the microfluidic channel allowed for observation of 
cell behaviour upon exposure to the activated serum.  From these videos, 
Sample % migration 10 
seconds 
% migration 100 
seconds 
% migration 
200 seconds 
Control (serum 
activated with PBS) 
0 1.3 3.3 
Serum activated 
with Fe2O3 
11.88 n/a n/a 
Serum activated 
with Fe2O3 (10%P) 
4.89 51.05 62.93 
Serum activated 
with Fe2O3 (10%S) 
18.87 71.42 82.14 
Serum activated 
with Fe2O3 (LLF) 
14.51 24.35 26.69 
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micrographs were acquired at 10 second intervals. The images can be seen in 
appendix (8.13). Exposure was generally up to 200 seconds but for the serum 
activated with Fe2O3 NM it was after 50 seconds as the cells were seen to migrate 
quickly.  Leaving the experiment to run for 200 seconds would have resulted in no 
remaining cells in the channel to examine.  The number of cells on each 
micrograph was counted and graphs generated thus figure 5.8(a)) show the 
percentage of remaining cells as a function of time.  
 
The nature of this study and the expense of the micro fabricated chips limited the 
amount of replicates (n=1), however this technique complements the static 
transwell assay (n=3) by allowing the cell behaviour in real time to be observed.  
These observational results indicated that cell migration (which was in the 
direction of the flow) was more pronounced when cells were exposed to the serum 
activated by the Fe2O3 NM without a plasma, serum or LLF corona.  
Conformational changes were observed immediately upon exposure of the 
activated serum as the cells began to migrate in the direction of the flow. Similar 
results were noted when the cells were exposed to the serum activated by Fe2O3 in 
the serum and plasma corona where the cells were seen to migrate and the cell 
conformational changes were apparent.  In direct comparison it can be seen that 
when the cells were exposed to serum activated by Fe2O3 in the LLF corona there 
seems to be much less migration and the cell shape does not alter.  Figure 5.8 (a) 
shows that the cells exposed to serum activated with NM in their serum and 
plasma corona caused the most cell migration over 200 second time point with a 
82% and 63% loss respectively.  The control had a 3% loss of cells due to 
migration in 200 seconds.  However it should be noted that the cells exposed to 
serum activated with the plain Fe2O3 were observed to move faster and the 
experiment could not be run for 200 seconds.   
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Figure 5.8(b)   
 
 
 
 
Figure 5.8 (b) Microfluidic analyses of cells exposed to Fe3O4 particle activated 
serum. The graph shows the percentage of cells that migrated over 200 seconds 
after exposure to serum activated by Fe3O4, and serum activated by in Fe3O4 with 
its associated plasma, serum and LLF corona with table showing percentage loss 
at 10 seconds, 100 seconds and 200 seconds.  
 
The microfluidic data was obtained from the experimental microfluidic 
chemotaxis assay as described in 5.3.4 As with figure 5.8 (a) this figure also 
represents the percentage of migrating cells after exposure to the serum activated 
by the particles with and without its plasma, serum and LLF corona. Images of 
migrating cells can be seen in the appendix (8.13). The least amount of cell 
migration was observed in the cells exposed to serum activated by the NM in the 
LLF corona, 7.47% after 200 seconds, compared to serum activated with serum 
Sample % migration 10 
seconds 
% migration 100 
seconds 
% migration 
200 seconds 
Control (serum 
activated with PBS) 
0 1.3 3.3 
Serum activated with 
Fe3O4 
8.57 n/n n/a 
Serum activated with 
Fe3O4 (10%P) 
0 15.43 49.66 
Serum activated with 
Fe3O4(10%S) 
0 24.95 47.18 
Serum activated with 
Fe3O4 (LLF) 
0 6.54 7.47 
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and plasma (49.66 and 47.18% respectively). Although these results are 
experimental (n=1) and should be treated with caution it is interesting to note the 
difference between the two iron oxide particles (Fe2O3 and Fe3O4) and their 
effects on macrophage migration.  Both activated serum samples had a similar 
pattern in that more cell migration was observed with the serum activated with the 
particles in their serum and plasma corona compared to the serum activated with 
the particles in their LLF corona.  However it can be seen that the serum activated 
with Fe2O3 caused more migration initially (i.e. after 10 seconds) compared to the 
Fe3O4 activated serum samples.  There was a 0% migration of macrophages 
exposed to serum activated with Fe3O4 in their plasma, serum and LLF corona 
comapred to a 18.87% (plasma), 4.89% (serum) and 14.51% (LLF) migration in 
the  cells exposed to Fe2O3 activated serum samples.  
 
Figure 5.8(c) 
 
 
  
 
Sample % migration 10 
seconds 
% migration 100 
seconds 
% migration 
200 seconds 
Control (serum 
activated with PBS) 
0 1.3 3.3 
Serum activated with 
200nm SiO2 
3.06 9.97 38.56 
Serum activated with 
200nm SiO2(10%P) 
59.61 62.6 65 
Serum activated with 
200nm SiO2(10%S) 
18.18 24.7 30.35 
Serum activated with 
200nm SiO2 (LLF) 
0 4.7 
 
9.43 
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Figure 5.8(c): Microfluidic analysis of cells exposed to 200nm silica activated 
serum.  The graph shows the percentage of cells that migrate over time after 
exposure to serum activated with 200nm silica particles and 200nm silica 
particles in a plasma, serum and LLF corona. 
 
Figure 5.8 (c) represents the percentage of migrating macrophages after exposure 
to the serum activated with 200nm silica particles and 200nm silica particles in a 
plasma, serum or LLF corona. Compared to the control cells exposed to serum 
activated with PBS, it can be seen that there was an increase in migration of cells 
for all samples tested.  The cells exposed to serum activated with the 200nm Silica 
NM in their plasma corona showing the most amount of cell displacement (65% 
after 200 seconds).  As was seen with the previous results (Figure 5.8 a and b) the 
macrophages which were exposed to serum activated by silica particles in their 
LLF corona showed the least amount of cell migration.  
 
Figure 5.8(d) 
 
.  
Sample % migration 
10 seconds 
% migration 100 
seconds 
% migration 200 
seconds 
Control (serum 
activated with PBS) 
0 1.3 3.3 
Serum activated with 
50nm SiO2 
52.00 57.00 66.00 
Serum activated with 
50nm SiO2 (10%P) 
23.77 28.90 34.80 
Serum activated with 
50nm SiO2(10%S) 
31.57 34.32 39.59 
Serum activated with 
50nm SiO2 (LLF) 
56.79 73.37 79.08 
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Figure 5.8(d): Microfluidic analysis of cells exposed to 50nm silica activated 
serum.  The graph represent the percentage of cells which migrate over time after 
exposure to serum activated by 500nm silica particles and 50nm silica particles 
with its associated plasma, serum and LLF corona with table showing percentage 
migration at 10 seconds, 100 seconds and 200 seconds.  
 
Figure 5.8(d) shows analysis of microfluidic data obtained from microfluidic 
chemotaxis assay as described in 5.3.4. As with the preceding graphs (figure 5.8 a 
, b and c) this graph represents the migration of macrophages upon exposure to 
serum activated with 50nm silica particles with and without a protein corona.  
Observation results show that upon exposure to the serum in the microfluidic 
channel the cell morphology was seen to change as the cells moved creating a 
clear leading edge and a tail or trailing end.  It is interesting to note that the cells 
exposed to serum activated with the silica NM in the LLF corona showed the 
largest amount of migration.  This is in direct comparison to that observed for all 
other samples tested in their LLF corona.  
 
Figure 5.8(e) 
 
1. 2   
 
Figure 5.8(e) Microfluidic analysis of cells exposed to serum activated with PBS. 
Image 1 at 0 seconds and image 2 at 200 seconds. The red line in the graph 
represents the % migrating cells.  
 
The microfluidic assay allowed for direct observation of cells behaviour in real 
time as they were exposed to the activated serum.  Conformational changes were 
observed immediately upon exposure of the activated serum and they began to 
migrate in the direction of the flow.  Cell polarization and migration was observed 
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in response to all treatments.  As can be seen in the control 5.8 (e) the cells did not 
appear to migrate after exposure to serum treated with PBS.  With a 3% loss of 
cells after 200 seconds noted and after 6 hours a 44% loss was recorded (6 hour 
data shown).  This was in direct comparison to the migration pattern of the cells 
observed after exposure to serum activated by Fe2O3 NM where the experiment 
was stopped after 50 seconds due to rapid cell migration with 32% cell loss after 
50 seconds.  Furthermore, the macrophages exposed to the non-coated iron and 
silica were observed to display an increased number of filopodia and protrusions 
along the leading edge. The cells treated with serum activated with particles in 
their LLF corona exhibited a low rate of migration for all samples except the 
serum activated with 50nm Silica in the LLF corona.  
 
5.3.4 Confocal Microscopy 
(a) Control 
         
(b) Fe2O3     (c) Fe3O4 
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(d) Silica 200nm    (e) Silica 50nm      
              
 
Figure 5.9: Confocal Imaging taken using 63X oil immersion lens 
showing (a) control (i.e. J774A1 cells exposed to media only) (b) cells 
exposed to serum activated with Fe2O3 particles (b) cells exposed to 
serum activated with Fe3O4 (d) cells exposed to serum activated with 
200nm silica particles and (e) cells exposed to serum activated with 
50nm silica particles. The cells imaged were those remaining on the 
microfluidic Cellix substrate chip from microfluidic analysis.  Cells 
were fixed in 3.7% paraformaldehyde and stained with Phalloidin-FITC 
and Hoechst. Images were obtained on a Zeiss Laser Scanning 
Microscope (LSM 510 META from Zeiss, Germany).  
After the microfluidic chemotaxis assay was completed the remaining cells on the 
biochips were fixed and stained (one chip per sample).  Observation of the cell 
morphology revealed long tail like protrusions displayed during cell migration.  It 
can be seen that these tails, filopodia and other protrusions include actin and that 
they were prevalent in the cells exposed to serum activated with the plain 
uncoated particles, plasma corona particles and serum corona particles.  This was 
not seen for the negative control (serum activated with PBS) and these structures 
were less evident when the serum was treated with particles with their LLF 
corona.  It was also interesting to see that that as the cells migrated they left 
behind some actin ‘debris’ which was clearly seen to remain along the 
microfluidic channels.  More images of these protrusions and the remaining actin 
can be seen in the appendix (8.14). 
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5.3.5 Cytokine Analysis 
(a) Fe2O3          (b) Fe3O4 
  
 
Figure 5.10: Cytokine analysis of J774.A1 cells exposed to activated 
serum. After the microfluidic chemotactic experiment (as described in 
5.2.4) the supernatant was saved and used to investigate cytokine 
release.  (a)Serum activated with Fe2O3 particles with and without 
corona as described in 5.1.1.  (b)Serum activated with Fe3O4 particles 
with and without corona as described in 5.1.1.  The positive control was 
media obtained during the microfluidic chemotaxis investigation of cells 
exposed to Zymosan activated serum. The negative control was the 
media obtained during the microfluidic investigation of cells expos ed to 
serum activated with PBS. 
 
All the Fe203 activated serum samples release of cytokine (IL-1β, TNF-α, 
IL-10 and MCP-1) were below the levels measured in the positive control 
(the positive control was statically significant from all other measured 
samples (p < 0.05)).  All the activated serum samples did have 
measureable cytokine levels greater than the negative control p (p< 
0.05) however this was not the case for the cytokine levels measured 
after exposure to Fe304 activated serum.  In particular FACS array 
analysis indicated that cells exposed to the serum activated with Fe304 
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10% serum did not have any detectable levels of cytokine. This was also 
the case in cells after exposure to serum activated with silica particles 
(data not shown).  Overall the Fe203 had the highest levels of 
measurable cytokine levels, which was significantly (p < 0.05) different 
from those measured in Fe304 samples.  The exception was TNF-α 
release measured after exposure to serum activated with Fe304 particles 
in their 10% plasma corona and in their LLF corona.  This was not 
significant.  
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5.4 Discussion 
The presence of complement enhances NM recognition by macrophages and in its 
activated form can lead to particle opsonization promoting receptor mediated 
phagocytosis.  Mass spectroscopy analysis (see Chapter 3 and 4) of the plasma 
and serum protein hard coronas formed on iron oxide and silica particles, 
suggested that complement proteins C3 and C4-A are present in both the plasma 
and serum corona profile of iron and silica particles.  These proteins play a central 
role in the complement system.  The ability of NMs to activate complement 
factors in serum was therefore investigated.  This was examined as the ability of 
NMs to activate complement in serum as indicated by increased macrophage 
migration towards this chemoattractant.  Both a standard transwell assay and an 
experimental microfluidic assay were used to investigate the ability of NMs to 
activate macrophage migration with an emphasis on the role of the protein corona.   
 
The transwell migration assay was used in order to confirm the presence of a 
chemotactic response.  This is a standard method used frequently in toxicology or 
migration assays [218].  Its advantage in this study was that the 24 well plate 
technique allowed for multiple screening of all samples simultaneously under the 
same conditions.  A positive control consisting of zymosan activated serum (ZAS) 
which is a rich source of C5a (a known macrophage chemoattractant) [233] was 
used. 
 
A 3 hour incubation time was first investigated as such time points have been 
previously reported for other studies investigating macrophage chemotaxis [229, 
233, 241].  After 3 hours a microscopic analysis indicated that the cells did not 
migrate to the bottom of the chamber but migrated through the filter and remained 
attached to the bottom of the filter.  Thus the technique to swab the top of each 
filter to remove cells that did not migrate was developed.  The cell viability of the 
remaining cells was determined using a cell proliferation assay.  The NM, when 
exposed to serum at 62.5µg/ml induced the generation of a complement factors 
which produced a significant increase in macrophage chemotaxis in vitro 
compared to the control (serum) and there was no difference between the ability 
of the iron oxide and silica particle activated serum to induce macrophage 
migration.  To investigate the possibility of slower migrating cells, a 24 hour time 
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point was also examined and it was found that there was a significant increase in 
the migration of macrophages towards iron oxide NM treated serum after 24 hours 
exposure compared to 3 hours. This was not observed for the silica treated serum. 
Overall it can be seen from figure 5.6 that all treatments at both time points were 
significant compared to the negative control for increased macrophage migration 
J774.A1 macrophages have a doubling time of 17 hours thus the 24 hour time 
point may not be a reliable indication of chemotaxis compared to the 3 hour time 
point.  It could be that any additional signal detected after 17 hours is due to either 
increased cell number or it may be an indication of chemokinetic migration rather 
than directed or pointed chemotactic directional movement.  Thus it may be a case 
that for this assay the 3 hour time point is more relevant to chemotaxis as it can be 
speculated that the increase cell migration at 24 hours may be due to (a) cell 
proliferation or (b) chemokinesis as opposed to chemotaxis (i.e. non directional 
cell migration). 
 
The ability of the NM protein corona to alter the chemotactic factor generation in 
serum was also investigated and it was found that all the particles (with and 
without a corona), resulted in a significant increase in macrophage chemotaxis in 
the transwell assay compared to the control.  More interesting it was noted that 
compared to the positive zymosan control, the Fe2O3 NM (naked and with a 
plasma and serum corona) and the silica (50nm) particles with a plasma corona 
had a significant effect in macrophage chemotaxis.   
 
Complement proteins are also normally found in lung lining fluid [242] and our 
previous work (conducted in Chapter 3 and 4) suggested that coating the NM in 
LLF promoted binding of complement proteins (in particular complement C3 and 
complement C4-A) to the surface of the NM when further coated in plasma or 
serum.  We proposed that these complement proteins could be activated via the 
alternative pathway to produce chemotactic factors.  Such an in vivo response in 
LLF of complement activation (for example to particle exposed lungs) may lead 
to macrophage migration and inflammation.  However, it was interesting to note 
that cells exposed to serum activated with NM in a LLF corona showed a decrease 
in cell migration compared to the plain particles with no corona although the 
difference was only significant when compared to the ability of Fe2O3 NM 
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activated serum after 3 hours it was significant compared to all other samples 
tested after 24 hours.  
 
Previous authors have demonstrated the ability of particles and fibres [174, 224, 
225, 228, 234] to activate the alternative complement pathway.  Although the 
exact chemoattractant component was not identified in this study the ability to 
activate serum complement in vitro is important to investigate as in vivo 
chemoattractants are regulators of cellular trafficking.  Their activation is not only 
essential to the immune system but also central to the pathogenesis of many 
inflammatory diseases.  The ability of NM to cause complement activation in 
serum in vitro suggests that in vivo they may contribute to rapid recruitment of 
macrophages to sites of particle deposition and to clearance of NMs from the 
circulation via complement receptor mediated phagocytosis.  This could be 
considered a positive mechanism allowing for clearance of particles from the 
body however it should be considered that in vivo the situation may be more 
complicated [174, 241].  Thus although the complement system allows for 
recruitment of macrophages, and our data suggests that NMs do generate these 
complement factors in vitro further investigation would be necessary in vivo to 
test the ability of recruited macrophages to clear particles.  It may be the case that 
any sustained chemotactic signal could retain macrophages at the sites of 
recruitment which in the case of the lung may hinder clearance by the normal 
mucocilliary route as suggested by Renwick et al. [95].  
 
A limitation of the transwell assay is the inability to maintain the serum activated 
complement gradient.  This assay thus may lead to an underestimation of any 
quantified chemotactic response due to the loss or diffusion of the gradient and so 
in order to observe the cells and their behaviour in response to activated serum a 
microfluidic system was prepared.  This experimental system did not have a 
maintained chemotactic gradient however the technique offers more observational 
information and compared to traditional static models the microfluidic assay 
provides much greater control over the cell microenvironment because the 
microfluidic system is run under physiologically relevant conditions.  Cells are 
subject to a constant controlled sheer stress in a way that resembles the body’s 
vasculature (i.e. blood vessels in vivo are subjected to differing shear stresses).  
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Shear stress is defined as ’the force per unit area (measured as dyne/cm2) exerted 
by a fluid on the surface of the tube’ [218].  In this study the cells within the 
microfluidic channels were exposed to activated serum under a sheer stress rate of 
0.5Pa (or 5dyn/cm
2
).  This was chosen as the physiological range of shear stresses 
is 1 to 5dyn/cm
2
 in venules and the physiological range of shear stresses for 
leukocyte recruitment is 1 to 6dyn/cm
2 
[243, 244].   
 
The microfluidic technique also allowed the cells to be observed as they 
responded in real time.  Immediately upon exposure to the serum activated RPMI 
samples (prepared as described in 5.2.1) cell migration was observed.  The 
migration was immediate in the case of the Fe2O3 and Fe3O4 activated serum 
samples the effect was rapid and the experiment was stopped within 100 seconds 
in order to retain cells on the chip for confocal analysis.  After 10 seconds it was 
calculated that there was an 8.57% migration of cells after exposure to the serum 
activated with Fe2O3 particles compared to no migration observed for the cells 
exposed to the serum activated with the same Fe2O3 particles in a serum, plasma 
and LLF corona.  It was interesting to note that after 200 seconds the rate of cell 
migration was lowest (7.47%) in the cells exposed to serum activated with Fe2O3 
in a LLF corona compared to the same particles in a plasma (9.66%) and serum 
(47.18%) corona.  This trend was also observed for the Fe3O4 particles.  A similar 
effect was seen in the transwell assay (i.e. that the LLF inhibited migration) 
although in the transwell assay it was not found to be a significant effect.  
Observation of these cells exposed to RPMI diluted with serum activated with 
particles (iron and silica) in a LLF corona during the experiment revealed the cell 
morphology did not change noticeably and the cell shape remained rounded in a 
similar manner to the control cells.  However, conformational changes were 
observed immediately in the cells that were exposed to serum activated with the 
naked particles or those in their serum and plasma corona.  Long tails were 
observed during cell movement.  Similar trends were observed for the cells treated 
with RPMI diluted in serum activated with silica particles (with and without their 
associated hard corona) although the overall the percentage of migration was 
lower than that observed for the iron treated cells.  There was one exception; cells 
exposed to serum activated with 50nm SiO2 in its LLF corona produced 79% 
migration. 
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Confocal analysis of the cells after exposure to the activated serum samples was 
carried out in order to further examine the cell morphology.  The cells were 
stained for actin which was present in the long tails of the cells.  These cell 
protrusions were very clear in the migrating macrophages.  However those cells 
that were exposed to RPMI diluted with serum activated with the plain particles 
did not behave in a similar manner.  Also these long protrusions were not so 
apparent in the cells after exposure to RPMI containing serum activated with 
silica NM or in any of the serum cells imaged after exposure to serum activated 
with particles in their LLF corona.  
 
The cytokines IL-1β, TNF-α, IL-10 and MCP-1 release were examined in the 
media saved after microfluidic chemotactic analysis by FACS array.  Serum 
activated with both the 200nm and the 50nm silica particles did not produce any 
measurable cytokine release.  In comparison, the media from the Fe2O3 treated 
serum experiments did produce detectable levels of all cytokines investigated and 
the levels were significantly lower than those produced by cells after exposure to 
the positive activated serum control.  It was interesting to note that the MCP-1 
levels were highest in the Fe2O3 treated sample.  This monocyte chemotactic 
protein (which is produced primarily by macrophages and endothelial cells) is a 
potent chemotactic factor for macrophages.  It was observed from the microfluidic 
chemotactic data that the Fe2O3 treated serum did result in enhanced migration 
compared to all other samples and the confocal images of these cells revealed long 
actin tails.  The transwell chemotactic data also shows that migration of the cells 
treated with Fe2O3 treated serum was higher than most other samples tested. It did 
not cause a greater amount of migration when compared to the Fe3O4 serum 
activated sample.  In all cases the cells exposed to Fe3O4 treated serum produced 
lower quantities of cytokine.  This is particularly evident in the cells exposed to 
the serum activated with Fe3O4 in a serum corona which did not have any 
detectable levels of cytokine release.  Overall the Fe2O3 treated cells had the 
highest levels of measurable cytokine production.  This was found to be 
statistically significant from those detected in Fe3O4 treated cells.  Although there 
was a release of TNF-α observed (another product of activated macrophages) 
measured after exposure to serum activated with Fe3O4 particles in their 10% 
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plasma corona and in their LLF corona it was found not significant.  The presence 
(or absence) of cytokines in a sample reflects a complex relationship between 
activation/production and inhibitory signals acting on the J774.A1 macrophage 
and thus care should be given to data that associates the presence or absence of 
detectable cytokine levels to their activity or their absence 
 
As described previously, it was concluded that the protein corona of the NMs 
changed the particle biological identity activity and impacted on their in vitro 
cytoxicity. For example, Chapter 3 describes how binding of serum and blood 
plasma proteins to iron oxide nanoparticles reduces cytoxicity to macrophages, 
there was a significant difference between the percentage LDH release from cells 
exposed to the untreated and LLF coated particles than those exposed to serum or 
plasma coated particles.  In Chapter 4 we also describe how the corona altered the 
toxicity of silica particles in the case of the plasma corona reduced toxicity.  
There have also been published reports that the corona mitigates toxicity as 
mentioned in Chapter 3 and 4 (see [162, 163]).  As complement proteins are part 
of the innate and/or adaptive immune responses [245], the ability of iron and 
silica particles to activate complement in serum was investigated and it is 
interesting to note that the corona also had an impact on the cell migration as 
indicated by the chemotactic assays.   
 
Although the main aim of this thesis was not to correlate the ability of NMs to 
generate chemotactic factors in serum to their toxicity some trends were seen.  For 
example, naked Fe2O3 particles were more toxic (as measured by LDH release) 
than the same particles in its serum and plasma corona using a macrophage cell 
line.  We can see from both the microfluidic chemotactic assay and transwell 
chemotactic assay that the plain Fe2O3 particles did generate chemotactic factors 
in serum and had the ability to cause macrophage migration at a higher rate than 
the same particles with a serum or plasma corona and the cells exposed to media 
in serum activated with plain Fe2O3 NMs released a greater amount of MCP-1. 
However this trend was not observed for all treatments and the same particles 
with a LLF corona was seen to be as toxic as the plain particles (LDH release in 
J774.A1 cell line) and these particles did generate chemotactic factors in serum, 
however it did not have a significant impact on cell migration compared to the 
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plain particles.  This same trend was observed for the Fe3O4 particles, in that the 
naked and LLF corona particles were more toxic than the particles in its plasma 
and serum corona.  The microfluidic chemotactic assay and the 24 hour transwell 
chemotactic assay show that these plain particles caused a high rate of cellular 
migration, again however it was seen that the cells exposed to media containing 
serum activated by Fe3O4 with a LLF corona was not observed to cause a high rate 
of cellular migration. 
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5.5 Conclusion 
The aim of this study was to determine if serum exposed to NMs can cause the 
generation of chemoattractant factors, to determine if NMs differed in their ability 
to activate chemoattractants in serum and to investigate the ability of NMs with 
their associated plasma, serum and LLF corona to activate complement factors in 
serum as seen by the ability of the activated serum to induce macrophage 
migration.  The results suggest serum when exposed to iron oxide and silica NMs 
at 62.5µg/ml induces the generation of a component which can induce significant 
increases in macrophage chemotaxis in vitro compared to serum exposed to PBS.  
There was no difference between the ability of the iron oxide and silica NM 
activated serum to induce macrophage migration.   
 
This study also suggests that the corona can impact on cell migration.  In 
particular, the Fe2O3 NM with its associated plasma and serum corona and the 
silica (50nm) particles in a plasma corona produced an increased response in 
macrophage migration compared with the ZAS.  
 
The use of a more physiologically relevant microfluidic model allowed a more in-
depth view of how J774.A1 cells responded to the activated serum samples.  It 
was shown that the cells migrated immediately after exposure to the RPMI with 
the activated serum.  In particular the serum activated with plain iron oxide 
particles produced the greatest response in terms of the number of migrating cells.  
Confocal microscopy revealed long actin tails formed by these cells as they 
migrated.  The LLF corona inhibited the cell migration and these cells did not 
appear to alter in their confirmation or become polarised. Morphologically, they 
remained rounded and did not migrate at the similar rate to all the other samples 
apart from 50nm silica. There were no detectable levels of MCP-1, IL-8, TNF-α 
and IL-10 in the media from silica treated cells, the greatest levels where detected 
in after exposure serum activated with Fe2O3 particles.  Overall, the study 
suggests that the iron particles without their plasma, serum and LLF corona are 
more active in producing chemoattractant products in serum than the same 
particles in their serum or plasma LLF corona.  
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Chapter 6 Discussion and Summary 
 
The introduction to this thesis described the increase in the number of studies 
investigating nanotoxicology over the last decades.  Despite numerous in vivo and 
in vitro studies examining the cytotoxic effects of NMs there is no conclusive 
position regarding their safety or toxicity and although the knowledge base 
continually increases, we are still only beginning to understand how NMs interact 
with biological systems.  There are various reasons for this, including the fact that 
NMs represents a diverse range of materials. NMs of the same materials can be 
created or functionalised in a variety of methods which confers unique physical 
and chemical properties.  For example, the cytotoxicity of iron oxide NMs can be 
mediated by the presence or absence of polymer coatings [246, 247].  Another 
layer of complexity is introduced when it is considered that given the large variety 
of testing methods and endpoints the same type of NM (i.e. naked, coated or 
functionalised) can produce variable in vitro toxicity data making it difficult to 
come to a consensus regarding their toxicity.  These challenges encountered when 
using classical toxicological assays can to some extent be overcome with 
extensive NM characterisation.  Such extensive characterisation allows not only 
for better experimental design, such as modification of standard assays to suit the 
test NMs but also allows for critical analysis of results obtained from standard 
toxicological assays that are not designed specifically for NMs.  This results in a 
stronger correlation between biological endpoints and particle properties [210]. 
The first conclusion of this thesis suggests that NMs demand comprehensive 
characterisation and the successful interpretation of any nanotoxicological assay 
relies on such characterisation. 
 
6.1 Characterisation 
 
Initially this study extensively characterised a set of iron oxide NMs.  The lack of 
nano specific characterisation tools available, the use of characterisation methods 
which have evolved from techniques employed in the non-nano field (such as the 
study of colloids and ultrafine particles) and the diversity of information required 
for full characterisation leads to a conclusion that a range of techniques are 
required for useful characterisation.  A range of techniques is therefore required to 
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make up for the lack of a gold standard.  Such a combined approach can help to 
build an understanding of the complex nature of particles at the nanoscale and 
how their physicochemical characteristics relate to their biological behaviour or 
toxicity. The interpretation of this data is of course also important as many 
techniques employed in NM characterisation are difficult to analyse.  For 
example, DLS, which is a fast and effective way of evaluating the hydrodynamic 
size of NMs under conditions that resemble the in vivo situation, produces size 
results that can be represented in a variety of ways such as intensity, volume and 
number distributions.  The characterisation studies used in this work, to examine 
the size of NMs, produced different results depending on the technique used.  
Each technique adds an extra layer of information which complements each other. 
For example, DLS and NTA analysis effectively measure the same property, 
hydrodynamic diameter.  However, each technique operates in a unique way.  
Where DLS can give information on the NM behaviour over time and can also 
investigate the zeta potential, it does tend to give results bias towards the larger 
particles in the sample, as the technique works by calculating the intensity of 
scattered light.  As large particles scatter more light than smaller particles, 
masking of the presence of the small particles may occur.  However, NTA 
analysis does not measure the intensity of scattered light like DLS, but allows 
NMs to be analysed individually thus avoiding any bias towards the larger 
particles in the sample.  It is important to note the limitations of each technique.  
For example, DLS can only be used with spherical particles and although TEM 
may produce visual data, the technique itself may cause particle agglomeration. 
NTA analysis is not accurate for concentrated samples requiring dilutions to be 
made for accurate analysis.  It is at this point that interpretation of data and 
experience in sample characterisation is vital.  This study concludes that it is not 
sufficient to rely on the manufacturers specifications of particle characteristics and 
particles should be characterised extensively by more than one technique.  
 
6.2 Nanomaterial Cytotoxicity in a J774.A1.AI cell line 
 
This thesis aimed to investigate if the properties of the NMs affect their 
cytotoxicity using a macrophage (J774.A1) cell line.  Initially this hypothesis was 
explored with iron oxide particles. However extensive characterisation of the iron 
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oxide NMs revealed that of the three particle types used in the study, there was no 
difference between the 280nm and the 22nm Fe2O3 particles in terms of size, size 
distribution and ZP.  Thus the work progressed with 280nm Fe2O3 and the 45nm 
Fe3O4 particles only.  As these are two separate types of iron oxide particle (Fe2O3 
and Fe3O4) it was not possible to directly compare their cytotoxicity in a way that 
revealed any correlation between their physical chemical properties and their 
cytoxicity.  However, it was interesting to note that there was no difference 
between the two particle types in their cytotoxicity (as assessed by LDH release or 
mitochondrial function).  The study indicates that relatively large concentrations 
(62.5µg/ml) of iron oxide particles were required to induce a cytotoxic effect.  It is 
difficult to compare these results with the published literature as there is a large 
volume of data on iron oxide toxicity.  The literature reports results for different 
types of iron oxide particles, in vitro using several cell lines and in vivo with 
different models or testing many endpoints, using different methods to determine 
toxicity, such as cytotoxicity, viability and oxidative stress, etc.  Many studies (for 
example as reviewed by Mahmoudi et al. [144]) do show that these types of NMs 
are tolerated at high levels and therefore this data, using two separate endpoints, 
does seem to support this.  
 
The cytotoxicity investigation of four different types of silica NMs in the J774.A1 
macrophage cell line suggests that that the physical properties (size and charge) 
did have an impact the cytoxicity (LDH release and cell viability).  At low 
concentrations (3.9 and 7.8µg/ml) the WST-1 assay revealed that the 50nm plain 
particles were more cytotoxic than the 200nm particles.  It was also seen that the 
50nm particles released more measurable LDH than the 200nm.  There was no 
significant difference between the 200nm Si02NH2 and the 50nm Si02NH2 NMs in 
terms of their impact on cell viability.  This work does correlate well with 
published literature which suggests that anamorphous silica NMs can have acute 
in vitro and in vivo effects as discussed in Chapter 4 and in particular studies have 
reported that these in acute toxicity to be a size dependant response ( in vitro 
[248-251] and in vivo (mouse model) [252, 253]).  
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6.3 Nanomaterial - Protein Interactions and the Hard Corona 
 
This thesis investigated the hypothesis that the protein corona of NMs can 
determine their biological identity in vitro.  In order to achieve this, the protein 
‘profile’ or identity of the corona was examined.  The protein corona of iron oxide 
and silica NMs in plasma, serum and LLF was examined to investigate whether or 
not the size, composition and charge influenced the affinity and degree of protein 
binding.  The plasma and serum corona were chosen to best compare the in vivo 
and in vitro situation and in order to model inhalation exposure followed by 
translocation, a corona of LLF followed by creation of a plasma and serum corona 
was also investigated using each particle type.  The particles in a plasma, serum 
and LLF corona were analysed using SDS-PAGE and mass spectroscopy.   
 
This thesis shows that the protein profile of the NM coronas vary depending on 
the NM type, size and charge.  The amount of protein bound to the iron oxide 
particle surface was measured by DCS and it was found that the corona shell dept 
varied according to the type of particle (Fe203 or Fe304).  Further to this the SDS-
PAGE results reveal the corona can significantly vary in composition depending 
on the concentration of protein the particles are suspended in and also on the type 
of biological fluid they are suspended in (plasma, serum or LLF). Investigation of 
the silica corona found that the binding patterns had some similarities to those 
observed with iron particles in that the silica particle corona varied according to 
the particle size (50nm or 200nm) and just as was discovered with the iron 
particles the protein binding patterns differed not only when in different 
concentrations of the same biological fluid (i.e. 10% and 55% plasma) but also 
between plasma and serum and LLF.  Overall the effect of particle charge did not 
appear to affect the protein profile of the corona however the SDS-PAGE gels do 
reveal a difference in the binding patterns of the 50nm plain and amino modified 
silica particles in the serum corona.   Thus this thesis shows that particle - protein 
interactions vary according to (i) the type of nanomaterial (silica or iron) used (ii) 
the biological fluid used to create the corona (serum or plasma or LLF), (iii) the 
concentration of the biological fluid used and also on (iv) on precoating in LLF.  
It is interesting to note that not only the type of biological material, but the 
concentration of that material impacts on the protein binding profile of the corona.   
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Although this has not been extensively researched in the published literature to the 
extent undertaken here, recent published literature does reveal that the 
composition of the protein corona does depends on the size, shape, and 
composition of the nanomaterial and the type of physiological environment in 
which it is exposed as discussed in Chapter 3 and 4 (see [102, 154, 212]. In 
particular a recent publication has shown that NMs (silica NMs) surface in bovine 
serum and in human serum varies (as this thesis finds) and recommends that 
human serum, rather than the animal serum, should be used while conducting in 
vitro research [254].  This study also reports that the most abundant protein in the 
serum and plasma corona of silica particles to be albumin, but they also found (as 
this thesis work shows) apolipoproteins and complement proteins to be part of the 
corona profile of silica NMs.  Although there is a limited amount of published 
work in this filed to date those that have investigated the corona in this way do 
show that particles bind these proteins (e.g. [151] for polystyrene and silica NMs; 
[153] for  silica and polystyrene particles [154] for polystyrene particles; and 
[212] review of 63 different types of NMs).  
 
The quantities of proteins that make up the hard corona vary, not only in type, but 
in quantity between plasma and serum.  The work presented in this thesis suggests 
that the most abundant proteins isolated from the Fe2O3 plasma corona and in the 
LLF/10%P corona were the same although their relative order of abundance was 
different.  These proteins in common were apolipoprotein B-100, complement C3 
and albumin. The Fe2O3 plasma corona was also found to contain apolipoprotein 
(a) and complement C4-A. For the Fe2O3 particles in its associated serum or 
LLF/10%S corona the most abundant proteins included albumin, apolipoprotein 
A-1 and proteins involved in cell adhesion (desmoglein-1, cystatin-A and 
fibronectin).  The LLF/10%S the corona included apolipoprotein A-I, alpha-1-
antitrypsin, Ig gamma-1chain C region and Ig kappa chain C region.   
 
Similar to Fe2O3 particle the most abundant proteins in the 200nm silica NM 
plasma hard corona included apolipoprotein B-100 complement C3 complement 
C4-A and albumin.  In addition, it also included histidine rich glycoprotein. The 
abundance of these proteins varied before and after precoating in LLF.  Again the 
corona of the 200nm silica particle in the serum corona was similar to the Fe2O3 
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particle and the most abundant proteins were again found to include serum 
albumin and apolipoporotein B-100 with the addition of apolipoprotein A-1, again 
after preincubation with LLF the relative abundance of these proteins varies 
slightly.   
 
It is interesting to see how the protein profile differs between particles in their 
serum corona and particles in their plasma corona suggesting the biological 
identity of these particles will be different in vivo and in vitro.  Also the protein 
profile of the particles first preincubated in LLF and then in plasma or serum are 
different again implying that the biological identity of these particles can be 
different upon inhalation as opposed to injection.  It is also interesting to note that 
both the iron and silica particles bind common proteins (in particular 
apolipoproteins and complement proteins as well as albumin). The ability to 
investigate the protein corona and quantify the protein profile in this manner may 
offer scope in relating the toxicity of particles to a particular route of exposure.  If 
we take into account the physiological relevance of these proteins it may be 
possible to hypothesise what effect such binding may have. Take for example the 
finding that both the silica and iron particles coronas (in serum and plasma) 
contained apolipoproteins- these proteins are involved in lipid transportation in 
the bloodstream and thus if they are present in the active form (i.e. if they have 
not be altered due to binding to the NP surface) it may affect the intracellular 
trafficking and transport of NMs in the body. Another protein found to be present 
in both the silica and iron serum and plasma coronas were complement proteins.  
Complement proteins (as discussed in Chapter 5) play a central role in the 
activation of the complement system and thus are part of the body’s non specific 
innate immune response, providing the mechanism to protect against infections 
and support the repair of damaged tissues. The ability of the particles to bind these 
types of proteins is very relevant in toxicological investigations. Complement 
binding therefore could lead to particle opsonization promoting receptor mediated 
phagocytosis in vivo.  
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6.4 The Hard Corona and Cytotoxicity 
Following exposure of the macrophage cell line to the iron oxide particles(both 
the  280nm and the 45nm particles) there no difference in cytoxicity in terms of 
the percentage LDH release) between plain particles and those with a LLF corona. 
However, cytotoxicity was lower after exposure (for the 280nm and the 45nm 
particles) in both their serum and protein corona suggesting that the presence of 
the plasma and serum corona somehow mitigated cytotoxicity.  Furthermore the 
particles in their plasma corona caused less LDH release than serum coated 
particles suggesting that these two media were not identical in terms of altering 
the cytotoxic response to the particles. Overall, this shows that the biological 
identity of the NM changes in vitro depending on their corona.  
The silica particles did not produce the same results as the iron oxide NMs in that 
there was no significant difference in the percentage LDH release after exposure 
to 200nm SiO2 particles and those with either a plasma or a serum corona.  
Therefore, it was not the case that this serum and plasma corona reduced the 
toxicity of the 200 nm SiO2 as was seen for the iron oxide particles.  However, 
despite this difference, the silica particles in their plasma corona were found to be 
significantly less cytotoxic than the serum and LLF coated particles.  The results 
also suggested that the particles with a LLF corona were more toxic than the 
naked non coated particles, an observation that was not made for the iron oxides.   
 
The effects of positively charged SiO2 (200nm) on cytotoxicity were also 
investigated.  Statistical analysis found that the only significant difference 
observed after exposure to 200nm SiO2 NH2 was between the particles dispersed 
in media only and the LLF coated particles where, in contrast to the uncharged 
200nm SiO2, the LLF reduced toxicity.  Plasma and serum derived corona did not 
alter the cytotoxicity of these particles.  In contrast, for the 50nm SiO2NH2 
particles, plasma, serum of LLF corona all significantly reduced toxicity to the 
J774.A1 cells.  It is unclear why the NH2 200nm SiO2 should be so different to the 
NH2 50nm Si02 particles with respect to the lack of protection against their 
cytotoxicity in the presence of serum or plasma in particular when it was found 
that there was no difference in their cytoxicity when compared without the 
corona.  
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The literature available on the hard corona of particles has tended in the past to be 
more descriptive, examining ways to investigate the corona or characterise it 
rather than relate it to its toxicity.  However, recent papers are emerging which 
correlate the corona to toxicity, finding that serum proteins bound to particles 
(carbon nanoparticles and graphine) mitigates cytotoxicity in vitro.  This study 
shows a similar trend for iron oxide particles but indicates that the LLF corona 
may increase the toxic potential of silica particles.   
 
The work presented here also suggests that the particles with and without a 
plasma, serum and LLF corona may affect the cell migration or chemotaxis of 
macrophages in vivo, as the in vitro findings from the chemotactic assay report 
that both iron oxide and silica particles when exposed to serum at 62.5µg/ml can 
induce significant increases in macrophage attraction.  This thesis finds the corona 
also plays a role in impacting this ability as the results show that particles without 
a protein corona allowed for an increased response in the ability to effect 
macrophage migration  
 
6.5 Implications for in vivo interpretations 
 
This study suggests that the cytoxicity of the NMs is dependent on the medium in 
which they are suspended, more specifically, that the cytoxicity is dependent upon 
the protein profile of the hard corona of the particles.  Thus it is the hard corona 
profile that is important in toxicological terms.  However, the nature of the hard 
corona is dependent upon the physical and chemical characteristics of the 
particles.  When developing in vitro assays it is important to keep this in mind, 
that in vitro, particles will associate with serum proteins and so the biological 
identity of the particles will be different from the same particles in vivo, where the 
particles associated with biological fluids such as LLF or blood plasma proteins.  
If in vitro tools are to be relevant in reflecting the in vivo toxicity of particles, this 
must be considered and all the advantages of in vitro cytotoxicity testing (speed, 
cost and elimination of testing on animals) will only be realised if the protein 
corona is taken into account.  As such this research suggests a role for designing 
particles preparation protocols that mimic the corona composition in vivo to better 
study cellular responses in vitro. 
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6.6 Future work 
 
Research on the protein corona is in its infancy and as much as this thesis has 
answered the research questions posed regarding the biological identity of the 
NMs it has also provided additional research questions.  This thesis focused on 
identifying proteins of the corona and investigating how the corona affects the 
cytotoxicity however it would be interesting to examine the nature of the protein 
binding to determine if adsorption of proteins incurs any conformational change 
in the protein tertiary structure.  Given that NMs adsorb specific proteins it would 
be interesting to investigate further how different NMs may affect the levels of 
certain proteins in the body, i.e. would protein adsorption to NMs lead to a 
depletion of critical proteins in the body or could protein adsorption allow for the 
delivery of large amounts of proteins to a target organ.  Having found that it is 
possible to characterise the protein corona future work could also investigate if 
any possible correlation between the proteins profile of a specific particle corona 
and a cytotoxic effect in vitro.  
 
Ultimately as NM toxicological effects are complex and involve a variety of 
factors, future work could always investigate the different modes of action, if/how 
particles are taken up by cells and to what extent the corona plays in uptake in 
various models. This work shows that solely relying on the physicochemical 
effects of NMs without consideration of their physical environment or 
characterisation will lead to erroneous results and to date the published literature 
does find conflicting toxicity results for identical NMs. Thus future work to 
investigate modes of action or uptake in various models as mentioned above will 
need to consider two main points (i) characterisation of the particles in a pertinent 
environment (ii) characterisation of the particles may result in having to alter 
standard in vitro assays to take into account the new information on particle 
characteristics (such as particle adsorption, sedimentation or biological identity in 
different cell culture media).  Indeed this last point on the need to quality control 
or custom designed in vitro cytoxicity assays represents a large body of work 
(given the diversity of NMs in the market) and although it is not the most exciting 
of laboratory work it would be the first step in advancing this field into a more 
harmonious future.  It would allow comparison of toxicological results from 
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laboratories across the world and could help in delivering a consensus or a new 
paradigm on NM toxicity. At the very least such a project would decrease the 
conflicting published literature and aid in comparison of toxicological reports.  
 
6.7 Concluding Remarks 
 
 NM characterisation is paramount in any nanotoxicological investigation. 
 
 It is not sufficient to rely on the NM manufacturers/suppliers 
physicochemical specifications instead characterisation experiments 
should be conducted before the investigation in an environment that best 
represents in vivo behaviour of NMs. 
 
 Given the absence of nano-specific characterisation methods and the 
number of measurable NM parameters (size, morphology, composition, 
charge, etc.) a range of characterisation tools is recommended when 
characterising NMs. 
 
 Toxicity (LDH release) of 45nm iron oxide in a macrophage lines after 4 
hours was only seen at high concentrations (500µg/ml). Toxicity (LDH 
release) was seen for both the 280nm and 45nm iron oxide particle.  After 
twenty four hours exposure toxicity as seen (LDH release) for both 
particle types at 62.5µg/ml.  There was no significant difference between 
the 2 particles. The percentage viability of the macrophages after 
exposure to Fe2O3 280nm and Fe3O4 45nm particles after 24 hours 
exposure showed a dose dependent increase in cytotoxicity as assessed by 
WST-1. 
 
 The cytotoxicity results obtained from the studies with silica particles 
found that the physical properties (size and charge) did have an impact the 
cytoxicity (LDH release and cell viability). 
 
 This thesis shows that the protein profile of the NMs vary depending on 
the NM type size and charge. The quantities of proteins that make up the 
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hard corona vary, not only in type, but in quantity between plasma and 
serum.  
 
 There is a clear difference but also similarities in the biological identity of 
the particles in plasma, serum and in LLF.  
 
 Iron oxide and silica NMs exposed to serum induces the generation of a 
component which can induce significant increases in macrophage 
attraction in vitro compared to serum exposed to PBS and the presence of 
a protein corona can impact this migration. 
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Chapter 8 Appendix 
 
8.1. DLS Measurements 
Table 8.1 Data (averages of n=3) obtained from Malvern zetasizer analysis. 
Replicate DLS measurements were carried out on 280, 22 and 45nm particles at 
100, 10 and 1µg/ml in water, RPMI and in RPMI with 0.1% BSA. Results show Z 
average, Standard error of all three measurements. Measurements were carried 
out as described in 2.2.2.3. 
Sample 
ID 
Average SE Sample 
ID 
Average SE Sample ID Average SE 
280nm 
in water  
100 
µg/ml 
318.70 9.77 280nm 
RPMI 
100 
µg/ml 
1029.60 151.
40 
280nm 100 
µg/ml 
RPMI + 
0.1% BSA 
507.98 57.93 
280nm 
in water  
10 µg/ml 
292.73 3.73 280nm 
RPMI 
10 µg/ml 
565.10 4.60 280nm 10 
µg/ml 
RPMI + 
0.1% BSA 
419.4 27.43 
280 nm 
in water  
1 µg/ml 
573.91 104.
32 
280nm 
RPMI 
1 µg/ml 
512.88 0.00 280nm 1 
µg/ml 
RPMI 
+0.1% 
BSA 
439.75 52.85 
22nm in 
water  
100 
µg/ml 
401.40 39.2
4 
22nm 
RPMI 
100 
µg/ml 
489.55 97.1
5 
22nm 100 
µg/ml 
RPMI + 
0.1% BSA 
518.6 63.53 
22nm in 
water  
10 µg/ml 
309.17 23.3
3 
22nm 
RPMI 
10 µg/ml 
627.65 32.7
5 
22nm 10 
µg/ml 
RPMI + 
0.1% BSA 
449 48.48 
22nm in 
water  
1 µg/ml 
493.44 64.5
6 
22nm 
RPMI 
1 µg/ml 
605.30 93.5
1 
22nm 1 
µg/ml 
RPMI + 
0.1% BSA 
511.4 59.19 
45nm in 
water 
100 
µg/ml 
1613.50 80.5
0 
45nm 
RPMI 
100 
µg/ml 
1725.50 34.5
0 
45 nm 100 
µg/ml in 
RPMI 
+0.1% 
BSA 
1648.33 68.42 
45nm in 
water  
10 µg/ml 
450.35 86.6
5 
45nm 
RPMI 
10 µg/ml 
1040.03 69.2
5 
45 nm 10 
µg/ml in 
RPMI 
+0.1% 
BSA 
791.87 91.20 
45nm in 
water  
1 µg/ml 
308.65 15.3
5 
45nm 
RPMI 
1 µg/ml 
714.54 82.1
1 
45nm 1 
µg/ml in 
RPMI + 
0.1% BSA 
324.32 80.07 
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8.2 Differential Centrifugal Sedimentation Analysis 
 
 
Figure 8.1 Differential centrifugal sedimentation analysis of 22nm and 280nm 
Fe2O3 and 45 nm Fe3O4 particles as described in 2.3.7. Here we can see the 22nm 
and 280nm data are similar peaking at 289nm and 282.2 nm respectively. 
 
8.3 DLS Study- Effect of pH on Hydrodynamic Diameter.  
 
 
Figure 8.2: As described in 2.4 image showing increasing hydrodynamic 
diameter of 280nm iron particles at decreasing pH. ___280 nm at 
pH7____280 nm at pH3_______280nm at pH2. 
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8.4 EDX Measurements Replicates 
 
8.4.1. EDX Measurements- 280nm Fe2O3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 8.3 Replicates of EDX mesurments of 280nm Fe2O3 particles as described 
in 2.23. 
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8.4.2. EDX Measurements- 22nm Fe2O3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.4 Replicates of EDX mesurments of 22nm Fe2O3 particles as described 
in 2.23. 
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8.4.3. EDX Measurements- 45nm Fe3O4 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.5 Replicates of EDX mesurments of 45nm Fe3O4 particles as described 
in 2.23. 
 
 
 
 
213 
 
8.5 Interference of 280nm Fe2O3 Particles on Absorbance Readings as Seen 
During WST-1 Assay (n=1) 
 
 
Figure 8.6 showing absorbance readings on a MRX plate reader at 440nm for 
WST-1 assay samples before and after removal of NM ( by centrifugation) as 
described in 3.4.  Particle interference in in vitro assays is an issue that needs to 
be addressed in the experimental design.  For both the LDH and the WST-1 assay 
it was decided to centrifuge each sample to remove NM before measuring 
absorbance in order to avoid and overestimation of viability. The graph show the 
difference in absorbance readings between samples where NM have and have not 
been removed.  
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8.6 Light Microscopy Images of J774.A1 Cells after Exposure to 280nm 
Fe2O3 Particles. 
 
A 96 well plate was seeded with 5*10
4
 J774.A1 cells and incubated for 48 hours, 
after which time there were exposed to a 500µg/ml r 125µg/ml  280nm  iron oxide 
particles in RPMI  imaged over various time points. 
A 
(i)   (ii)   (iii)   (iv) 
 
B 
(i)   (ii)   (iii)       (iv) 
 
 
Figure 8.7  Light microscopy (20x) images of J774.A1 macrophages after 
exposure to Fe2O3 particles for (a) 24 hours and ( b) 48 hours,  where (i) control 
(ii) exposure to 0.5mg/ml (iii) exposure to 125µg/ml and (iv) exposure to 
125µg/ml in RPMI with 1% BSA , as described in 3.3.1 
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8.7 SDS-PAGE Gels 
 
(a)  Analysis of the protein corona by SDS-PAGE after incubation in 10% plasma 
as described in 3.2.6. The first two lanes show the proteins of the Fe2O3
 
and 
Fe3O4 10% plasma corona. Lane 6 and 7 show 50nm Si02-Nh2 with 10% plasma 
corona. Lane 2 and 3 are found in figure 3.3 and lanes 6 and 7 in figure 4.2.  
1. 
Ladder 
2. 
Fe203 
(280nm) 
3. 
Fe304 
(45nm) 
4. 
SiO2 
(50nm) 
5. 
SiO2 
(50nm) 
6. 
SiO2 
(50nm) 
7. 
SiO2-
Nh2 
(50nm) 
 
 
(b)  Analysis of the protein corona by SDS-PAGE after incubation with LLF and 
then in 10% plasma as described in 3.2.6.  
1. 
ladder 
2. 
Fe203 
280nm 
3. 
Fe304 
45nm 
4. 
SiO2 
200nm 
5. 
SiO2-Nh2 
200nm 
6. 
SiO2-
Nh2 
50nm 
7. 
SiO2-
Nh2 
50nm 
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(c) Analysis of the protein corona by SDS-PAGE after incubation with 10% 
plasma as described in 3.2.6. 
1. 
ladder 
2. 
Fe203 
280nm 
3. 
Fe304
45nm 
4. 
SiO2 
 200nm 
5. 
SiO2-Nh2 
200nm 
6. 
SiO2-
Nh2/LLF
200nm 
7. 
SiO2-
Nh2/LLF 
200nm 
 
 
(d) Analysis of the protein corona by SDS-PAGE after incubation with 55% 
plasma as described in 3.2.6.  
1. 
ladder 
2. 
Fe203 
280nm 
3. 
Fe304 
45nm 
4. 
SiO2 
200nm 
5. 
SiO2 
 50nm 
6. 
SiO2-Nh2 
200nm 
7. 
6. 
SiO2-
Nh2/ 
50nm 
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(e)  Analysis of the protein corona by SDS-PAGE after incubation with LLF and 
then in 55% plasma as described in 3.2.6.  
ladder 2. 
Fe203 
280nm 
3. 
Fe304 
45nm 
4. 
SiO2 
200nm 
5. 
SiO2 
 50nm 
6. 
SiO2-
Nh2 
200nm 
7. 
6. 
SiO2-Nh2/ 
50nm) 
 
 
(f)  Analysis of the protein corona by SDS-PAGE after incubation 10% serum as 
described in 3.2.6.  
ladder 2. 
Fe203 
280nm 
3. 
Fe304 
45nm 
4. 
SiO2 
200nm 
5. 
SiO2 
 50nm 
6. 
SiO2-
Nh2 
200nm 
7. 
6. 
SiO2-Nh2/ 
50nm) 
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(g)  Analysis of the protein corona by SDS-PAGE after incubation with LLF and 
then  in 10% serum as described in 3.2.6.  
ladder 2. 
Fe203 
280nm 
3. 
Fe304 
45nm 
4. 
SiO2 
200nm 
5. 
SiO2 
 50nm 
6. 
SiO2-
Nh2 
200nm 
7. 
6. 
SiO2-Nh2/ 
50nm) 
 
 
Figure 8.8 (a-f) SDS-PAGE gels prepared as described in Chapter 3 and Chapter 
4 methods and materials (3.2.6; 4.4.2). These above images are supplementary to 
the information and graphs found in 3.3.5 and 4.3.3. 
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8.8 Proteins Identified by Mass Spectroscopy after SDS-PAGE Analysis of 
the Nanomaterial Corona.  Samples Prepared as Described in 3.2.4.  
 
Briefly after staining using a mass spectroscopy compatible staining procedure, 
selected lanes (280nm Fe2O3 in 10% plasma, 10% serum corona, and after pre 
incubation in LLF lanes) were trypsin digested and analysed using MS. The tables 
below show the results from Mass Specectroscopy 
280nm Fe2O3 with 
Associated 
Plasma Hard 
Corona (10%P) 
MW Acc No. XC Score P EP % C 
Peptide 
Hit 
Apolipoprotein B-
100  515.28 P04114 350.29 1.11E-15 12.80 35  
Complement C3  187.03 P01024 260.30 2.00E-13 24.60 27  
Serum albumin  69.32 P02768 110.30 2.40E-11 20.70 12  
Apolipoprotein(a)  500.99 P08519 60.27 2.86E-09 18.20 6  
Complement C4-A  192.65 P0C0L4 50.27 3.07E-07 3.60 5  
Plasma protease  55.12 P05155 50.22 8.03E-07 11.60 5  
Histidine-rich 
glycoprotein  59.54 P04196 50.20 2.28E-10 14.10 5  
Ig mu chain 49.27 P01871 40.19 8.28E-07 13.50 4  
Coagulation factor 
XI 70.063 P03951 30.23 7.02E-09 8.50 3  
 Coagulation factor 
XII  67.77 P00748 20.29 1.25E-13 5.90 2  
Actin, cytoplasmic  41.71 P60709 20.28 5.42E-13 12.80 2  
 Hemoglobin 
subunit beta  15.989 P68871 20.22 7.22E-07 23.80 2  
 Hemoglobin 
subunit alpha  15.25 P69905 20.20 2.06E-07 21.80 2  
Ig kappa chain C 
region 11.60 P01834 20.16 1.19E-06 17.00 2  
 Plasminogen  90.51 P00747 10.26 4.60E-13 2.70 1  
 Trypsin-3  32.50 P35030 10.25 1.49E-06 6.60 1  
Complement C1q 
subcomponent 
subunit C 25.76 P02747 10.23 7.06E-07 7.30 1  
Apolipoprotein C-
II  11.28 P02655 10.22 1.36E-09 20.80 1  
Actin, aortic 
smooth muscle  41.98 P62736 10.20 5.62E-09 4.20 1  
Ig heavy chain V-
III region BRO  13.22 P01766 10.20 5.71E-09 15.80 1  
Ig gamma-1 chain 
C region  36.08 P01857 10.20 4.22E-11 4.80 1  
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 Hornerin 282.22 Q86YZ3 10.18 2.02E-07 1.70 1  
Apolipoprotein A-I  30.76 P02647 10.17 4.45E-07 5.20 1  
Apolipoprotein C-
III  10.84 P02656 10.17 1.76E-06 16.20 1 
Vitronectin  54.27 P04004 10.16 1.71E-08 3.10 1 
Platelet factor 4 
variant 11.54 P10720 10.15 2.13E-04 14.40 1 
Alpha-1-antitrypsin  46.71 P01009 10.13 4.76E-07 3.30 1 
 
 
280nm Fe2O3 
LLF/10% Plasma MW Acc. No.  XC Score PEP %C 
Peptide 
Hit 
Complement C3  187.03 P01024 440.30 1.55E-14 39.00 48 
Serum albumin  69.32 P02768 230.29 6.91E-12 45.50 25 
Apolipoprotein B-
100  515.283. P04114 190.29 9.58E-11 7.30 19 
Filamin-A  280.56 P21333 170.28 7.63E-11 12.40 17 
Myosin-9  226.39 P35579 120.28 1.09E-09 9.60 12 
Talin-1  269.59 Q9Y490 80.34 2.45E-12 6.10 8 
Apolipoprotein(a)  500.99 P08519 50.20 5.33E-09 25.60 5 
Ig kappa chain C 
region  11.60 P01834 40.25 5.24E-10 67.00 5 
 Fibrinogen alpha 
chain  94.91 P02671 40.23 6.84E-07 6.60 4 
Actin, cytoplasmic 
1  41.70 P60709 30.31 1.43E-10 16.30 3 
Hemoglobin 
subunit beta  15.98 P68871 30.23 1.49E-08 33.30 3 
Alpha-actinin-1  102.99 P12814 30.23 2.90E-11 5.20 3 
Integrin beta-3  87.00 P05106 30.22 6.62E-10 6.50 3 
Actin, aortic 
smooth muscle  41.98 P62736 30.21 5.77E-11 8.50 4 
 Ig lambda-1 chain 
C regions  11.34 P0CG04 30.20 6.75E-06 46.20 3 
Thrombospondin-1  129.29 P07996 30.19 1.23E-04 4.30 3 
 Apolipoprotein A-
I  30.75 P02647 30.16 1.83E-06 10.10 3 
Apolipoprotein A-
IV  45.37 P06727 20.26 1.10E-08 7.10 2 
Ig gamma-1 chain 
C region 36.08 P01857 20.26 2.91E-11 10.60 2 
Apolipoprotein C-
II  11.27 P02655 20.25 4.55E-14 20.80 2 
Band 3 anion 
transport protein  101.72 P02730 20.21 1.25E-09 3.70 2 
Integrin alpha-IIb  113.30 P08514 20.20 1.76E-07 3.30 2 
Hemoglobin 
subunit alpha  15.24 P69905 20.19 2.00E-10 31.00 2 
Complement C4-A  192.64 P0C0L4 20.17 9.94E-05 1.10 2 
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 Ig mu chain C 
region  49.27 P01871 20.17 1.35E-06 6.90 2 
 Histone H2B type 
1-B  13.94 P33778 20.17 9.28E-08 11.90 2 
Alpha-2-
macroglobulin  163.18 P01023 20.17 8.02E-07 1.80 2 
 
 
280nm Fe2O3 
LLF/10% Serum Acc No MW Score P EP %C 
Peptide  
Hits 
Serum albumin  P02768 69.32 170.28 1.27E-09 35.80 18  
Apolipoprotein A-I  P02647 30.76 40.20 3.81E-10 17.60 4  
Alpha-1-antitrypsin  P01009 46.71 30.25 3.92E-12 12.20 3  
 Ig gamma-1 chain 
C region P01857 36.08 30.24 9.62E-12 17.58 3  
Ig kappa chain C 
region  P01834 11.60 20.25 4.71E-12 32.08 2  
 Glyceraldehyde-3-
phosphate 
dehydrogenase  P04406 36.030.4 20.20 4.45E-09 11.34 2  
Hemoglobin 
subunit alpha  P69905 15247.9 20.20 7.68E-10 21.83 3  
 Desmoglein-1  Q02413 113676.0 20.19 8.22E-10 3.24 2 
Thrombospondin-1  P07996 129299.2 20.18 2.21E-07 2.22 2  
 Complement C3  P01024 187029.3 20.18 2.49E-05 2.16 2  
 Alpha-1-acid P02763 23496.8 10.25 2.44E-07 7.46 1  
280nm Fe2O3 with 
Associated Serum 
Hard Corona 
(10%S) Acc No. MW Score PEP %C 
Peptide 
Hits 
Serum albumin P02768 69.32 60.19 2.71E-12 10.80 7  
Trypsin-3 P35030 32.50 10.25 1.19E-06 6.60 2  
 Apolipoprotein A-
I  P02647 30.75 10.20 4.20E-10 6.00 1  
Desmoglein-1  Q02413 113.67 10.20 3.98E-05 1.50 1 
 Cystatin-A  P01040 10.99 10.19 6.70E-06 18.40 1 
Protein S100-A9  P06702 13.23 10.18 7.74E-04 13.20 1 
Fibronectin  P02751 262.45 10.17 8.90E-04 0.80 1 
Dermcidin  P81605 11.27 10.15 3.06E-05 12.70 1 
Ubiquitin-60S 
ribosomal protein 
L40  P62987 14.71 10.14 2.40E-04 12.50 1 
Hemoglobin 
subunit alpha  P69905 15.24 10.14 3.62E-04 10.60 1 
Desmoplakin  P15924 331.56 10.13 8.10E-05 0.30 1 
Lysozyme C  P61626 16.52 10.13 1.84E-06 8.10 1 
Glial fibrillary 
acidic protein P14136 49.84 8.15 1.81E-05 2.50 1 
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glycoprotein 1  
Hornerin  Q86YZ3 282225.7 10.24 2.27E-07 1.68 1  
Trypsin-3  P35030 32508.0 10.24 1.06E-07 6.58 2  
Fibronectin  P02751 262457.6 10.21 3.17E-06 0.80 1  
Ig gamma-2 chain 
C region  P01859 35877.8 10.18 3.80E-10 4.91 1  
Transthyretin  P02766 15877.1 10.17 1.11E-08 8.84 1  
 Antithrombin-III  P01008 52569.0 10.16 6.03E-05 2.37 1  
 Hemoglobin 
subunit beta  P68871 15988.3 10.16 3.74E-04 12.93 1  
Dermcidin  P81605 11276.8 10.16 1.65E-05 12.73 1  
Apolipoprotein C-
III  P02656 10845.5 10.16 3.37E-06 16.16 1  
 Alpha-2-
macroglobulin  P01023 163187.4 10.15 3.96E-05 0.95 1  
 Tetranectin  P05452 22552.3 10.14 8.16E-05 5.94 1  
 Apolipoprotein B-
100  P04114 515283.6 10.14 6.51E-05 0.33 1  
 Serotransferrin  P02787 77013.7 10.13 2.01E-05 2.01 1  
 Glial fibrillary 
acidic protein  P14136 49849.7 8.15 1.97E-05 2.55 1 
 
 
SiO2 (200nm) with 
10% P Corona Acc No MW 
XC  
Score %C PEP 
Peptide       
Hits 
Apolipoprotein B-
100  P04114 515.28 480.32 16.31 
2.55E-
14 48 
Complement C3  P01024 187.03 398.30 35.30 
9.99E-
15 43 
 Histidine-rich 
glycoprotein  P04196 59.54 160.31 37.71 
6.66E-
11 58 
Complement C4-A  P0C0L4 192.65 130.29 12.44 
8.61E-
12 13 
 Serum albumin  P02768 69.32 110.28 21.51 
6.44E-
09 12 
 Apolipoprotein A-
I  P02647 30.76 80.23 31.46 
2.98E-
09 10 
C4b-binding 
protein alpha chain  P04003 66.99 60.24 14.07 
5.74E-
07 6 
Apolipoprotein(a)  P08519 500.99 40.23 10.95 
9.15E-
07 4 
Apolipoprotein A-
IV  P06727 45.37 30.22 12.12 
3.51E-
11 3 
Complement 
component C9  P02748 63.13 30.16 6.80 
2.58E-
06 3 
 Apolipoprotein C-
II  P02655 11.27 20.26 20.79 
1.76E-
10 2 
 Actin, aortic 
smooth muscle  P62736 41.98 20.20 8.49 
9.93E-
09 2 
 Ig mu chain C 
region  P01871 49.27 20.19 6.86 
1.61E-
06 2 
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Hemoglobin 
subunit beta  P68871 15.98 20.18 23.81 
1.99E-
08 2 
 Ig kappa chain C 
region  P01834 11.60 20.17 32.08 
9.41E-
09 3 
 Actin, cytoplasmic 
1  P60709 41.70 10.28 8.00 
4.87E-
10 1 
 Complement C4-B  P0C0L5 192.67 10.27 1.55 
6.01E-
11 1 
 Ig heavy chain V-
III region BRO  P01766 13.21 10.21 15.83 
4.42E-
05 1 
 Apolipoprotein C-
III  P02656 10.84 10.20 16.16 
2.10E-
05 1 
Band 3 anion 
transport protein  P02730 101.72 10.20 1.87 
5.26E-
04 1 
 Ig gamma-1 chain 
C region P01857 36.08 10.20 4.85 
4.37E-
09 1 
 Trypsin-3 P35030 32.50 10.20 6.58 
4.50E-
06 2 
Ig gamma-2 chain 
C region P01859 35.87 10.19 4.91 
7.93E-
06 1 
 Protein S100-A9  P06702 13.23 10.18 13.16 
2.35E-
04 1 
Fibrinogen alpha 
chain  P02671 94.91 10.17 1.62 
2.54E-
08 1 
Uromodulin-like 1  Q5DID0 144.20 10.17 2.43 
2.49E-
04 1 
 Desmoplakin  P15924 331.56 10.16 0.49 
7.10E-
04 1 
 Ubiquitin-60S 
ribosomal protein 
L40  P62987 14.71 10.16 12.50 
2.35E-
04 1 
 Complement C5  P01031 188.18 10.15 0.66 
6.57E-
04 1 
 Putative beta-
actin-like protein 3  
Q9BYX
7 41.98 10.15 2.93 
2.04E-
04 1 
Coagulation factor 
XI  P03951 70.06 10.14 1.92 
2.53E-
04 1 
 Ig lambda-2 chain 
C regions  P0CG05 11.28 10.14 17.92 
7.30E-
05 1 
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SiO2 (200nm) PC 
and 10% P 
Corona Acc No MW 
XC  
Score % C PEP 
Peptide 
Hits 
Apolipoprotein B-
100  P04114 515.28 590.31 21.60 
1.00E-
30 59 
 Complement C3  P01024 187.03 300.31 28.40 
5.55E-
15 30 
Serum albumin  P02768 69.32 200.32 46.10 
8.88E-
15 21 
Histidine-rich 
glycoprotein  P04196 59.54 100.28 26.30 
1.69E-
11 11 
Hemoglobin 
subunit beta  P68871 15.99 70.21 44.90 
7.97E-
12 7 
 Apolipoprotein(a)  P08519 500.99 40.28 19.00 
3.33E-
15 4 
 Myosin-9  P35579 226.39 40.26 3.50 
5.24E-
11 4 
Serotransferrin  P02787 77.01 40.26 9.30 
4.71E-
10 4 
Filamin-A  P21333 280.56 40.25 2.70 
2.08E-
10 4 
 Alpha-2-
macroglobulin  P01023 163.18 40.20 4.60 
1.27E-
11 4 
Actin, cytoplasmic 
1  P60709 41.70 30.31 18.40 
1.00E-
30 3 
 Ig kappa chain C 
region  P01834 11.60 20.28 33.00 
3.34E-
09 2 
Platelet basic 
protein P02775 13.88 20.26 22.70 
1.25E-
09 2 
Apolipoprotein C-
II  P02655 11.27 20.25 20.80 
5.08E-
09 2 
Actin, aortic 
smooth muscle  P62736 41.98 20.22 4.20 
1.49E-
05 2 
Ig gamma-1 chain 
C region  P01857 36.08 20.22 10.90 
7.45E-
10 2 
 Integrin beta-3  P05106 87.00 20.22 4.20 
2.83E-
06 2 
 Integrin alpha-IIb  P08514 113.30 20.20 3.80 
1.14E-
06 2 
 Complement C5  P01031 188.18 20.20 2.10 
9.91E-
08 2 
Apolipoprotein A-I  P02647 30.75 20.19 10.50 
4.97E-
08 2 
Hemoglobin 
subunit alpha  P69905 15.24 20.18 21.80 
4.91E-
08 2 
Ig mu chain C 
region  P01871 49.27 20.18 6.90 
8.37E-
09 2 
Vinculin  P18206 123.72 10.26 1.90 
7.33E-
14 1 
 Prothrombin  P00734 69.99 10.25 2.60 
6.68E-
09 1 
Alpha-1-acid 
glycoprotein 1  P02763 23.49 10.23 7.50 
1.10E-
09 1 
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Thrombospondin-1  P07996 129.29 10.22 1.80 
4.30E-
13 1 
 Myosin-11  P35749 227.19 10.19 0.80 
1.75E-
06 1 
Fibrinogen alpha 
chain  P02671 94.91 10.19 1.60 
2.36E-
10 1 
Ig kappa chain V-
III region SIE  P01620 11.76 10.19 16.50 
4.23E-
04 1 
Plasminogen  P00747 90.51 10.19 2.70 
2.37E-
05 1 
Alpha-actinin-1  P12814 102.99 10.18 1.80 
5.65E-
06 1 
 Myosin-10  P35580 228.85 10.18 0.90 
2.76E-
04 1 
 Trypsin-3  P35030 32.50 10.18 6.60 
5.19E-
04 2 
Haptoglobin  P00738 45.17 10.18 3.40 
1.35E-
07 1 
Tubulin alpha-1B 
chain  P68363 50.11 10.17 3.10 
1.16E-
04 1 
 Putative beta-
actin-like protein 3  
Q9BYX
7 41.98 10.16 2.90 
1.29E-
06 1 
 Histone H2A type 
1-B/E  P04908 14.12 10.15 14.60 
6.76E-
05 1 
 Protein S100-A9  P06702 13.23 10.14 13.20 
9.56E-
04 1 
 Apolipoprotein A-
IV  P06727 45.37 10.14 3.50 
2.03E-
04 1 
Complement 
component C9  P02748 63.13 10.14 2.30 
3.46E-
04 1 
 Talin-1  Q9Y490 269.59 10.14 0.40 
1.59E-
04 1 
 Apolipoprotein C-
III  P02656 10.84 10.13 16.20 
1.02E-
05 1 
 U5 small nuclear 
ribonucleoprotein 
200 kDa helicase  O75643 244.35 10.13 0.80 
2.64E-
04 1 
Beta-actin-like 
protein 2  Q562R1 41.97 8.13 4.80 
8.69E-
05 1 
 
SiO2 (200nm)  
10% s Corona Acc No MW XScore %C PEP 
Peptide 
Hits 
Serum albumin  P02768 69.32 60.21 12.32 
8.79E-
10 8 
 Apolipoprotein B-
100  P04114 515.28 30.18 0.88 
2.29E-
06 3  
 Apolipoprotein A-
I  P02647 30.75 30.17 11.24 
2.45E-
08 3 
Heat shock protein 
HSP 90-alpha  P07900 84.60 28.25 5.74 
3.12E-
10 3 
Thrombospondin-4  P35443 105.80 20.25 3.54 
1.29E-
07 2 
 Fibronectin  P02751 262.45 20.18 1.38 
2.44E-
05 2 
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Complement C3  P01024 187.02 20.15 2.53 
1.50E-
06 2 
 Trypsin-3  P35030 32.50 10.25 6.58 
3.35E-
08 2 
 Hornerin  
Q86YZ
3 282.22 10.20 1.68 
1.16E-
08 1 
 Ig gamma-1 chain 
C region  P01857 36.08 10.20 6.67 
6.02E-
08 1 
Apolipoprotein C-
III  P02656 10.84 10.18 16.16 
2.73E-
04 1 
Actin, cytoplasmic 
1  P60709 41.70 10.17 4.80 
1.38E-
06 1 
 Cartilage 
oligomeric matrix 
protein  P49747 82.80 10.15 2.11 
2.41E-
04 1 
 Dermcidin  P81605 11.27 10.15 12.73 
2.65E-
08 1 
Vitronectin P04004 54.27 10.14 3.10 
5.06E-
04 1 
Hemoglobin 
subunit alpha  P69905 15.24 10.13 10.60 
5.71E-
07 3 
Putative heat shock 
protein HSP 90-
beta 2 Q58FF8 44.32 10.13 3.10 
4.79E-
06 1 
 Secreted 
phosphoprotein 24 
OS=Homo sapiens 
GN=SPP2 PE=1 
SV=1 Q13103 24.32 10.13 5.70 
5.93E-
05 1 
 Glial fibrillary 
acidic protein  P14136 49.84 8.15 2.50 
4.64E-
06 1 
 
 
8.9 LDH Release from J774.A1 Macrophages after Exposure to 280 nm and 
22nm Fe2O3 Particles (as described in 3.2.7) 
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8.10 Percentage LDH Release from of J774.A1 Macrophages after Exposure 
to Fe2O3 280nm and 45NM Fe3O4 Particles for 4 Hours.  
 
 
 
Figure 8.9 Values represent the means of 3 experiments ± SD There is 
no significant differences between exposure to the particle panel and the 
cells in media only expect at for the 45nm Fe3O4 Particles at 500µg/ml 
where P=0.0445 
 
 
 
 
 
 
 
 
 
 
 
 
* 
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8.11 SDS-PAGE Gel Lanes (LLF) 
 
 
Figure 8.10 SDS-Gel lane shows Proteins Associated with 280nm Fe2O3 and the 
45nm Fe3O4 LLF corona. Proteins were separated as described in materials and 
methods section 3.2.4 and 3.2.5.  
 
8.12 Macrophage Migration in Transwell Chemotaxis Assay 
 
(a)Macrophage migration in transwell chemotaxis assay towards RPMI culture 
media and RPMI with 10% FCS after 3 and 24 hours. (b) Macrophage (serum 
starved and non serum starved) migration in transwell chemotaxis assay towards 
serum treated with 65.5µg/ml Fe2O3 particles. 
(a) (b)  
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8.13 Experimental Chemotaxis Assay 
(a) 
 
1. 2.   
(i) Serum activation with 62.5µg/ml Fe2O3.  
 
1. 2.   
(ii) Serum activation with 62.5µg/ml Fe2O3 10%P corona 
 
1. 2.   
(iii) Serum activation with 62.5µg/ml Fe2O3 10%S corona 
1. 2.   
(iv) Serum activation with 62.5µg/ml Fe2O3 LLF corona 
 
Figure 8.11(a) Microfluidic analysis of cells exposed to Fe2O3 particle activated 
serum. Image one at 0 seconds and image two at 200 Seconds.  The graph shows 
the percentage of remaining cells, the red line represent the cells that migrated 
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(b) 
 
1. 2   
(i) Serum activation with 62.5µg/ml Fe3O4.  
 
1. 2.   
(ii) Serum activation with 62.5µg/ml Fe3O4 10%P corona 
 
1. 2   
(iii) Serum activation with 62.5µg/ml Fe3O4 10%S corona 
 
1. 2   
(iv) Serum activation with 62.5µg/ml Fe3O4 LLF corona 
 
Figure 8.11(b) Microfluidic analysis of cells exposed to Fe3O4 particle activated 
serum. Image 1 at 0 Seconds and image 2 at 200 Seconds. The graph shows the 
percentage of remaining cells, the red line represent the cells that migrated. 
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(c) 
 
1. 2.   
(i) Serum activation with 62.5µg/ml Silica NM (200nm) 
 
1. 2.   
(ii) Serum activation with 62.5µg/ml 200nm Silica NM (200nm) NM 10%P 
corona 
 
1. 2.   
(iii) Serum activation with 62.5µg/ml Silica (200nm) NM 10%S corona 
 
1. 2.   
(iv)Serum activation with 62.5µg/ml Si (200nm) NM LLF corona 
 
Figure 8.11(c):  Microfluidic analysis of cells exposed to 200nm silica activated 
serum image 1 at 0 Seconds and image 2 at 200 Seconds. The graph shows the 
percentage of remaining cells, the red line represent the cells that migrated. 
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(d) 
1. 2   
(i) Serum activation with 62.5µg/ml Si NM (50nm)  
 
1. 2.   
(ii) Serum activation with 62.5µg/ml 200nm Si (50nm) NM 10%P corona 
 
1. 2.   
(iii) Serum activation with 62.5µg/ml Si (50nm) NM 10%S corona 
 
1. 2   
(iv)Serum activation with 62.5µg/ml Si (50nm) NM LLF corona 
 
Figure 5.8(d) Microfluidic analysis of cells exposed to 50nm silica activated 
serum. Image 1 at 0 Seconds and image 2 at 200 Seconds. The graph shows the 
percentage of remaining cells, the red line represent the cells that migrate. 
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8.14 Confocal Image-Supplementary Data to Section 5.3.4  
 
 
 
 
 
Figure 8.12  Confocal Imaging taken using 63X oil immersion lens 
showing J774.A1 cells exposed to serum activated with (a) Fe2O3 
particles (b) Fe3O4 particles (c)Channel after cells have migrated.  The 
cells imaged were those remaining on the microfluidic Cellix substrate 
chip from microfluidic analysis.  Cells were fixed in 3.7% 
paraformaldehyde and stained with Phalloidin-FITC and Hoechst. 
Images were obtained on a Zeiss Laser Scanning Microscope (LSM 510 
META from Zeiss, Germany).  
